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Decoding microbial metabolism is of great importance in revealing the
mechanisms governing the physiology of microbes and rewiring the cellular
functions

in

transcriptomics,

metabolic

engineering.

proteinomics

and

Complementing

metabolomics

analysis

the
of

genomics,
microbial

metabolism, fluxomics tools can measure and simulate the in vivo enzymatic
reactions as direct readouts of microbial metabolism. This dissertation develops
and applies broad-scope tools in metabolic flux analysis to investigate metabolic
insights of non-model environmental microorganisms.
13

C-based pathway analysis has been applied to analyze specific carbon

metabolic routes by tracing and analyzing isotopomer labeling patterns of
different metabolites after growing cells with

13

C-labeled substrates. Novel

pathways, including Re-type citrate synthase in tricarboxylic acid cycle and
.
ii

citramalate pathways as an alternate route for isoleucine biosynthesis, have been
identified

in

Thermoanaerobacter

microorganisms.

Via

the

same

X514

approach,

and
the

other
utilizations

environmental
of

diverse

carbon/nitrogen substrates and productions of hydrogen during mixotrophic
metabolism in Cyanothece 51142 have been characterized, and the medium for a
slow-growing bacterium, Dehalococcoides ethenogenes 195, has been optimized.
In addition,

13

C-based metabolic flux analysis has been developed to

quantitatively profile flux distributions in central metabolisms in a green sulfur
bacterium,

Chlorobaculum

tepidum,

and

thermophilic

ethanol-producing

Thermoanaerobacter X514. The impact of isotope discrimination on

13

C-based

metabolic flux analysis has also been estimated.
A constraint-based flux analysis approach was newly developed to
integrate the bioprocess model into genome-scale flux balance analysis to
decipher the dynamic metabolisms of Shewanella oneidensis MR-1. The suboptimal metabolism and the time-dependent metabolic fluxes were profiled in a
genome-scale metabolic network. A web-based platform was constructed for
high-throughput metabolic model drafting to bridge the gap between fast-paced
genome-sequencing and slow-paced metabolic model reconstruction. The
platform provides over 1,000 sequenced genomes for model drafting and diverse
customized tools for model reconstruction. The in silico simulation of flux
distributions in both metabolic steady state and dynamic state can be achieved via

.
iii

flux balance analysis and dynamic flux balance analysis embedded in this
platform.
Cutting-edge fluxomics tools for functional characterization and metabolic
prediction continue to be developed in the future. Broad-scope systems biology
tools with integration of transcriptomics, proteinomics and fluxomics can reveal
cell-wide regulations and speed up the metabolic engineering of non-model
microorganisms for diverse bioenergy and environmental applications.

.
iv
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Chapter 1
Introduction
1.1 Systems biology of microbial metabolism
Microbial metabolism is a complex biological system that involves the
interactions of thousands of genes, proteins and metabolites (1). Toward a systemlevel investigation of microbial metabolism, high-throughput “omics” tools are
being developed and applied to capture the behaviors of different metabolic
components. Transcriptomics, proteomics and metabolomics tools have been used
to characterize the responses of gene expressions, protein productions and
metabolite

concentrations,

respectively,

to

metabolic

perturbations.

In

complementary to the aforementioned omics tools, fluxomics analysis has become
instrumental in the systems biology of microbial metabolism. In fluxomics study,
the metabolite turnover rates (i.e. metabolic fluxes) are measured or predicted as a
direct readout of the functional output of metabolism (2). By developing and
applying diverse fluxomics tools, the novel metabolic features in environmental
microorganisms can be revealed and the knowledge-based rewiring of cellular
functions can be achieved in metabolic engineering.
Fluxomics tools are often categorized into two groups based on the
principles of design: constraint-based metabolic flux analysis and

13

C-based

pathway and flux analysis (Figure 1.1). Constraint-based metabolic flux analysis
.
1

profiles the “optimal” microbial metabolisms for in silico simulations and
predictions. Three components are utilized to find intracellular fluxes in this
fluxomics approach: the stoichiometry of the metabolic reactions in a
reconstructed metabolic model, an objective function based on prior knowledge of
microbial metabolism, and a series of boundary conditions imposed on metabolic
reactions (3). In comparison,

13

C-based pathway and flux analysis measures in

vivo operation of a metabolic network. It is carried out by culturing microbes with
defined

13

C-labeled carbon source, tracing the transitional paths of the labeled

atoms between metabolites in the biochemical network, and analyzing the
labeling profiles in various metabolites both qualitatively and quantitatively.

13

C-

based pathway and flux analysis provides the most accurate readouts of microbial
metabolisms (4).
1.2 Constraint-based metabolic flux analysis
Flux balance analysis (FBA) is commonly used for constraint-based
metabolic flux analysis. To formulate a FBA problem, the metabolic model of a
target microorganism, often in genome scale, needs to be reconstructed (3). A
draft metabolic model is first constructed based on genome annotation, which is
then iteratively refined by adjusting the metabolic functionality to fill the gaps
between model simulations and experimental observations (5). From the
reconstructed metabolic model, the stoichiometry matrix S is generated in FBA,
with each row in S representing one metabolite and each column in S representing
.
2

one metabolic flux. The vector of metabolic fluxes, v, follows S ∙ v = 0 under
metabolic steady state and is constrained within feasible ranges identified from
the physical, chemical and biological characteristics (e.g., thermodynamic
directionality, and enzyme capacity). Since the FBA problem is normally
underdetermined with a larger number of variables (i.e., reactions) than that of
equations, an objective function (e.g., maximizing growth rate) is assumed for the
microbial metabolism to pinpoint the unique flux distributions in the metabolic
network. The FBA is constructed as a linear programming (3,6):

max c T v
s.t. S v 0
lb

v ub

where c is a vector that represents the objective function in FBA.
As a mathematical approach for in silico simulation of microbial
metabolism, FBA is equipped with a strong predictive capability to prove or
disprove various assumptions in systems biology of microbial metabolism.
However, since FBA relies on a biologically appropriate objective function to
quantify the flow of metabolites through metabolic network, it cannot always give
realistic metabolic readouts due to the lack of a priori knowledge of microbial
metabolism (7).
1.3 13C-based metabolic pathway and flux analysis
.
3

The

13

C-based metabolic pathway analysis aims at qualitative elucidation

of metabolic pathway activity by applying isotopic labeling approaches (8). In
general, the microbes are cultured using a carbon source with a known
distribution of

13

C isotopomers. As the

13

C-labeled carbon source is being used

for different metabolic pathways, the metabolites synthesized in microbial
metabolism (e.g. amino acids) acquire unique labeling patterns, which are
measured by gas chromatography–mass spectrometry (GC-MS). To elucidate the
route for metabolites synthesis, the “fingerprinting” labeling patterns of
metabolites are generated by tracing the

13

C carbon transitions in the proposed

pathway; and compared with the corresponding experimental measurements to
reveal whether the metabolic pathway is active.
The

13

C-based metabolic flux analysis (13C-MFA) is a quantitative

approach to identify the metabolic flux distributions under metabolic and isotopic
steady state, in which the pool size and the

13

C-labeling patterns of intracellular

metabolites are invariable (4,9). By integrating isotopic labeling approach and in
silico computation, 13C-MFA is formulated as an inverse problem to find a set of
fluxes that leads to the best match of the experimentally measured isotopomer
abundances. The nonlinear programming of
(10,11):

.
4

13

C-MFA is formulated as follows

n

min (vn )

Mi

i 0

s.t. S v
lb

N i (v n )

2

i

0
v

ub

where vn are the unknown fluxes to be optimized in the program, Mi are the
measured isotopomer labeling patterns of metabolites from GC-MS, Ni are the
corresponding model-simulated labeling patterns of metabolites, and δi are the
corresponding standard deviation in GC-MS measurement. The unknown
metabolic fluxes are searched to minimize ε.
The method of

13

C-based pathway and flux analysis allows for precise

determinations of metabolic states in a particular growth condition. Compared to
FBA,

13

C-based pathway and flux analysis cannot directly predict the metabolic

behaviors. However, it provides a physiologically reliable description of
microbial metabolism.
1.4 Recent advances in fluxomics
Fluxomics study is an emerging area in systems biology. In the past
decade, various approaches have been developed and improved to investigate the
cellular metabolic behaviors in response to environmental and genetic
perturbations; which yield significant achievements in both mechanistic studies of
cell physiology and rational designs in metabolic engineering.
.
5

1.4.1 Advances in constraint-based metabolic flux analysis
By integrating genome annotations, gene-protein-flux (GPR) correlations,
and experimental validations, genome-scale metabolic models are powerful
platforms in constraint-based flux analysis and have been constructed and applied
for various microorganisms (5). Simulations from genome-scale FBA have been
widely used in a number of studies (12), including interpreting various “omics”
data (13), directing hypothesis-driven discoveries (14), investigating metabolic
network properties (15), and predicting dynamic metabolisms of microorganisms
(16,17). Advanced computational approaches, such as MOMA (18), OptKnock
(19), and OptStrain (20), have been developed to guide the in silico design of
genetic manipulations in metabolic engineering. Additionally, the multi-species
relationships in mixed cultures are starting to be analyzed by constraint-based
metabolic flux analysis (21).
1.4.2 Advances in 13C-based pathway and flux analysis
State-of-the-art

mass

spectrometry

technologies,

such

as

liquid

chromatography–mass spectrometry (LC-MS), have been developed to directly
measure the 13C-labeling patterns of low-abundant and fast-turnover metabolites.
Mass spectrometry technologies could take the snapshot of transient metabolism
and can be used for novel pathways identification (22) and kinetic flux profiling
(23). As an improvement to conventional 13C-MFA under metabolic and isotopic
steady state, an advanced experimental and computational framework has been
.
6

proposed and employed to quantitatively investigate intracellular metabolism
under metabolic steady state but isotopic non-steady state (24,25). To unravel the
time profiles of metabolic fluxes under metabolic non-steady state, several
approaches have been developed by tracing and analyzing the

13

C-labeling

patterns of either fast-turnover intracellular metabolites (26), or slow-turnover
proteinogenic amino acids (27). Additionally, pioneering fluxomics studies have
recently been achieved to provide subpopulation-specific metabolic pathway
usage in mixed cultures via 13C-MFA of reporter proteins (28).
1.4.3 Advances in fluxomics software development
Multiple software toolboxes have been developed to facilitate fluxomics
studies. The hallmark of software development in constraint-based metabolic flux
analysis is the COBRA toolbox (29), which provides a computational platform for
model constructions and FBA studies. Other toolboxes, such as OptFlux (30),
have facilitated advanced FBA approaches for microbial strain design. A few
software tools for

13

C-MFA are also available, including OpenFLUX (31) and

FiatFlux (32). Moreover, web-based platforms have been constructed for
metabolic model generations and FBA. For example, BioMet Toolbox is a webbased resource for FBA and transcriptome analysis (33). Webcoli supplies diverse
approaches for users to reconstruct a genome-scale E.coli metabolic model (34).
Model SEED (35) has been developed to automatically generate genome-scale
metabolic models for different microbes.
.
7

1.5 Scope of dissertation
Decoding microbial metabolisms is of great importance in revealing the
mechanisms governing the physiology of microbes and rewiring the microbial
metabolism for bioenergy and biomaterial production. As one of the fundamental
approaches to characterize microbial metabolism, the fluxomics tools have not yet
been developed or applied as extensively as the other omics approaches in
systems biology. Noteworthy hurdles are also present in fluxomics study of
industrial biotechnology (Chapter 2). During my Ph.D. training, the

13

C-based

pathway analysis has been applied to a wide range of environmental
microorganisms, including Cyanothece 51142 (36,37), Thermoanaerobacter
X514 (38), Mycobacteria smegmatis (39), Shewanella oneidensis MR-1 (40),
Roseobacter denitrificans (41), Heliobacterium modesticaldum (42), and
Dehalococcoides ethenogenes 195 (43), with a cluster of novel metabolic features
uncovered to enrich the knowledge of microbial metabolisms (Chapter 3). The
metabolic flux distributions in a green sulfur bacterium, Chlorobaculum
tepidumgreen (10), have been investigated by 13C-MFA to reveal the functionality
of reversed TCA cycle; and the impact of isotope discrimination on 13C-MFA has
been rigorously evaluated using flux analysis of heterotrophic metabolism in
E.coli (Chapter 4). A novel computational approach has been developed to
decipher the dynamic metabolism of Shewanella oneidensis MR-1 by integrating
the bioprocess model with dynamic flux balance analysis (Chapter 5). In addition,
.
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MicrobesFlux, a web-based platform for metabolic model drafting has been
constructed to bridge the gap between fast-paced genome-sequencing and slowpaced metabolic model reconstruction (Chapter 6). Several broad-scope studies
have also been accomplished to supplement the systems biology of microbial
metabolism; and advanced fluxomics tools are expected to be developed in future
investigations (Chapter 7).
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2.1 Abstract
Metabolic flux analysis is a vital tool used to determine the ultimate output
of cellular metabolism and thus detect biotechnologically relevant bottlenecks in
productivity.

13

C-based metabolic flux analysis (13C-MFA) and flux balance

analysis (FBA) have many potential applications in biotechnology (1). However,
noteworthy hurdles in fluxomics study are still present. First, several technical
difficulties in both

13

C-MFA and FBA severely limit the scope of fluxomics

findings and the applicability of obtained metabolic information. Second, the
complexity of metabolic regulation poses a great challenge for precise prediction
and analysis of metabolic networks, as there are gaps between fluxomics results
and other omics studies. Third, despite identified metabolic bottlenecks or sources
of host stress from product synthesis, it remains difficult to overcome inherent
metabolic robustness or to efficiently import and express non-native pathways.
Fourth, product yields often decrease as the number of enzymatic steps increases.
Such decrease in yield may not be caused by rate-limiting enzymes, but rather is
accumulated through each enzymatic reaction. Fifth, high throughput fluxomics
tool hasn’t been developed for characterizing non-model microorganisms and
maximizing their application in industrial biotechnology. Refining fluxomics
tools and understanding these obstacles will improve our ability to engineer
highly-efficient metabolic pathways in microbial hosts.
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rate-limiting
2.2 Introduction
Numerous chemical compounds, ranging from the anti-malaria drug
artemisinin (2) to the “biofuel” butanol (3,4), have been produced with the aid of
synthetic biology tools. The ability to efficiently synthesize natural or unnatural
products requires a systems-level understanding of metabolism. Functional
genomics tools such as genome sequencing, profiling of mRNA transcripts, and
proteomics, are widely used to attain a comprehensive knowledge of how
metabolic components (genes, proteins and metabolites) are regulated. In contrast
to traditional omics tools, flux analysis (measurement of metabolite turnover
rates) has become instrumental for physiological prediction and enzymatic rate
quantification in metabolic networks (5). This technology also allows for the
identification of metabolic interactions and the knowledge-based design of
cellular functions. As such, one can utilize this tool to rationally modify biological
hosts and analyze global physiological changes resulting from genetic
modifications.
Fluxomics, the cell-wide quantification of intracellular metabolite turnover
rates, was first performed via Flux Balance Analysis (FBA). This method uses the
stoichiometry of the metabolic reactions in addition to a series of physical,
chemical and biological characteristics (thermodynamics, energy balance, gene
.
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regulation, etc.) to constrain the feasible fluxes under a given objective function
(e.g., maximal biomass production). FBA is an underdetermined model (the
number of constraints is smaller than the number of reactions in the metabolic
network), which may give unrealistic metabolic readout.

In spite of this

limitation, FBA provides a useful framework for predicting a wide variety of
cellular metabolisms. A complementary approach,

13

C-based metabolic flux

analysis (13C-MFA) allows for precise determinations of metabolic status under a
particular growth condition. The key to

13

C-MFA is isotopic labeling, whereby

microbes are cultured using a carbon source with a known distribution of 13C. By
tracing the transition path of the labeled atoms between metabolites in the
biochemical network, one can quantitatively determine intracellular fluxes.
Flux analysis can not only provide genetic engineers with strategies for
“rationally optimizing” a biological system, but also reveal novel enzymes useful
for biotechnology applications (5). However, flux analysis platforms are still not
routinely established in biotechnology companies. This review paper addresses
current developments and challenges in the field of fluxomics, which may guide
future study to bridge the gap between systems analysis of cellular metabolism
and application in biotechnology.
2.3 Advances and limitations in metabolic flux analysis
2.3.1 Steady-state flux model

.
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FBA and 13C-MFA concentrate on the stoichiometric (rather than kinetic)
properties of metabolic networks. FBA has been widely applied to predict cell
growth rate, product yield using different feedstocks, lethality of gene knockouts,
and advantageous pathway modifications (6). Such a model provides general
guidelines for metabolic engineering and thus is a viable first step towards
improving biosynthetic yield (7). The hallmark of large scale FBA is the
COnstraint-Based Reconstruction and Analysis Toolbox (COBRA) (8), which
provides a general platform for fluxomics studies.
A number of optimization algorithms and computational strategies for
resolving in silico and in vivo inconsistencies have been proposed to improve the
applicability of FBA (7,9). For example, incorporation of thermodynamic
principles into FBA can constrain solution space (i.e., energy balance analysis)
and obtain both stoichiometrically and thermodynamically feasible fluxes (1). To
describe the “non-optimal” metabolic behaviors, FBA can use a bi-level
optimization approach to estimate the potential trade-off between biomass
accumulation and the yield of a desired product (10). FBA can also relax the
objective function for maximization of the biomass and apply a Minimization of
Metabolic Adjustment Algorithm to solve fluxes in mutant strains (1). Such an
algorithm calculates fluxes by minimizing the difference between the wild-type
flux distributions and the knockout-strain fluxes. Furthermore, FBA can be
integrated with metabolic pathway analysis (MPA). MPA is a qualitative
.
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technique that examines functional routes existing in a metabolic network without
requiring knowledge of reaction rates (11). Combining MPA with FBA can
quantitatively trace the plausible paths for optimal product synthesis, calculate
cellular metabolism, and predict phenotypes under genetic manipulations or
culture conditions (12). One main advantage of FBA is its capability for genomescale modeling (including thousands of reactions), which bridge genomic
annotation and functional metabolic output. Accordingly, the number of FBA
models has increased exponentially since 1999 (13).
13

C-MFA aims to rigorously quantify pathway activities in intracellular

metabolism by using both the isotopic labeling approach and in silico
computation. 13C-MFA is accomplished by feeding microbes a 13C-labeled carbon
source, measuring the enrichment pattern of the isotopomer in metabolites (e.g.
amino acids), and deciphering the fluxes via computational routines (14). Since
carbon fluxes through a metabolic network generate unique labeling patterns in
metabolites, the overall flux distributions can be determined using isotopomer
information. Advances in

13

C-MFA, including mass spectrometry-based

metabolomics and isotopomer modeling approaches (such as novel algorithm
using elementary metabolite units), have been discussed in recent papers
(5,15,16).
Furthermore, open-source software has recently been published that
facilitates in silico modelling. For example, WEbcoli is web-based software for
.
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flux balance analysis of E.coli (17). In addition, OpenFLUX is computationally
efficient software for

13

C-MFA (15), which incorporates the Elementary

Metabolite Unit (EMU) framework for calculation of isotopomer balances (18).
User-friendly software such as this allows biologists to perform fluxomics studies
with little programming knowledge.
Methodologies for FBA and

13

C-MFA share two key characteristics: the

use of a metabolic network and the assumption of a steady metabolic state (for
internal metabolites). However, the two techniques have different purposes. FBA
profiles the “optimal” metabolism for the desired performance;

13

C-MFA

measures in vivo operation of a metabolic network. The two approaches to flux
analysis are complementary when developing a rational metabolic engineering
strategy. By comparing existent metabolic fluxes which were empirically
determined via 13C-MFA to the optimal metabolisms predicted by both FBA and
other “omics” tools (such as transcription analysis), one can deduce gene targets
for solving biotechnologically relevant productivity bottlenecks (19). Figure 2.1
shows that iterative flux analysis and genetic engineering of microbial hosts can
remove competitive pathways or toxic byproducts, amplify genes encoding key
metabolites, and balance energy metabolism (7).
2.3.2 Metabolic control and dynamic flux analysis
FBA and

13

C-MFA disregard dynamic intracellular behavior. This avoids

the difficulties in developing kinetic models and performing intracellular
.
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experimental measurements. However, many biological systems may not maintain
a meaningful metabolic (or isotopic) steady state during the fermentation process
(20,21,22). The description of metabolic perturbation and regulatory mechanisms
requires kinetic modeling and control theories. For example, metabolic control
analysis (MCA) couples local enzyme kinetics with systematic behavior to predict
the control exerted on the targeted pathways by different components (e.g.
transcription, enzymes) (23). Although MCA is not a quantitative measurement of
flux, MCA can pinpoint bottle-neck enzymes (enzymes having the largest effect
on the desired flux) in a pathway and allow the analysis of steady-state
metabolism in response to changes in the cellular environment (24). In addition to
MCA, the cybernetic approach (a model based on process dynamics and control)
has been introduced for study of multi-enzyme systems and metabolic regulation
(25). By incorporating both the enzyme kinetics in pathways and the enzyme
synthesis kinetics, the cybernetic approach emphasizes microbial process
dynamics and control during complicated fermentations (26).
Both MCA and the cybernetics approach focus on a simplified pathway
network. To perform cell-wide quantitative analysis of a dynamic system, it is
necessary to integrate the kinetic modeling with FBA and

13

C-MFA. Dynamic

FBA (dFBA) has been developed to illuminate changing global enzyme activities
(27,28). To avoid ordinary differential equations and dynamic optimization for
describing intracellular metabolism, dFBA can use the Static Optimization
.
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Approach (SOA) (29) which divides the time-course into numerous small
intervals. At each time interval, a steady-state flux is calculated under the
assumption of fast intracellular dynamics. By combining stoichiometric FBA for
intracellular metabolism with dynamic mass balances on extracellular substrates
and products, it is possible to reconstruct dFBA model for genome-scale analysis
of microbial metabolisms in industrial fermentations, where product synthesis is
often under dynamic control (30,31).
Recently,

13

C-dMFA (dynamic metabolic flux analysis) has been

developed for isotopically nonstationary cultures. To profile the flux distributions
for fed-batch cultures (slow dynamic metabolism), isotopic pseudo-steady state
was assumed and two dilution parameters were introduced to account for isotopic
transients. Another approach (Kinetic Flux Profiling) for solving intracellular
fluxes is to create a sudden increase of the portion of
then measure time-course samples as

13

13

C in the substrate feed,

C moves from the substrate into the

metabolites (32). The fluxes can be calculated based on the rates of isotopic
enrichment multiplied by the intracellular metabolite concentrations. A similar
principle has been proposed for the flux analysis of photoautotrophic
microorganisms (33) and E. coli in an isotopic transient phase (34). If the culture
is under both metabolic and isotopic non-stationary state, exploratory and
sophisticated 13C-dMFA (dynamic 13C-MFA) models have to be used to calculate
both metabolic and isotopic kinetics (20,35,36). To solve the 13C-dMFA problem
.
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efficiently, a set of computational algorithms have been developed for tracing
non-stationary isotopomer labeling in response to in vivo flux distributions
(20,35,36). The EMU (elementary metabolite unit) framework has also been
applied in

13

C-dMFA (18,37), because such algorithm can significantly improve

computational times for tracing the labeling information (38). To avoid extensive
simulation of dynamic isotopomer patterns, the SOA has to be applied by dividing
the growth period into small time intervals (30~60 min), then the “mini” quasisteady state

13

C-MFA can be applied at each time interval based on constraints

from simultaneous isotopomer analysis of the fast turnover metabolites (39). By
examining flux profiles over all time intervals, one can resolve the metabolic
transients during the entire cultivation period.
2.3.3 Technical limitations of fluxomics
Cell-wide fluxomics tools (i.e., FBA and

13

C-MFA) have technical

limitations. In genome-scale FBA models, the number of constraints (i.e., the
availability of quantitative metabolite data) is much smaller than the number of
reactions in the metabolic network. The calculation of such underdetermined
systems depends on objective functions where one assumes that the metabolism
optimizes its native ‘‘goals’’ (such as biomass or co-factor production) (40). This
optimization principle has been questioned for several reasons. First, biological
systems (e.g., Bacillus subtilis) seem to display sub-optimal growth performance
(41). Second, a previous study examined 11 objective functions in E. coli and
.
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found no single objective function that can perfectly describe flux states under
various growth conditions (42). For example, unlimited aerobic growth on
glucose is best described by a nonlinear maximization of the ATP yield per flux
unit, but nutrient-limited continuous cultures favor biomass yield as the objective
function. Third, some native cellular processes cannot be simply described by
FBA. For example, cyanobacterial species (i.e., Cyanothece 51142) maintain their
circadian rhythms (e.g., nitrogen fixation and light dependent reaction activities)
under nutrient-sufficient and continuous light conditions (43,44).
The application of

13

C-MFA in industrial biotechnology also has several

bottlenecks. The most prevalent constriction occurs because current techniques
are insufficient for measuring large-scale metabolic networks. Obtaining labeling
information of free metabolites rather than amino acids and solving large-scale
nonlinear flux models pose two key challenges. As a result, most obtained flux
information is limited to central metabolism. To date, only two large-scale

13

C-

MFA (>300 reactions) have been reported, but many fluxes in their reports cannot
be precisely determined due to insufficient constraints (45,46). The genome-scale
13

C-MFA is still in its infancy and requires further development of the relevant

experimental techniques and computational tools (47). A second issue is that 13CdMFA is still poorly developed for determining dynamic metabolic behavior. It is
difficult for rapid sampling and precise measurements of metabolites at short time
intervals throughout the entire culture period. For example, to measure absolute
.
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intracellular metabolite concentrations, one has to grow cell in fully

13

C-labeled

medium, then the labeled cells are extracted with quenching solvent containing
known concentrations of unlabeled internal standards (the concentrations of
metabolites are calculated using the isotope ratio-based approach) (48). Such
measurement requires extremely high cost of analytical efforts including quick
sampling, rapid metabolite extraction, and a high resolution LC-MS instrument.
Furthermore, the time-dependent model includes ordinary differential equations
and significantly increases the computational complexity (20,34). Third, flux
determination assumes that enzymatic reactions are homogenous inside the cell
and that there are no transport limitations between metabolite pools. However,
eukaryotes have organelles (compartments) that may have diffusion limitations or
metabolite channeling (14,49). Compartmentalization of amino acid biosynthesis
further clouds the obtained amino acid-based labeling information (50).
Therefore, confident 13C-MFA for eukaryotes not only requires the combination
of different analytical tools (GC-MS, LC-MS and NMR) to obtain extensive
labeling information (51), but also adequate sample processing and extraction
methods (e.g. separation of compartments by ultracentrifugation). A fourth
problem is that some industrial hosts and the great majority of environmental
microbes resist cultivation in minimal media, and introducing other nutrient
sources often significantly complicates metabolite labeling measurements and
flux analyses (52). Finally, a microbial community demonstrates complex
metabolic interactions between species. To date, only a few FBA models have
.
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been developed for community studies (53,54). The exchange of metabolites
among species is nearly impossible to unravel by

13

C-MFA because complete

separation and measurement of metabolites from a single species in a microbial
community is impossible (5). These technical limitations in both FBA and MFA
models are responsible for the gap between fluxomics and its applicability in
biotechnology.
2.4 Integration of fluxomics with other “omics”
It is desirable to integrate the concepts of systems biology (which
combines the readouts from transcription as well as protein/metabolite profiling)
with fluxomics (Figure 2.2) (47). For example, 13C-MFA, enzyme activity assays,
and RT-PCR analysis can be used together to study E.coli mutants’ metabolism
(55). Additionally, the responses of E. coli to genetic modification have been
systematically examined by utilizing multiple high-throughput “omics” methods
(56). The results illuminate relatively small changes in mRNA and proteins in
response to genetic disruptions, which allow the cell to maintain a stable
metabolic state under changing growth conditions. A similar approach to the study
of Synechocystis 6803 has shown that the regulation of some enzymes is sensitive
to light conditions (57). Many other regulatory mechanisms, however, still remain
unknown. Furthermore, global regulators in industrial microorganisms have been
successfully identified by correlating transcript/transduction levels and metabolic
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fluxes (58,59,60,61). The discovery of functioning regulators provides insight to
the entire regulation in metabolic network.
On the other hand, challenges in integrated “omics” studies are also
present. The lack of understanding of metabolic regulation at different metabolic
levels complicates the rational design of biological systems, which is a major
barrier in industrial biotechnology. For example, post-transcriptional regulation
poses a significant challenge in integrating fluxomics with other “omics” studies.
It is well known that transcript and protein data correlate relatively well for
specific pathways, yet this correlation can be poor in cell-wide analyses (62).
Furthermore, most mRNA expression studies insufficiently predict enzyme
activities or flux changes in many E. coli pathways (63). In studies on the
adaptation of E. coli to environmental perturbations, the tricarboxylic acid cycle is
found to correlate well with molecular changes at the transcriptional level, but
flux alterations in other central metabolic pathways seem to be uncorrelated to
changes in the transcriptional network (64). Because of the complexity of
regulatory mechanisms spanning multiple cellular processes, fluxomics and other
“omics” studies may have inconsistent observations which complicate systemslevel analyses.
2.5 Fluxomics of microbes for industrial biotechnology
FBA allows in silico simulations of metabolism in “industrial
workhorses,” from which desired strains or targeted mutations can be identified.
.
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13

C-MFA can assess in vivo metabolism of engineered strains under specific

growth conditions and validate FBA results. Here, we summarize recent
applications of FBA and

13

C-MFA for commonly-used industrial chassis (i.e., E.

coli, B. subtilis and S. cerevisiae) and for non-model microorganisms (i.e., lesscharacterized or newly-discovered microorganisms).
2.5.1. Escherichia coli model
E. coli is the most commonly utilized species in fermentation industry. E.
coli flux models were reported as early as the 1990s (65,66). For biotechnology
applications, the Liao group first applied metabolic pathway analysis (MPA) to
guide the genetic manipulation of E.coli strains and channel the metabolic fluxes
from carbohydrate to the aromatic amino acid pathway (67). The Maranas group
has integrated cell growth and product synthesis in the OptKnock toolbox (10)
and applied it to construct high performance mutants. The computer-aided designs
have shown improved lactic acid, succinate, and 1,3-propanediol production (68).
FBA can predict lethality in a metabolic network where deletions of more than
one non-essential gene mutants may trigger the death of the organism. For
example, the Maranas group (69) analyzed the gene/reaction essentiality in a
genome-scale model of E. coli and systemically identified possible pairs of
synthetic lethals: non-essential genes whose simultaneous knockouts would have
a potentially lethal effect. Incorporating information about synthetic lethality into
the new model will curb the construction of ill-designed biological systems for
.
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biotechnology. Furthermore, FBA can be used to find rate-limiting steps for
product synthesis. For example, FBA revealed gene targets, and modification of
those genes (i.e., knocking out the genes for pyruvate forming enzymes, overexpression of the glyoxylate shunt and glucose transport system) resulted in more
than a ten-fold increase in succinate production (70,71,72). FBA has also been
used to improve genetic strategies for the overproduction of secondary
metabolites, such as amino acids (73) and lycopene (74).
Besides genetic strategies, FBA can provide useful information for the
design of optimal fermentation conditions. For example, an FBA model was used
to identify nutrient limitations during recombinant interleukin-2 (IL-2) production
in E. coli. By supplementing specific amino acids, IL-2 production increased twofold in fed-batch fermentation (75). Recently, a reactor-scale dFBA model was
developed via a Static Optimization Approach to analyze E. coli metabolism for
the production of a biopharmaceutical drug (27). dFBA contains a steady state
FBA model embedded within a dynamic kinetic model that describes the time
evolution of fermentation process variables (e.g., biomass growth, glucose
consumption and products synthesis). Such a model provided guidelines for the
optimization of fermentations at the scale of a 1000L process.
The 13C-MFA model was first used to investigate metabolic regulation in
E.coli under different genetic and environmental conditions (76).

13

C-MFA has

also been used to examine various biotechnological processes involved in the
.
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production of pharmaceuticals, amino acids and polymers. A large scale 13C-MFA
with over 300 reactions was successfully developed for amorphadiene (a
precursor of the anti-malaria drug) producing E. coli strains (45). Another study
revealed a growth phase-dependent metabolic shift in a lysine-producing E. coli
strain (77). This work was performed in a fed-batch culture with rich medium
(containing yeast extract), and metabolic fluxes in both exponential growth and
stationary phases were estimated by measuring free metabolites. Metabolic
analysis of the stationary phase is important since many products are synthesized
during a non-growth phase. In a third example,

13

C-MFA of a 1,3-propanediol

producing E. coli strain was conducted in fed-batch fermentation (78). The

13

C-

MFA results showed a decrease in the split ratio between glycolysis and the
pentose phosphate pathway over the time-course of the culture in response to
increasing 1,3-propanediol fluxes.
2.5.2 Bacillus subtilis model
B. subtilis is the industrial organism of choice for the production of
vitamins, antibiotics, enzymes, and nucleosides. The FBA model for B. subtilis
was constructed based on a combination of genomic, biochemical, and
physiological information (79). The FBA model was iteratively corrected and
improved using information from high-throughput phenotypic screens of mutants,
substrate utilization, gene essentiality, and sequence analyses. The B. subtilis flux
model is mostly studied for riboflavin production, focusing on four aspects:
.
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investigating phenotypes of wild type and knock-out strains, assessing production
capacity, identifying the impact of different carbon sources on biosynthesis, and
characterizing the cellular response to different culture conditions. The Sauer
group has extensively investigated riboflavin-producing strains. They first used an
FBA model to quantify growth maintenance coefficients, the maximum growth
yield, and the specific riboflavin production rate in continuous cultivation (80).
Later on, they applied

13

C-MFA to the same strain and found that genetic

manipulations should target the NADPH balance and riboflavin biosynthetic
pathways (81). In other studies on B. subtilis, they revealed several guidelines for
high yield riboflavin production: 1. they compared the metabolic flux
distributions and maintenance energy of eight Bacillus strains and discovered that
B. licheniformis was the most suitable for industrial biotechnology (82); 2. they
found that using malate as a substrate resulted in a suppressed respiratory TCA
cycle and an enhanced overflow metabolism (83); 3. they found the pentose
precursors of riboflavin were mainly synthesized via the non-oxidative pentosephosphate pathway, so any suggested genetic modification should decrease the
activity of the oxidative pentose phosphate pathway (84). Recently, they
developed a 13C-dMFA model for B. subtilis to identify the metabolic response of
riboflavin overproduction under a glucose-limited fed-batch culture (39). This
dynamic flux analysis was obtained by recording changes in labeling patterns of
intracellular amino acids under a metabolic pseudo-steady state assumption.
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2.5.3 Saccharomyces cerevisiae model
S. cerevisiae is a robust eukaryotic chassis used for the expression of a
wide range of products. For example, flux analysis revealed target genes in two
native pathways for the over-expression of succinate: the TCA and glyoxylate
cycles (85). Another study showed the enhancement of sesquiterpene production
via in silico driven metabolic engineering (86). Additionally, flux analysis has
been extensively applied for improving ethanol production. First, a number of
strategies were developed for the metabolic engineering of redox processes in S.
cerevisiae, resulting in a decrease in the yield of glycerol by 40% and an increase
in ethanol production under both glucose and xylose/glucose growth conditions
(87). Second, Dikicioglu et al. (88) applied a genome-scale FBA model to analyze
respiration-deficient mutants of S. cerevisiae for ethanol production. They found
that many genetic manipulation strategies (e.g., the overexpression of the
glutamate synthase gene) were unnecessary in a respiration-deficient metabolic
background. This indicates that the rate limiting steps for ethanol production can
change after the initial genetic manipulations of targeted genes. Third, a 13C-MFA
model was used to screen ethanol production in 14 hemiascomycetous yeast
strains (50). This study suggests that S. cerevisiae is the ideal ethanol production
candidate due to a strong NADPH-driven pentose phosphate pathway. Other 13CMFA studies characterized the metabolic shift between oxidative growth and
fermentative growth with ethanol production (89), investigated alternative carbon
.
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substrate (xylose) metabolisms (90), revealed key factors influencing biomass
growth on xylose (91), and examined the consumption of ethanol and other
storage carbohydrates in a glucose-limited chemostat culture (92).
Furthermore, a genome-scale FBA indicates an apparent enzyme
dispensability, i.e., 80% of yeast genes seem to be non-essential for viability
under laboratory conditions (93). The FBA illustrated the influence of nonessential genes on metabolic robustness and environmental fitness due to genetic
buffering through alternative genes, while a

13

C-MFA (consisting of over 700

reactions) revealed a similar effect of metabolic network robustness on null
mutations (46). Understanding the role of these redundant genes is important for a
valid and efficient genetic modification.
2.5.4 Non-model microorganisms
Fluxomics is an important tool for the rigorous study of metabolism in
less-characterized microbes that provides novel insights for application of these
species to biotechnology. However, fluxomics have not been sufficiently applied
to non-model microorganisms as compared to model microbial hosts. Table 2.1
summarizes some milestone papers in fluxomics studies on non-model species
that are potentially useful for synthetic biology. Compared to the work done in the
field of fluxomics for industrial workhorses, far fewer studies have been
performed on non-model microorganisms. This is due to the complicated growth
conditions, poorly-understood metabolic networks, and significant lack of genetic
.
34

and molecular biology tools. However, non-model environmental microorganisms
are also important for industrial biotechnology because they often possess native
biochemical pathways for chemical synthesis or the ability to utilize cheap
substrates (94). Furthermore, flux analysis can be used to discover novel enzymes
that can be cloned into industrial microbes to improve their capacity for product
synthesis. For example,

13

C-MFA revealed a citramalate pathway for isoleucine

biosynthesis (independent of the common threonine ammonia-lyase pathway)
(95,96). Citramalate synthase, which has also been detected in some
environmental bacteria (97,98,99), can be engineered into E. coli for 1-propanol
and 1-butanol production. The new pathway bypasses threonine biosynthesis and
represents the shortest keto-acid-mediated pathway; as such, it improved biofuel
yield 9 to 22-fold (100). Currently, high-throughput genome sequencing methods
are mapping genomes in novel microbes at a pace that far exceeds the pace of
functional characterization of these species. Therefore, a high throughput

13

C-

MFA technique is required for screening non-model microorganisms for new
enzymes and maximizing their application in industrial biotechnology (5).
2.6 Finding bottlenecks for Industrial Biotechnology
One of the main goals of fluxomics is to indentify bottlenecks for
industrial biotechnology and thereby assist in the creation of rational engineering
strategies. Simple measurements of metabolism, however, are not enough to
overcome unpredictable challenges in industrial biotechnology. Metabolic
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regulation is very complex, and systems biology tools are incapable of revealing a
general strategy for synthetic biology (101).
Bottlenecks in industrial biotechnology can be explained from the view of
fluxomics. First, metabolic robustness (the ability to maintain metabolic
performance under genetic or environmental perturbations) is a long-recognized
key property of microbial systems (102). This basic mechanism is often
responsible for the gap between computationally aided design and final
experimental outcomes. For example, a

13

C-MFA study indicates that E. coli

shows remarkable robustness in the central carbon metabolism in the presence of
genetic variation, and is even more flexible in response to altered environmental
conditions (e.g., different nutrients or oxygen levels) (76). Analyses of E. coli
components at multiple “omics” levels also reveal unexpectedly small changes in
messenger RNA, proteins and metabolite levels for most genetic disruptions. This
is because E. coli actively regulates enzyme levels to maintain a stable metabolic
state in the presence of perturbations (56,64). Similarly, B. subtilis shows rigidity
and suboptimal performance for its flux regulation in over 137 genetic
backgrounds (41). Furthermore, gene essentiality and pairwise genetic
interactions have been investigated in S. cerevisiae (93,103). It has been found
that a gene’s function is buffered by duplication in S. cerevisiae genomic DNA or
by an alternative biochemical pathway. Although only 13% of genes were
suggested to be essential by single knockout experiments, simultaneous deletion
.
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of pairs of non-essential genes (>70% of the total metabolic genes) were found to
inhibit growth. Invariability of metabolic flux under mutagenic genotypes seems
to be an important feature in many biological systems, and thus successful
metabolic strategies highly depend on an understanding of robust cellular nature
(104,105,106).
Metabolic engineering of industrial chassis is based on the premise that
the yield of a desired product can be increased by identifying and over-expressing
the enzymes that catalyze the rate-limiting steps in a given metabolic pathway.
However, a method based on over-expressing rate-limiting enzymes will only
work if these rate-limiting enzymes exist and remain rate-limiting when their
activities are increased. Previous studies have shown that the commonly-believed
“rate-limiting” enzymes may not exist in some industrial microbes and an
increase in productivity has to be achieved by coordinated expression of entire
pathways (107). Furthermore, rate-limiting steps in a metabolic network often
shift after initial targets have been engineered. For example, phenotypic data in S.
cerevisiae mutants revealed that some FBA-predicted gene targets for ethanol
production are invalid if the cell’s respiratory genes have been knocked-out (88).
Another example of this phenomenon is highlighted by the metabolic
consequences of the deletion of the methionine and cysteine biosynthesis
repressor protein (McbR) in Corynebacterium glutamicum, which yielded no
overproduction of methionine but drastic accumulation of homolanthionine (108).
.
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The above evidence indicates that rate-limiting steps often shift after initial targets
have been engineered. Additionally, simultaneous importation and expression of a
few heterologous genes to improve the rate-limiting pathway may fail if the nonnative pathway is incompatible with the host. These efforts often lead to
metabolic imbalance and accumulation of toxic metabolites (3,4).
Based on the recent publications, we have constructed a linear regression
model which shows that the yield of biosynthetic products decreases
exponentially as a function of the steps away from central metabolism in S.
cerevisiae (Figure 2.3). It is easier to achieve high carbon fluxes to the central
metabolites, possibly because enzyme efficiency in central metabolism is usually
high (109). However, the yields of secondary metabolites are smaller because
each additional enzymatic step may not be perfectly efficient (model regression
shows an average of ~67% efficiency in each enzymatic step in secondary
metabolisms). This loss of yield is unavoidable due to the metabolism channeling
the intermediates away from the desired product. Potential solutions to this
problem include: 1. designing host-compatible enzymes with high product
specificity (110); 2. feeding intermediates to the cell to reduce the number of
enzymatic steps to final product (111); 3. creating synthetic protein scaffolds,
which significantly improve intermediate conversion efficiency and overall
biosynthetic yield (112).
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In conclusion, fluxomics studies enable the quantification of intracellular
metabolism. However, this tool is not fully developed, and it remains difficult to
deduce cell-wide pathway bottlenecks and to provide effective strategies for
biotechnology applications. Numerous technical difficulties in developing flux
analysis methods and complicated metabolic regulatory mechanisms have
severely limited the scope of fluxomics in industrial biotechnology. It is necessary
for the future development of flux analysis to combine other advanced “omics”
analysis and molecular biology techniques to resolve challenges in the fluxomics
fields.
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Figure 2.1. An iterative approach of fluxomic analysis and rational metabolic
engineering
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Figure 2.2. 13C-assisted cellular metabolism analysis
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Figure 2.3. Product yields as a function of enzymatic steps from central
metabolism. The solid line is the regression of published product yields by S.
cerevisiae as a function of reaction steps from intermediate metabolites in central
metabolism (including glycolysis, TCA cycle and pentose phosphate pathways).
The yield declines exponentially as the number of reaction steps increases. The
dotted lines are boundary curves with yield efficiencies of 30% and 70%
respectively. All yield data from initial carbon sources are estimated from recent
papers using our best judgment. The synthesized products and reaction steps are:
Poly(R-3-hydroxybutyrate)

(113)

(steps=3);

Glycerol

(114)

(steps=2);

Artemisinic acid (2) (steps=10); Amorphadiene (115) (steps=9); Pyruvate (116)
(steps=0); Geranylgeraniol (117) (steps=10); Hydrocortisone (118) (steps=19);
Squalene (119) (steps=9); β-carotene (120) (steps=12); Lycopene (120)
(steps=11); Phytoene (120) (steps=10); p-hydroxycinnamic acid (121) (steps=12);
Naringenin (122) (steps=14); Pinocembrin (122) (steps=14); Xylitol and Ribitol
(123) (steps=3); Ethanol (124) (steps=2); L-ascorbic acid (125) (steps=8).
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Table 2.1. Recent application of fluxomics of non-model microbes to bio-product
synthesis
Species

Corynebacterium
glutamicum

Product

Lysine

Model
description

Substrate

Glucose
(sucrose,
fructose)

13

C-MFA

13

Corynebacterium
glutamicum

Methionine

C-MFA
only focuses
on flux
distribution
in the
methionine
pathway.

Glucose

13

Corynebacterium
glutamicum

Glutamate

C-MFA
(focus on
anaplerotic
pathways)

Glucose

13

Actinobacillus
succinogenes

Succinate
formate and
acetate

C-MFA
(via NMR
and GC-MS)
and enzyme
assay

Glucose
NaHCO3
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Results from study
MFA models
(combining
transcriptome,
metabolome
analysis) have been
developed to study
fluxes under
different cultivation
modes (minibioreactor, batch,
fed-batch) using
various carbon
sources.
The C. glutamicum
mutant (mcbR)
showed no
overproduction of
methionine, but
accumulation of
homolanthionine.
The flux from
phosphoenolpyruvat
e to oxaloacetate
catalyzed by
phosphoenolpyruvat
e carboxylase
(PEPc) was active in
the growth phase,
whereas pyruvate
carboxylase was
inactive.
The model indicated:
1. NADPH was
produced primarily
by transhydrogenase
and/or by NADPdependent malic
enzyme; 2.
oxaloacetate and
malate were
converted to
pyruvate; 3. the
effects of NaHCO3
and H2 on metabolic
fluxes were
quantified.

Reference

(126)

(108)

(127)

(128,129)

Geobacillus
thermoglucosidasiu
s

Clostridium
acetobutylicum

Ethanol

Butanol

FBA and 13CMFA

Glucose

Genome
scale-FBA

Glucose

13

Penicillium
chrysogenum

Synechocystis sp.
PCC6803

Penicillin

Hydrogen

C -MFA
(focus on
pentose
phose phase
pathway and
glycolysis)

Gluconate
/glucose

CO2

FBA

13

Synechocystis sp.
PCC6803

Light energy
& Biomass

C-MFA and
dynamic 13C MFA

Glucose/CO2

Chlamydomonas
reinhardtii

Light energy
& Biomass

CO2

FBA model
including
three
metabolically
active
compartment
s

Zymomonas mobilis

Ethanol

Glucose/

FBA with
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The model
characterized the
ethanol production
under three oxygen
conditions. The FBA
analysis pointed out
several gene targets
for improving
ethanol production.
The engineered
strain was able to
produce 154 mM
butanol with 9.9 mM
acetone at pH 5.5,
resulting in a butanol
selectivity (a molar
ratio of butanol to
total solvents) of
0.84.
The model
determined the
pentose phosphate
pathway split ratio
and estimated
NADPH
metabolism.

(19)

(130)

(131)

The results included
H2 photoproduction,
strategies to avoid
oxygen inhibition,
and analysis of
hetero-, auto-, and
mixotrophic
metabolisms.

(132,133)

The model analyzed
heterotrophic,
autotrophic and
mixotrophic
metabolisms.

(33,57)

The model indicated
that heterotrophic
growth had a low
biomass yield on
carbon, while
mixotrophical and
autotrophical growth
had higher carbon
utilization
efficiency.
Model analyzed the

(134)

(135)

xylose

various
biological
objectives

13

Zymomonas mobilis

Coculture
(Desulfovibrio
vulgaris and
Methanococcus
maripaludis)

Community
(oxygenic
phototrophs,
filamentous
anoxygenic
phototrophs, and
sulfate-reducing
bacteria).

Phaffia rhodozyma
and Haematococcus
pluvialis

Ethanol

CH4

Biomass and
nitrogen
fixation

Astaxanthin

C–MFA via
1H-NMR
31P-NMR
spectroscopy

Glucose
/frucose/
xylose

Lactate

CO2

Glucose with
(peptone &
yeast extract)
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The model
characterized the
intracellular
metabolic state
during growth on
glucose, fructose and
xylose in defined
continuous cultures.

FBA analysis
of microbial
consortia

The model predicted
the ratio of D.
vulgaris to M.
maripaludis cells
during growth. It
was possible to
eliminate formate as
an interspecies
electron shuttle, but
H2 transfer was
essential for
syntrophic growth.

FBA and
elementary
mode
analysis

The model predicted
and described
relative abundances
of species, byproducts, and the
metabolic
interactions.

FBA analysis
of mix
culture

.

metabolic
boundaries of Z.
mobilis. The study
indicated that
ethanol and biomass
production depend
on anaerobic
respiration
stoichiometry and
activity.

The two major
astaxanthinproducing
microorganisms
exhibited elevated
yields (2.8-fold)
under mixed culture
conditions compared
to pure culture.

(136)

(54)

(53)

(137)

Chapter 3
13

C-Pathway Analysis of Environmental Microorganisms

3.1 13C-pathway analysis protocol
Novel metabolic features of environmental microorganisms can be
revealed by 13C-pathway analysis. As a complementary method to transcriptomics
and proteomics studies,

13

C-pathway analysis can be used to uncover novel

enzymes, investigate mixotrophic metabolism, and optimize the medium for slowgrowing microbes. A protocol for

13

C-pathway analysis of environmental

microorganisms is attached in Appendix 1. In general,

13

C-pathway analysis has

three major steps.
The first step is to grow microbes on 13C-labeled carbon substrates. Three
key factors affect the

13

C-pathway analysis: medium composition,

13

C-labled

carbon substrate, and culture modes. To avoid measurement noises from nonlabeled carbon in nutrient supplements, a minimal medium with only one

13

C-

labeled carbon source is required in tracer experiments. To collect the
“fingerprinting” labeling patterns of metabolites synthesized from different
pathways, singly labeled carbon substrates (>98% pure) are normally
recommended in

13

C-pathway analysis. To guarantee both metabolite and

isotopomer steady state are achieved in 13C-pathway analysis, microbes can either

.
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be cultured under chemostat mode, using typical bioreactors with continuous
feeding, or batch mode, using shake flasks or small-scale mini-batch reactors.
The second step is to analyze amino acid labeling patterns using GC-MS.
Amino acids are abundant in protein and thus can be obtained from biomass
hydrolysis. To make the amino acids volatile enough for GC separation, amino
acids are derivatized by N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide
(TBDMS) prior to analysis. The TBDMS-derivatized amino acids can be
fragmented by MS and result in different arrays of fragments, including four
characteristic arrays of fragments that can reflect the

13

C-labeling patterns of

amino acids: fragment (M-15)+, which contains the entire amino acid but has lost
a 15 MW methyl group; fragment (M-57)+, which contains the entire amino acid
but has lost a 57 MW tert-butyl group; fragment (M-159)+, which has lost a 159
MW group that contains the 1st carbon (α carboxyl group) of the amino acid; and
fragment (f302)+, which consists of a 302 MW group containing the amino acid
without its R group. The final isotopic labeling patterns of proteinogenic amino
acids are reported as mass fractions, such as M0, M1, M2, M3 and M4, to
represent the percentage of fragments containing zero to four 13C labeled carbons.
The third step is to trace

13

C carbon transition in the proposed pathways

and to verify whether the labeling patterns in key metabolites are consistent with
the annotated enzymatic reactions. Since errors or gaps within annotated
pathways are common for poorly characterized microorganisms, the pathway
.
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activity uncovered from

13

C-pathway analysis can be useful in functional

characterization of metabolic pathway activities. Derived from the isotopic
analysis of amino acids, labeling information about eight metabolites in the
central carbon metabolism is provided and is used to reflect the functions of
associated metabolic pathways.
13

C-pathway analysis is a powerful tool to probe active carbon metabolic

pathways in vivo. Table 3.1 illustrates several carbon metabolic pathways that can
be revealed by 13C-labeled proteinogenic amino acids. In cooperation with in vivo
physiological

studies,

transcription

assays,

and

in

vitro

biochemical

characterizations, new insights to carbon metabolisms of organisms can be
illustrated.
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Table 3.1 Fingerprinting 13C-labeling patterns of amino acids for identifying
novel metabolic pathways and enzymes.
13

Pathways and
enzymes

C-carbon
substrate

Key amino
acids

“Fingerprinting”
labeling patterns
Notably lower (with [113
C] glucose) or higher
(with [6-13C] glucose)
13
C abundance in Ser

The EntnerDuodroff (ED)
pathway

[1- C] glucose, or
[6-13C] glucose

Ser & Ala

The reductive
TCA cycle

Non-labeled CO2
with [3-13C]
pyruvate

Ala, Asp, &
Glu

Notably lower 13C
abundance in Asp and
Glu than in Ala

The branched
TCA cycle

[3-13C] pyruvate,
or
[2-13C] glycerol

Asp & Glu

Different labeling
patterns in Asp versus in
Glu

(Re)-citrate
synthase in TCA
cycle

[1-13C] pyruvate

Glu

Non-labeled α-carboxyl
group of Glu

The citramalatepathway in
isoleucine
biosynthesis

[2-13C] pyruvate
or [1-13C] acetate

Leu & Ile

Identical labeling
patterns in Leu and Ile

The CalvinBenson cycle

Non-labeled CO2
with labeled
organic carbon

His & Ser

Significantly low 13C
abundance in Ser and
His

Ala

non-labeled Ala >50%

13

The oxidative
pentose phosphate [1-13C] glucose
pathway
The CO2anaplerotic
pathways

13

C-bicarbonate
with non-labeled
organic carbon

Ala & Asp
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Enriched 13C abundance
in Asp
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3.2.1 Abstract
The unicellular diazotrophic cyanobacterium, Cyanothece sp. ATCC
51142 (Cyanothece 51142), is able to grow aerobically in nitrogen-fixing
conditions under alternating light-dark cycles or continuous illumination. This
study investigated the impacts of carbon and nitrogen sources on Cyanothece
51142 metabolism via

13

C-assisted metabolite analysis and biochemical

measurements. Under continuous light (50 µmol photons/m2/s) and nitrogenfixing conditions, we find glycerol addition promoted aerobic biomass growth (by
twofold) and nitrogenase-dependent hydrogen production (up to 25 µmol H2/mg
chlorophyll/hr), but strongly reduced phototrophic CO2 utilization. Under
nitrogen-sufficient conditions, Cyanothece 51142 was able to metabolize glycerol
photoheterotrophically, and the activity of light dependent reactions (e.g., oxygen
evolution) was not significantly reduced. In contrast, Synechocystis sp. PCC 6803
showed apparent mixotrophic metabolism under similar growth conditions.
Isotopomer analysis also detected that Cyanothece 51142 was able to fix CO2 via
anaplerotic pathways, and to uptake glucose and pyruvate for mixotrophic
biomass synthesis.
Key words:

13

C-assisted, anaplerotic pathway, CO2 utilization, glycerol,

hydrogen, nitrogenase
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3.2.2 Introduction
Rising concerns about global warming due to the greenhouse effect have
renewed research focused on biological capture of CO2. Cyanobacteria have
versatile metabolic capabilities, which allow them to grow under autotrophic,
heterotrophic, and mixotrophic conditions (1,2,3). More importantly, some
cyanobacteria can capture solar energy to fix nitrogen and generate H2, thereby
serving as a source of biofertilizer and biofuel, while simultaneously consuming
atmospheric CO2 (4,5,6,7,8,9). Cyanothece 51142, a unicellular diazotrophic
cyanobacterium, is able to grow aerobically under nitrogen-fixing conditions and
has been recognized for contributing to the marine nitrogen cycle. The recent
sequencing of the Cyanothece 51142 genome and its transcriptional analysis
uncovered the bacterium’s diurnally oscillatory metabolism in alternating lightdark cycles (photosynthesis during the day and nitrogen fixation at night)
(10,11,12). In general, cyanobacteria use spatial or temporal separation of the
oxygen-sensitive nitrogen-fixation and the oxygen-evolving photosynthesis as a
strategy for diazotrophic growth (9,13). Interestingly, Cyanothece 51142
demonstrates simultaneous N2 fixation and O2 evolution under continuous light
conditions, though it appears to be unicellular (14,15). For example, a recent
study on transcriptional and translational regulation of continuously-illuminated
Cyanothece has revealed strong synthesis capability for nitrogenase and circadian
expression of 10% of its genes (10,11). Furthermore, Cyanothece strains usually
.
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utilize exogenous carbon substrates for mixotrophic growth under light and for
heterotrophic growth under dark conditions (16). Carbon substrates are key
factors controlling the efficiency of cyanobacterial aerobic growth and hydrogen
production (7,16,17,18,19). Genome analysis studies have revealed that
Cyanothece 51142 has a unique gene cluster on its linear chromosome containing
key genes involved in glucose and pyruvate metabolism (12). However, the
ability of this strain to metabolize glucose or pyruvate remains unknown.
To quantitatively examine the effect of carbon and nitrogen sources on
Cyanothece central metabolism, this study investigated the impact of three carbon
sources (glucose, glycerol, and pyruvate as representatives of sugar, lipid
derivatives, and organic acids from central metabolic pathways, respectively) on
Cyanothece 51142 growth and metabolism. Two nitrogen sources other than N2,
ammonia and nitrate, were also examined. Precise readouts on metabolic state and
activity were based on

13

C-assisted metabolite analysis integrated with

biochemical assays and the gene expression patterns obtained by reverse
transcription PCR (RT-PCR) (20,21,22,23,24,25). Superior to the traditional
method (1), the non-radioactive

13

14

C

C method can provide rich information about

which carbons within a metabolite are labeled, and thus enable an in-depth
understanding of carbon utilization and metabolic regulation in Cyanothece
51142.
3.2.3 Materials and methods
.
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Bacterial strains and growth conditions. Cyanothece 51142 were first
grown in 150 mL Erlenmeyer flasks fed with ASP2 medium (16) without nitrate.
Ambient carbon dioxide provided the sole carbon source. For experiments
examining the effect of nitrogen sources, 18 mM NaNO3 or 17 mM NH4Cl was
added into the medium. Cultures were grown aerobically under continuous light
(50 µmol photons∙m-2∙s-1) on a shaker at 150 rpm and 30°C. Cells at late mid-log
phase were sub-cultured into different cultural media with various nitrogen and
carbon sources. Isotopically-labeled carbon substrates (Cambridge Isotope
Laboratories, Andover, MA) were used for mixotrophic growth, including 54 mM
glycerol (2-13C, >98%), 26 mM glucose (U-13C, >98%) and 11 mM sodium
pyruvate (3-13C, >98%). For tracer experiments, a 3% inoculum from unlabeled
stock culture was used to inoculate a 50 mL medium containing labeled carbon
sources. At the mid-log phase of growth, a 3% inoculum from the first isotopic
labeled culture was used to inoculate 50 mL sub-cultures with the same medium
to remove the effect of unlabeled carbon introduced from the initial inoculum.
Cell growth was monitored by a UV-Vis spectrometer (Genesys, Thermo
Scientific, USA) at 730 nm. To perform a comparative study, a glucose tolerant
Synechocystis strain PCC 6803 (a model cyanobacterium for studying
fundamental processes of photosynthetic metabolism) was also cultured in BG11
medium (pH=7.6) under the same growth conditions (continuous light and 30 oC,
(26). The BG11 medium was supplemented with 6 mM glucose (U-13C, >98%) to
support mixotrophic growth. Synechocystis PCC 6803 were also sub-cultured in
.
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the same labeled medium twice before sampling for

13

C-labeled metabolite

analysis.
Metabolite and photosynthetic activity analysis. To analyze metabolites
in Cyanothece 51142, biomass was harvested at the middle-log phase of growth
(~90 hours) by centrifugation at 7,000 rpm for 15 min at 10˚C. The concentrations
of pyruvate, glucose and glycerol were analyzed with enzymatic assay kits (RBiopharm, Germany). To measure hydrogen produced by Cyanothece 51142, 20
ml of culture solution was taken from the culturing flask after three days and
transferred into 35.2 ml glass vials sealed with rubber septa and kept under
continuous light (50 µmol photons∙m-2s-1). A modified protocol was used to
quantify hydrogen (27). Briefly, hydrogen that accumulated in the headspace of
the sealed culture vials (for 5 hours) was withdrawn with a Hamilton gas-tight
syringe and quantified on an Agilent 6890N Gas Chromatograph with a molseive
5A 60/80 column (inner dimensions 6’×1/8”) and Thermal Conductivity Detector.
Injection, oven, and detector temperatures were 100°C, 50°C, and 100°C,
respectively. Argon was the carrier gas (flow rate of 65 ml∙min-1). All
measurements included three biological replicates.
Photosynthesis activities were determined based on measurements of
chlorophyll fluorescence and oxygen evolution. Chlorophyll fluorescence profiles
of photosystem II (PSII) of Cyanothece 51142 under different nutrient conditions
were detected by a FL100 fluorometer (Photon Systems Instruments, Brno, Czech
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Republic) as detailed before (28). All samples taken for measurement were
diluted to OD730 ~0.2 using cell-free ASP2 medium. The samples were first
adapted for 3 min in total darkness. During the measurement (performed at room
temperature), the fluorometer emitted saturating light pulses to determine
samples’ fluorescence yield. The photosynthesis activity was derived by the
maximum quantum yield (Fv/Fm) according to the formula Fv/Fm = (Fm - F0)/Fm,
where F0 is initial fluorescence and Fm is maximum fluorescence at the beginning
of measurement (29).
Oxygen evolution rates of Cyanothece 51142 grown under different
nutrient conditions were measured with a Hansatech oxygen electrode. Assays
were performed at 30 °C on whole cells in ASP2 media with a saturating light
intensity of 8,250 μmol photons∙m-2s-1 for 2 mins in a 2.5-mL reaction volume.
For each reaction, the chlorophyll concentration of each sample was diluted to ~6
μg∙ml-1. The oxygen evolution rates (μmol O2•mg chlorophyll-1•hr-1) were then
measured and normalized based on chlorophyll concentration.
RNA extraction and reverse transcription PCR (RT-PCR). The
bacteria grown under different cultural conditions were harvested at mid-log
phase according to the corresponding growth curves. The total RNA was
extracted by using a PureLink™ RNA Mini Kit (Invitrogen, California),
following the manufacturer’s instruction. cDNA was synthesized from ~2 μg
RNA by using a High-Capacity cDNA Reverse Transcription Kit (Invitrogen,
.
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California). The primers for RT-PCR reactions were designed using Primer
Premier 5 software (PREMIER Biosoft) and analyzed by OligoAnalyzer 3.0
software (Integrated DNA Technologies, Coralville, USA). The forward primer
(AGCGGTGGAGTATGTGGT)

and

reverse

primer

(GGCTGGGTTTGATGAGATT) were employed to amplify a 16S rRNA gene as
a control. The forward primer (CCGACTACACTCCGAAAG) and reverse primer
(ACGTAACGCCCGTAATGC) were used to amplify the Rubisco (rbcL) gene
and the forward primer (TAATCACGAAACGGGAG) and reverse primer
(CACCACATCAGCGTATTG) to amplify the prk gene. The PCRs were
conducted with the following cycle conditions: 2 min of activation of the
polymerase at 94 °C followed by 30 cycles consisting of 1 min at 94 °C, 30 s at
53 °C and 2 min at 72 °C; finally, a 10 min extension process was performed at
72 °C. The final PCR product was observed directly on 2% agarose gels after
electrophoresis.
Isotopic analysis. The preparation and isotopic analysis of proteogenic
amino acids were performed as previously described (30,31). In brief,
exponentially growing biomass from ~20 ml culture was collected by
centrifugation (8,000×g, 10 min, 4˚C) and hydrolyzed in 6 M HCl at 100°C for 24
h. The amino acid mix was dried and derivatized in tetrahydrofuran (THF) and N(tert-butyl dimethylsilyl)-N-methyl-trifluoroacetamide (Sigma-Aldrich, St. Louis,
MO) at 70°C for 1 h. A gas chromatograph (GC) (Hewlett-Packard, model
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7890A, Agilent Technologies Inc., Ballwin, MO) equipped with a DB5-MS
column (J&W Scientific, Folsom, CA) and a mass spectrometer (MS) (5975C,
Agilent Technologies Inc., Ballwin, MO) were used for analyzing amino acid
labeling profiles. The ion [M-57]+ from unfragmented amino acid was detected
and mass fractions of key amino acids were calculated (32). The substrate
utilization ratios R (reflecting the degree of mixotrophic metabolism) were
calculated from the labeling patterns of proteogenic amino acids:
C

0.98 n Vsub 0.01 VCO 2
Amino acid X:
m Vsub VCO 2

(

i Mi)
i 1

C

R

Vsub
(1)
VCO 2

where the ratio R indicated the utilization of labeled carbon substrate over
unlabeled CO2 for producing an amino acid X (and its precursors). Mi was the
GC-MS isotopomer fraction for the given amino acid X (i.e., M0 was the
unlabeled fraction, M1 was the singly labeled fraction, M2 was the doubly labeled
fraction, M3 was the triply labeled fraction, etc). C was the total number of carbon
atoms in the amino acid molecule. Vsub was the carbon flux from

13

C labeled

substrate, VCO2 was the carbon flux from CO2; 0.98 was the purity of the labeled
carbon substrate; 0.01 was the natural abundance of 13C, m was the total number
of carbons in the substrate molecule, and n was the total number of labeled
carbons in the substrate molecule. The ratio R indicated the amount of labeled
carbon that percolated through the central metabolic networks (Figure 3.2.1).
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3.2.4 Results
Cell growth with different carbon and nitrogen sources. Figure 3.2.2
and Supplementary Figure 3.2.S1 shows the effect of carbon and nitrogen
substrates on the growth of Cyanothece 51142 under continuous light. Biomass
growth was significantly enhanced by addition of glycerol to ASP2 medium. For
example, glycerol addition doubled the specific growth rate from 0.28 day-1 to
0.63 day-1 under N2 fixing conditions. These results are consistent with an earlier
report on two Cyanothece strains (16). On the other hand, Cyanothece growth was
not apparently enhanced by either glucose or pyruvate (Supplementary Figure
3.2.S1), and high concentration pyruvate (64 mM) inhibited Cyanothece growth.
Compared to nitrogen fixing cultures, the presence of nitrate salts in the growth
media increased Cyanothece autotrophic growth rates from 0.28 day-1 (N2 fixation
condition) to 0.37 day-1 (nitrate-sufficient condition). Similarly, the presence of
glycerol enhanced growth rate by two-fold (from 0.60 day-1 to 1.02 day-1). As
expected, high concentrations of ammonium salts (17 mM) fully inhibited growth
(data not shown) because of its well-known deleterious effect on photosystems of
cyanobacteria (33,34).
Isotopic analysis of amino acids.

13

C enrichment patterns in key

metabolites were used to estimate the relative utilization of labeled carbon
substrates (i.e., glucose, pyruvate, or glycerol) and CO2 for metabolite synthesis
under mixotrophic growth. Figure 3.2.1 shows the central metabolic pathways in
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Cyanothece 51142 (http://www.genome.jp/kegg/). Five amino acids were
analyzed for their labeling: histidine (precursor: ribose-5-phosphate and 5,10
methyl-THF), synthesized from the Calvin Cycle and pentose phosphate pathway;
serine (precursor: 3-phosphoglycerate, a product from the Calvin Cycle); alanine
(precursor: pyruvate, originated from carbon substrate or CO2 fixation); and
aspartate

and

glutamate

(precursors:

oxaloacetate

and

2-oxoglutarate,

respectively, synthesized from the citric acid cycle). Under nitrate-sufficient
conditions, glycerol could be used as the sole carbon source for synthesis of
alanine, serine, and histidine (as indicated by approximately infinite R values).
This indicates that the cell was undergoing completely heterotrophic metabolism.
R values of some key amino acids in glucose and pyruvate cultures were positive
and thus the two carbon sources were actually utilized for biomass synthesis
(Table 3.2.1). However, their measured R values were between 0 and 0.3, which
indicated that CO2 was the main carbon source for metabolite synthesis. This
result was consistent with the fact that glucose and pyruvate did not apparently
improve the biomass growth. Compared to nitrogen-sufficient conditions,
nitrogen fixing conditions further limited glucose and glycerol utilization, as
shown by the decreased labeling fractions of three key amino acids (i.e., alanine,
serine, and histidine) (Table 3.2.1).
Nitrogenase-dependent hydrogen production, photosynthesis and
Calvin Cycle activity. Hydrogen production under continuous light with different
.
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carbon substrates (N2 as the sole nitrogen source) was measured in the
exponential (day 4) and stationary (day 9) growth phases, respectively
(Supplementary Figure 3.2.S2). In the exponential growth phase under nitrogen
fixing conditions, hydrogen production rates were as follows: for glycerol (25±6
µmol H2/mg chlorophyll/hr); for glucose (13±9 µmol H2/mg chlorophyll/hr); for
pyruvate (4±2 µmol H2/mg chlorophyll/hr); and in the photoautotrophic condition
(5±1 µmol H2/mg chlorophyll/hr). Under all nitrate or ammonium chloride
conditions, hydrogen production was not detected regardless of the carbon
substrate.
The measurement of photosynthetic parameters (Figure 3.2.3) suggested
that, compared to photoautotrophic conditions, addition of an exogenous carbon
source (glycerol, glucose, or pyruvate) did not strongly suppress the maximal
quantum yield of PSII (Fv/Fm) or the oxygen evolution rate. Nitrate-sufficient
conditions enhanced the oxygen evolution rates by 2~3 fold compared to
nitrogen-fixing conditions, while the change of quantum yields of PSII were much
less significant (10~30%). Gene expression in the carbon fixation pathway was
also determined (Figure 3.2.4). Reverse transcription PCR (RT-PCR) results
indicated that two key enzymes in Calvin Cycle (ribulose-1,5-bisphosphate
carboxylase oxygenase (Rubisco, rbcL) and phosphoribulokinase (prk)) were
functional under growth conditions with glycerol or glucose. The above
measurements confirm that the light dependent reactions were active under all
.
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culture conditions, even though carbon substrates reduced the relative amount of
CO2 fixation for biomass synthesis.
3.2.5 Discussion
Carbon substrate utilization and regulation.

In continuous light,

Cyanothece 51142 can efficiently utilize glycerol for aerobic growth. Based on
the measurement of carbon substrates in the culture medium during the
exponential growth phase, the uptake rates of glycerol were 0.22±0.05 g∙(g dry
biomass•day)-1 under nitrogen fixing and 0.35±0.06 g∙(g dry biomass•day)-1 under
nitrate-sufficient conditions. Glycerol promoted Cyanothece 51142 growth
because it provided carbon and energy sources. Under nitrate-sufficient
conditions, the unlimited large value of R from serine, alanine and histidine
labeling data indicated that 3-phosphoglycerate node, pyruvate node and ribose-5phosphate node in the central metabolic pathways (Figure 3.2.1) were completely
originating from glycerol, while the contribution of CO2 photofixation to those
metabolite nodes was negligible. As a comparison, a glucose-tolerant strain of
Synechocystis sp. strain 6803 was cultured with fully labeled glucose under
continuous light and nitrogen-sufficient conditions (Supplementary Figure 3.2.3).
The measured R values (Table 3.2.1) for serine (0.87), alanine (0.92) and histidine
(1.73) indicated that Synechocystis 6803 had a typical mixotrophic growth. In
general, cyanobacterial heterotrophic growth has been reported only under three
conditions: complete darkness, dim light, and pulses of light (35,36). When the
.
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light is sufficient for photoautotrophy, Cyanothece photoheterotrophic growth
was only achieved by addition of photosystem II inhibitors (16). This study shows
that rapidly-growing Cyanothece 51142 cells can shift their metabolic strategies
from mixotrophic or autotrophic growth to photoheterotrophic growth, possibly
because maximal utilization of energy-rich carbon substrate (glycerol) can reduce
energy costs related to CO2 fixation (fixation of one CO2 consumes two ATP and
one NADPH) and building block synthesis so that maximal biomass growth can
be achieved.
On the other hand, glucose was not apparently consumed by Cyanothece
51142 (the consumed concentrations were below 1mM in all experiments). In the
[U-13C] glucose experiments (Table 3.2.1), all five amino acids contained labeled
carbons, which indicated that the labeled glucose had percolated through the
entire central metabolic pathways, thereby confirming the ability of Cyanothece
51142 to metabolize glucose. The R values of all key amino acids were below
0.05 for both nitrogen fixation and nitrate-sufficient conditions, suggesting that a
large fraction of the carbon in the biomass had originated from CO2 fixation. In
contrast, glucose was the most favorable carbon source for Synechocystis species
(3), and the R values (Table 3.2.1) from key amino acids were around (0.4~1.7).
While both Synechocystis 6803 and Cyanothece 51142 have completely annotated
central pathways for glucose metabolism, Synechocystis 6803 contains a glucose
transporter (gene code Sll0771) that shares a sequence relationship with
.
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mammalian glucose transporters (1,37,38). So far, the presence of a glucose
transporter in Cyanothece 51142 has not been rigorously verified. From the
genome database (DOE Joint Genome Institute, www.jgi.doe.gov/), a gene
(cce_3842) was identified as a glucose transport protein that shared weak (25%)
amino acid identity with the Sll0771 protein of Synechocystis PCC6803. Based on
the glucose-dependent growth data, we conclude that the enzymes involved in
glucose transport or utilization in Cyanothece 51142 may not be as efficient as
those of Synechocystis PCC6803.
Analysis of labeled pyruvate-grown Cyanothece cells showed that serine
(whose precursor is 3-phosphoglycerate) and histidine (whose precursor is ribose5-phosphate) were completely unlabeled (R=0). Such labeling profiles suggest
that CO2 was used as the sole carbon source for synthesis of metabolites in
glycolysis and the pentose phosphate pathway (i.e., there was no gluconeogenesis
activity). Pyruvate was used only to synthesize alanine (R=0.3~0.6) and
metabolites in the TCA Cycle: (pyruvateoxaloacetateAsp) (pyruvateacetylCoAcitrate2-oxoglutarateGlu), as reflected by the labeled carbon present
in glutamate and aspartic acid. Interestingly, the R values of alanine (=0.60) and
glutamate (=1.25) were higher under nitrogen-fixing conditions compared to the
nitrate-sufficient conditions, indicating that relatively more labeled pyruvate was
used for glutamate synthesis under these conditions. The nitrogen fixation was via
nitrogenase: N2 + 6 H+ + 6 e− → 2 NH3, and the nitrogenase-generated
.
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ammonium was assimilated into amino acids through the glutamine
synthetase/glutamate synthase pathway (39). Utilization of supplemented
pyruvate for glutamate synthesis could facilitate the nitrogen fixation process.
The enzyme ribulose-1,5-bisphosphate carboxylase oxygenase (RuBisCO)
is known to be the rate-limiting factor in the Calvin Cycle for capturing CO2 to
synthesize three-carbon sugar (glycerate 3-phosphate) (40,41,42). We examined
Rubisco (rbcL) and phosphoribulokinase (prk) gene expression to reveal the
metabolic regulation in the Calvin Cycle at the transcriptional level. Under
photoautotrophic, mixotrophic, and heterotrophic growth conditions, the
expression of the two genes encoding ribulose-1,5-bisphosphate carboxylase
oxygenase (rbcL) and phosphoribulokinase (prk) were clearly observed. Although
Calvin

Cycle

genes

were

expressed,

Cyanothece

51142

still

grew

heterotrophically in the presence of glycerol and nitrate based on the isotopomer
data (no apparent incorporation of CO2 from Calvin Cycle). These inconsistencies
indicate that

13

C-assisted metabolite analysis provides direct readout on actual

metabolic status, while gene expression results cannot be solely relied upon as
there are many possible post-transcriptional regulations involved.
Furthermore, Cyanothece 51142 can fix CO2 via anaplerotic pathways
(i.e., C4 carbon fixation) (43). In the presence of glycerol and nitrate-sufficient
conditions (Table 3.2.1), R ratios for aspartate synthesis were 1.53, much smaller
than the R ratios (R=∞) of Ala, Ser, and His. This indicates the utilization of CO2
.
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for the synthesis of C4 metabolites in the TCA Cycle via anaploric pathways,
even though phototrophic CO2 fixation was significantly inhibited: (1)
PEP+CO2oxaloacetate (catalyzed by phosphoenolpyruvate carboxylase or
phosphoenolpyruvate carboxykinase) or (2) pyruvate+CO2malate (catalyzed by
malic oxidoreductase). Such anaplerotic pathways synthesized key TCA Cycle
metabolites like oxaloacetate and succinate (precursors for chlorophyll).
Meanwhile,

CO2

was

generated

by

two

reactions

(i.e.,

pyruvateacetylCoA+CO2; isocitrate2-oxoglutarate+CO2), which are essential
steps for glutamate synthesis. These catabolic processes cause the loss of
unlabeled carbon when 2nd position labeled glycerol is used as the main carbon
source. Therefore, the coefficients VCO2 (CO2 utilization flux) and R (carbon
utilization ratio) were both negative for glutamate synthesis (Equation 1) in
glycerol supplemented cultures (both nitrogen fixation and nitrate-sufficient
conditions) (Table 3.2.1).
Photosynthesis activity. Photosynthesis activity was estimated by the
Fv/Fm parameter (maximum quantum efficiency of photosystem II) (44). When
glycerol or glucose were utilized, the maximum quantum yield Fv/Fm (i.e,
efficiency of photosystem II) in Cyanothece 51142 was not significantly affected
(changes are within ~30%, Figure 3.2.3a). Although chlorophyll fluorescence
estimation is not an accurate method for determination of absolute PSII activity
(45,46), we have used it in our study as a tool only to confirm active photon
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capture in the light-harvesting antenna complexes of photosystem II under both
heterotrophic and mixotrophic conditions.
Oxygen evolution was measured as one molecule of the pigment
chlorophyll absorbs one photon and uses its energy to generate NADPH, ATP,
and O2 in the light-dependent reactions (47). The oxygen evolution rates in
Cyanothece 51142 rose by 2~3 fold under all nitrate-sufficient conditions
compared to corresponding nitrogen fixation conditions (Figure 3.2.3b). The
significantly higher rates of oxygen evolution indicated that the photosynthetic
process of water splitting was more active and provided more energy (ATP and
NADPH) to support biomass growth under nitrate-sufficient conditions.
Finally, precise determination of the photosynthetic activity is difficult for
Cyanothece 51442, since the metabolic behavior of Cyanothece 51442 fluctuates
under continuous light due to its circadian rhythm (10,15). The photoreaction
activities in Figure 3.2.3 are only qualitative (not quantitative) evidences to
support the presence of active light-dependent reactions under all culture
conditions.
Nitrogen utilization and nitrogenase-dependent hydrogen production.
Under anaerobic condition (using argon gas to flush the culture), hydrogen
production rates of Cyanothece 51142 were as high as 100 µmol/mg
chlorophyll/hr (data not shown). Under aerobic conditions, hydrogen production
enzyme (hydrogenase) was completely inactivated by oxygen (7). Cyanothece
.
80

51142 used nitrogenase for both nitrogen fixation and hydrogen production.
Nitrate, ammonium or some amino acids inhibit nitrogenase activity and thus
fully prohibit aerobic hydrogen production by cyanobacteria (48). Furthermore,
NH4+ is a direct nitrogen source (nitrate is reduced to NH4+) that can be
incorporated into biomass via glutamine / glutamate synthase (49). Cyanothece
51142, however, only grows with low concentration NH4+ (below 1 mM) because
of an observed inhibition effect (48,50). Nitrogen fixation is an energy demanding
process (N2+8H++8e-+16ATP→2NH3+H2+16ADP +16Pi). Addition of glycerol
reduces CO2 fixation via the Calvin Cycle, so more energy (ATP and NADH) can
be directed to nitrogen fixation and thus improve hydrogen production by 4~5
fold (4,5). Glucose and pyruvate cannot significantly promote hydrogen
production because their utilization is very low and their effect on energy
economy is limited. Hydrogen production rates dropped for all mixotrophic
cultures of Cyanothece 51142 after 9 days, suggesting that inhibitory metabolites
accumulated during the cultivation which reduced nitrogenase activities
(40,41,42). Finally, the coexistence of oxygen-evolving photosynthesis and
oxygen-sensitive nitrogen fixation (indicated by hydrogen evolution) is an
attractive characteristic in some cyanobacteria (13,14). Unlike filamentous
cyanobacterial species where nitrogen fixation and oxygenic photosynthesis are
spatially segregated (51), Cyanothece 51142 is able to maintain activities for N2
fixation, respiration, and photosynthesis within the same cell under continuous
light. The strain not only has a strong ability to scavenge intracellular oxygen and
.
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synthesize nitrogenase (9,15), but also develops a highly circadian mechanism for
nitrogen fixation (52).
This study improves our understanding of Cyanothece 51142 physiology
under different carbon and nitrogen sources as well as its potential application for
hydrogen production applications. In general, exogenous carbon substrates may
improve cellular growth, but have strong negative effects on CO2 fixation.
Continuously illuminated Cyanothece 51142 shows simultaneous oxygen
evolution and nitrogenase-dependent hydrogen production, while hydrogen
production can be significantly enhanced by the addition of glycerol. A
comparison of metabolic status under autotrophic, mixotrophic and heterotrophic
growth conditions indicated that Cyanothece 51142 has an inherent metabolic
strategy for maximal biomass production at low energy cost. Finally, this study
has further confirmed that

13

C-assisted metabolite analysis is a high throughput

method which can provide new and precise information to understand a biological
system.
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Figure 3.2.1. Central metabolic pathways of Cyanothece 51142 with glucose,
glycerol, and pyruvate as carbon substrates. The dashed line shows the metabolic
pathway with glycerol as carbon substrate; the bold line indicates glucose; the
solid line shows the common pathway for all carbon conditions. Abbreviations:
ACCOA, acetyl-coenzyme A; Ala, alanine; E4P, erythrose-4-phosphate; F6P,
fructose-6-phosphate; G6P, glucose-6-phosphate; GAP, glyceraldehyde 3phosphate; 3PG, 3-phosphoglycerate; GLY, glycerol; GLU, glucose; His,
histidine; ICIT, citrate/isocitrate; MAL, malate; OAA, oxaloacetate; OXO, 2oxoglutarate; PEP, phosphoenolpyruvate; PYR, pyruvate; R5P, ribose-5phosphate (or ribulose-5-phosphate); R15P, ribulose-1,5-bisphosphate; S7P,
sedoheptulose-7-phosphate; Ser, serine; Xu5P: xylulose-5-phosphate.
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Figure 3.2.2. Cyanothece 51142 growth curves under different nitrogen and
carbon sources (biological replicates, n=3). ◊: Glycerol+Nitrate; □: Glycerol+N2;
Δ: CO2+ Nitrate; ○: CO2+N2. The error bars are smaller than the symbols.
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Figure 3.2.3. Maximum quantum yields (Figure 3.2.3a) of PSII and oxygen
evolution rates (Figure 3.2.3b) in Cyanothece 51142 under different growth
conditions (biological replicates, n=3). All samples were taken at the exponential
growth phase based on the growth curve. Black column, N2 as nitrogen source;
white column, NaNO3 as nitrogen source; Error bars, SD.

(a)

(b)
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Figure 3.2.4. Reverse transcription PCR (RT-PCR) study for ribulose-1,5bisphosphate carboxylase oxygenase (rbcL) and phosphoribulokinase (prk) under
different mixotrophic growth conditions. (a) CO2+N2; (b) CO2+NaNO3; (c)
glycerol+NaNO3; (d) glucose+NaNO3. The 16S rRNA gene was used as the
internal reference; the no template control (NTC) was added under each
mixotrophic growth conditions.
16S

rbcL prk NTC

(a)

16S rbcL prk NTC

(b)

16S

rbcL prk NTC

(c)
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16S rbcL prk NTC

(d)

Supplementary Figure 3.2.S1. The growth of Cyanothece 51142 in the presence
of different carbon and nitrogen substrates under continuous light (n=3). (a) N2 as
□, glucose

nitrogen source; (b) NaNO3 as nitrogen sour

▲, pyruvate (9 mM). The error bars are smaller

(26
than the symbols.
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12

Supplementary Figure 3.2.S2. Hydrogen production under mixotrophic
conditions. Open bars, hydrogen production at day 4; filled bars, hydrogen
production at day 9. The asterisk indicates that hydrogen production was below
the minimum detectable level.
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Supplementary Figure 3.2.S3. Growth of Synechocystis 6803 in the presence of
glucose (6 mM) under continuous light (n=3). 13C-labelled samples were taken in
the midexponential phase (~80 h), when there was still sufficient glucose in the
medium. The error bars are smaller than the symbols.
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Table 3.2.1. Isotopic analysis of the labeling profiles of amino acids in
Cyanothece 51142 and Synechocystis 6803 under different growth conditions (the
standard error for GC-MS measurement was below 0.02, technical replicates,
n=2)
Amino

N2

+

Synechocystis
6803 (nitratemedium)

NaNO3

[M-57]

Glucose R1 Pyruvate

Acids

Ala

Ser

Asp

Glu2

R

Glycerol

R

Glucose

R

Pyruvate

R

Glycerol R Glucose

R

0.04

M0

0.67

0.41

0.19

M1

0.19 0.032

0.55

0.597 0.71

M2

0.11

0.03

M0

0.65

0.98

M1

0.22 0.033

0.02

M2

0.10

0

0.09

0.16

0

0.10

0.28 0.87

M0

0.58

0.54

0.10

0.59

0.94

0.07

0.04

M1

0.24 0.030

0.43

0.195 0.64

0.20 0.032

0.06 0.005 0.78 1.53 0.05 0.44

M2

0.11

0.04

0.25

0.17

0

0.15

0.19

M3

0.06

0

0.01

0.03

0

0

0.47

M0

0.43

0.15

0.02

0.38

0.47

0.01

0.02

M1

0.26 0.041

0.44

0.22 0.051

0.49 0.170 0.15

M2

0.21

0.37

0.62

0.27

0.04

M3

0.07

0.04

0.21

0.09

0

0.10

0.07

M4

0.02

0

0.01

0.03

0

0

0.53

M0

0.44

0.91

0.05

0.33

0.92

0.01

0.01

M1

0.28

0.08

0.28

0.24

0.08

0.21

0.01

M2

0.17 0.032

0

M3

0.07

0

M4

0.03

M5

0

His

0

1.25

0.61

0.51

0.19 0.042

0.48 0.327 0.85

0.10

0.17

0.01

0.07

0.28

0.20

0.58

0.97

0.08

0.04

0.22 0.046

0.03

0.72

0.14

3.7

2.2

1.78

0

0.81

+∞

+∞

0.05 0.92

0.06

0.02 0.76
2.11 0.04
0.74

0.02 1.73

0

0.16

0.12

0

0.20

0.03

0

0

0.07

0

0.03

0.06

0

0

0.01

0

0

0.22

2.83

0

0.55

+∞

0.22 0.049

0

0.50

4.2

0.07

Note: 1. Bold values were the carbon substrate (glycerol, pyruvate, or glucose) utilization
ratios (substrate/CO2 fixation) for amino acid synthesis calculated according to Equation
(1). 2. The glutamate synthesis pathway involved the loss of two carbons from pyruvate
to α-ketoglutarate. Such a microbial process changed the labeling enrichment, and the
negative value indicated the net loss of unlabeled CO2.
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Feng X, Mouttaki H, Lin L, Huang R, Wu B, Hemme CL, He Z, Zhang B, Hicks
LM, Xu J, Zhou J, Tang YJ. Characterization of the central metabolic pathways in
Thermoanaerobacter sp. strain X514 via isotopomer-assisted metabolite analysis.
Appl Environ Microbiol. 2009, 75(15):5001-8.
3.3.1 Abstract
Thermoanaerobacter sp. X514 has great potential in biotechnology due to
its capacity to ferment a range of C5 and C6 sugars to ethanol and other
metabolites under thermophilic conditions. This study investigated the central
metabolism of strain X514 via 13C-labeled tracer experiments using either glucose
or pyruvate as both the carbon and energy source. X514 grew on a minimal
medium and thus contains complete biosynthesis pathways for all macromolecule
building blocks. Based on genome annotation and isotopic analysis of amino
acids, three observations can be obtained about the central metabolic pathways in
X514. First, the oxidative pentose phosphate pathway in X514 is not functional,
and the TCA cycle is incomplete under fermentative growth conditions. Second,
X514 contains (Re)-type citrate synthase activity, although no gene homologous
to the recently characterized (Re)-type citrate synthase of Clostridium kluyveri
was found. Third, the isoleucine in X514 is derived from acetyl-CoA and
pyruvate via the citramalate pathway rather than being synthesized from threonine
via threonine ammonia-lyase. The functionality of the citramalate synthase gene
(CimA, Teth514_1204) has been confirmed by enzymatic activity assay, while the
.
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presence of intracellular citramalate has been detected by mass spectrometry. This
study demonstrates the merits of combining

13

C-assisted metabolite analysis,

enzyme assays, and metabolite detection not only to examine genome sequence
annotations but also to discover novel enzyme activities.
Key words: ethanol, 13C, (Re)-type citrate synthase, isoleucine, citramalate
3.3.2 Introduction
Rising global energy demand and the depletion of fossil energy resources
have resulted in significant environmental, economic, and social impacts.
Production of renewable, biomass-derived energy sources has been suggested as a
partial solution to this problem. Among renewable energy sources, ethanol is an
attractive short-term solution owing to its strong research foundation and its ready
integration with the current petroleum-based infrastructure (53,54). Plant-based
cellulose is the most attractive raw material for bioethanol production (55).
However, the use of anaerobic cellulosic bacteria in consolidated bioreactors has
been proposed as an efficient means of rapid conversion of cellulosic biomass to
ethanol (56). Thermophilic bacteria of the genus Thermoanaerobacter have the
ability to naturally ferment a wide variety of monomeric and polymeric
carbohydrates, including D-xylose, into ethanol (57,58,59). While not celluloseutilizing themselves, Thermoanaerobacter species in co-culture with thermophilic
cellulose-utilizing Clostridium species have significantly higher yields of ethanol
from both cellulose and hemicellulose than from monoculture alone (60,61).
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Therefore, the investigation of carbon metabolism in Thermoanaerobacter sp.
X514 has implications for understanding X514’s potential in bioenergy
production.
Despite the potential importance of X514 in biofuel production, a rigorous
investigation of the central metabolic pathways in X514 has yet to be conducted.
Although an array of functional genomics tools has been applied in predicting this
species’ metabolism (62,63,64), a precise description of cellular metabolism is
complicated by misannotation and by post-transcriptional regulation of protein
synthesis (20,65). The complete genome sequence of X514 from the KEGG
database (http://www.genome.jp/kegg/) suggests a few gaps in several essential
pathways involved in the biosynthesis of amino acids (e.g. isoleucine) and in the
TCA cycle (e.g., citrate synthase). Therefore, X514 would not survive without
supplements of isoleucine or other essential nutrients. However, X514 can
actually grow in a completely minimal medium. Hence, the metabolism of X514
cannot be precisely revealed by genome sequence annotation alone. At this time,
one of the most physiologically reliable methods for determining cell metabolism
remains 13C-based isotopic analysis (20,21,22,66). Based on 13C-labeling patterns
in key amino acids, the active pathways can be traced back, and new enzymes can
be revealed. In this study,

13

C-based isotopic analysis was applied to accurately

examine the annotated pathways in X514 and to investigate gaps in key
biosynthetic pathways (22,31,67). Specifically, glucose (1st or 6th carbon labeled)
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and pyruvate (1st carbon labeled) were used respectively as the sole source of
carbon to grow X514. By analyzing the mass spectra of different fragmentations
in proteogenic amino acids derived from various pathways, we have determined
the active fluxes of intracellular pathways (e.g., the pentose phosphate pathway
and citric acid cycle). Meanwhile, misannotations in the genome sequence were
checked and unknown enzymes involved in the pathway were identified. The
isotopomer analysis linked the genome annotation to the final enzyme-functional
output and thus significantly improved our understanding of the regulation of the
central metabolism of X514.
3.3.3 Materials and methods
Medium and cultivation conditions. Thermoananerobacter sp. X514
was grown anaerobically at 60°C without shaking (68). The minimal medium
contained (per liter) 1 g of NaCl, 0.5 g of MgCl2, 0.2 g of KH2PO4, 0.3 g of
NH4Cl, 0.3 g of KCl, 0.015 g of CaCl2, 0.25 mg of resazurin, 0.031 g of Lcysteine-HCl, 0.048 g of Na2S, 2.52 g of NaHCO3 and 1 ml trace element
solution. One liter of trace element solution included: 10 ml 25% w/w HCl
solution, 1.5 g of FeCl2, 0.19 g of CoCl2, 0.1 g of MnCl2, 70 mg of ZnCl2, 6 mg of
H3BO3, 36 mg of Na2MoO4, 24 mg of NiCl2, 2 mg of CuCl2, 6 mg of Na2SeO3, 8
mg of Na2WO4, and 0.5 g of NaOH. The pH of the medium was adjusted with
NaOH to 7.2-7.3. The vitamin solution was prepared according to the method
developed by Wolin et al. (69). The rich medium was prepared by adding 0.1%
.
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yeast extract to the minimal medium. Three types of 13C-labeled carbon substrates
were obtained from Cambridge Isotope Laboratories, Inc. (Andover, MA) and
used for cell culture: pyruvate ([1-13C], 98%), glucose ([1-13C], 98%), or glucose
([6-13C] , 98%). The medium was flushed with N2 and was filter-sterilized. All
gases, including nitrogen and a nitrogen-CO2 mixture, were obtained from Airgas,
Inc. (Radnor, PA). The strain was initially grown in a 50-ml culture medium with
an unlabeled carbon source (glucose or pyruvate). At the mid-log phase of
growth, a 3% inoculum was added to a 50-ml culture containing one of the
following carbon sources: 2.1 g/L of [1-13C] glucose, 2.1 g/L of [6-13C] glucose,
or 2.2 g/L 1st-position labeled pyruvate. At the mid-log phase of growth in this
culture, 3% inoculum from the first

13

C-labeled culture medium was used to

inoculate a 50-ml sub-culture (with the same labeled carbon source), which
reduced the effect of unlabeled carbon from the initial stock.
Analytical methods. Biomass was harvested at the late-log phase of
growth by centrifugation at 8,000 g for 15 min at 10°C. The concentrations of
glucose, acetate, ethanol, and lactate were analyzed with a high performance
liquid chromatography apparatus (Agilent Technologies, CA) equipped with a
variable wavelength (190-600 nm) detector (VWD) (the UV absorption at 245
nm), and an ion exclusion column (Aminex HPX-87H, 300 mm × 7.8 mm, BioRad Laboratories, CA) operating at 55°C. The mobile phase consisted of 0.025 %
sulfuric acid at a flow rate of 0.6 ml/min.
.
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Isotopic analysis. The preparation and isotopic analysis of proteogenic
amino acids were performed as previously described (30,67). In brief, biomass
was hydrolyzed in 6 M HCl at 100°C for 24 h. The amino acid solution was dried
under air flush overnight, and amino acid samples were derivatized in
tetrahydrofuran

(THF)

and

N-(tert-butyl

dimethylsilyl)-N-methyl-

trifluoroacetamide (Sigma-Aldrich, St. Louis, MO) at 70°C for 1 h.

A gas

chromatograph (GC) (Hewlett-Packard, model 7890A, Agilent Technologies, CA)
equipped with a DB5-MS column (J&W Scientific, Folsom, CA) and a mass
spectrometer (MS) (model 5975C, Agilent Technologies, CA) was used for
analyzing amino acid labeling profiles. Three types of charged fragments were
detected by GC-MS for most amino acids: the [M-57]+ group, which contained
unfragmented amino acids; the [M-159]+ group, which contained amino acids
losing α carboxyl group; and the [f302]+ group, which contained only 1st (α
carboxyl group) and 2nd carbons in an amino acid backbone. (However, [f302]+
cannot be detected in some amino acids.) Published algorithms were used to
correct the effects of natural isotopes on the mass distributions of amino acids
(32), and the final isotopomer distribution was shown in Tables 3.3.S1 and 3.3.S2.
Ion mass fractions in Tables 3.3.S1 and 3.3.S2 were given for the amino acid
fragments. M0, M1, M2… were fractions of unlabeled, singly labeled, and doubly
labeled amino acids, respectively.
Confirmation of citramalate synthase. The citramalate synthase activity
.
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was assayed by monitoring the pyruvate-dependent production of CoA over time
(70,71). In brief, X514 cells from a 10-ml culture in the mid-log phase were
centrifuged (19,000 g for 10 min, 4°C). The total protein content in the biomass
was estimated using Bradford protein assay (Bio-Rad Laboratories, Inc, CA).
X514 cell extracts were then prepared by sonication of X514 pellets for 3 minutes
(30 sec on / 20 sec off) in 2 ml of a 0.1 M TES [N-tris (hydroxymethyl) methyl-2aminoethanesulfonic acid, pH 7.5] buffer. Samples to be measured were brought
to a final volume of 1000 μl by mixing with cell extracts (100 μl), the TES buffer
(0.2 M, pH 7.5, 500 μl), pyruvate (10 mM, 100 μl), acetyl-CoA (50 mM, 20 μl),
and distilled water. The resulting solutions were then incubated in the oven at
60°C for 2 h. At intervals of 20 min, 100 μl of either test samples or blank
samples were taken from the oven and mixed with a 900-μl stop solution. The
stop solution was prepared in distilled water with 50 μl of 10 mM DTNB [5, 5’dithio-bis (2-nitrobenzoic acid)] in 0.1 M Tris-HCl and with 70 μl of 1 M TrisHCl. The absorbance at 412 nm was recorded immediately and blanked against an
identical incubation sample without pyruvate. The micromoles of HS-CoA
produced were calculated from a standard curve generated with known
concentrations (0 to 1 mM) of 2-mercaptoethanol and based on the linear function
between the product formation and the amount of enzyme added over the 2-hour
time period of the assay. All the chemicals employed in this measurement were
from Sigma-Aldrich (MO, USA).
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LC-MS/MS was further applied to confirm the presence of citramalate in
X514. In this study, the free intracellular metabolites were extracted with a cold
methanol-water solution (60%, v/v) and chloroform mixture (1:1), held at -20°C
overnight. Subsequently, cold water was added to separate free metabolites from
those components that might interfere with the results. The extracts were then
lyophilized. After being dissolved with 1% formic acid in water, 50 µL samples
were injected into the LC-MS/MS for separation and detection. The LC-MS/MS
system was composed of a Shimadzu LC system (Shimadzu Corporation, Japan,
http://www.shimadzu.com),

a

LEAP

CTC

PAL

autosampler

(LEAP

Technologies, USA, http://www.leaptec.com), and an Applied Biosystems 4000
QTRAP

mass

spectrometer

(Applied

Biosystems,

USA,

http://www.appliedbiosystems.com) equipped with a TurbolonSpray electrospray
ion source. 5 µM of citrate, malate, and citramalate standards (Sigma, MO, USA)
in water were separately infused into the mass spectrometer to optimize
compound-dependent parameters for multiple reaction monitoring (MRM)
detection and to obtain corresponding MS/MS spectra. LC separation was
achieved by coupling three 4.6×300 mm Onyx Monolith C18 columns
(Phenomenex, CA) in tandem. The LC gradient was delivered at 1 ml/min with
Solvent A: 0.1% formic acid in water, and Solvent B: 0.1% formic acid in
methanol. The gradient started from 5% B and was kept isocratic for 4 min, then
ramped to 20% within 7 min, and increased to 95% B within 1 min. Finally, after
being held at 95% B for 8 min, the gradient was ramped down to 5% B, where it
.
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remained for 4 min to re-equilibrate the column.
3.3.4 Results
Growth and metabolite curves. When X514 was cultivated in the
minimal medium, the lag phase for X514 in the 13C labeled glucose was 12 hours
and was followed by an exponential growth phase with a doubling time of ~15-19
hours (Fig. 3.3.1a). This rate was much slower than X514’s growth rate in the rich
medium (with 0.1% yeast extract), which was measured a doubling time of 6
hours. Fig. 3.3.1b shows both the glucose consumption and the production of
ethanol, acetate, and lactate when X514 was grown in the minimal glucose
medium. No formate was detected during the culturing. The ability to grow in the
minimal medium using glucose (or pyruvate, data not shown) indicates that X514
contains the necessary biosynthetic pathways for all macromolecule building
blocks (i.e., for synthesizing amino acids).
Confirmation of amino acid biosynthetic pathways. According to the
genome annotation from the KEGG resource (http://www.genome.jp/kegg/), two
amino acid biosynthetic pathways (isoleucine and proline) were incomplete. To
examine biosynthetic pathways in X514, the labeling profiles of 14 proteogenic
amino acids were analyzed (Tables 3.3.S1 and 3.3.S2). Since pyruvate is the key
metabolite in the central pathway (i.e., glycolysis, pentose phosphate pathway,
and TCA cycle), the labeling profiles of amino acids from tracer experiments that
use 1st-position labeled pyruvate as the carbon source can easily identify the
.
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precursors of several key amino acids (Table 3.3.S2). For example, alanine,
valine, and serine demonstrated the same carbon molecule-labeling pattern as that
of pyruvate (Table 3.3.S2), which confirms that pyruvate is the common precursor
of these three amino acids (Fig. 3.3.2). The aromatic amino acids phenylalanine
and tyrosine were derived from phosphoenolpyruvate (also synthesized from
pyruvate). The labeling patterns of the [f302]+ group (containing the 1st and 2nd
carbons of fragmented amino acids) for alanine, phenylalanine, and tyrosine were
all identical. This fact indicates that the 1st and 2nd carbons of all three amino
acids are originally derived from the 1st and 2nd carbons of pyruvate.
In tracer experiments using the 1st-position labeled pyruvate, the similar
labeling patterns of aspartate, methionine, and threonine in Table 3.3.S2 suggest
the same precursor (oxaloacetate) for the three amino acids. Based on the KEGGgenerated pathway map, oxaloacetate is expected to be synthesized from pyruvate
(labeled at its first position), and CO2 (labeled because it is cleaved from the 1st
carbon of pyruvate), leading to the labeling of two carbons in oxaloacetate and
aspartate (both α- and β- carboxyl group) (Fig. 3.3.2). In tracer experiments using
[1-13C] or [6-13C] glucose as the carbon source, the labeling percentage of
methionine was higher than that of aspartate from the same experiment, as a result
of the addition of

13

C-enriched C1 pool (5, 10 methyl-THF) into the carbon

backbone of methionine (synthesis route: aspartate + C1 poolmethionine). The
labeled carbon entered the C1 pool via the glucoseserineglycine+C1 pool
.
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(Fig. 3.3.2), which caused more methionine to be labeled.
Alternate

isoleucine

pathway.

Anaerobic

bacteria

such

as

Methanococcus jannaschii and Leptospira can biosynthesize isoleucine from
citramalate by direct condensation of acetyl-CoA and pyruvate (70,72). Recently,
Risso et al. (71) first used

13

C-assisted metabolic flux analysis and biochemistry

assays to discover an alternate isoleucine pathway in Geobacter sulfurreducens.
Interestingly, X514 may also contain a similar alternate isoleucine pathway. The
labeling patterns of leucine and isoleucine in both glucose and pyruvate tracer
experiments were similar. For example, the pyruvate experiment demonstrated
that the M0 ([M-159]+, without the carboxyl group) of both leucine and isoleucine
was >91%, indicating that the C2~C6 carbons in both leucine and isoleucine were
mostly unlabeled. Such labeling patterns in isoleucine are unexpected unless
isoleucine shares the same precursors (pyruvate and acetyl-CoA) as leucine.
According to the genome annotation, X514 lacks threonine ammonia-lyase (EC
4.3.1.19), which is necessary for the biosynthesis of isoleucine from threonine;
this result is supported by our labeling data: when [1-13C] pyruvate was used as
the carbon source, threonine was labeled with two carbons (M2 [M-57]+ >93%),
while isoleucine (C2~C6) was not labeled (note: the GC-MS could not detect the
labeling information for the first carbon of isoleucine due to the peak overlap
(73)). We propose an alternate isoleucine synthesis pathway via the citramalate
pathway that uses pyruvate and acetyl-CoA as precursors (Fig. 3.3.3). The key
.
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enzyme regulating the citramalate pathway (citramalate synthase, CimA) is
annotated in X514 (gene: Teth514_1204) (22,71).
In order to determine whether the citramalate pathway was active in X514,
crude soluble extracts from mid-log phase cells were tested for the presence of
citramalate synthase activity (about 27±9 nmol/mg protein/min). Furthermore, we
applied high sensitivity mass spectrometry to detect whether there was any
intracellular citramalate in X514. Fig. 3.3.S1 indicates that malate, citrate, and
citramalate were clearly detected in the X514 soluble extracts by LC/MS/MS in
the MRM mode. The retention time and the ratio of multiple MRM transitions
selected for each of the three targeted compounds are in agreement with those of
the respective authentic standards. Although CID spectra signals for the three
targeted compounds in X514 soluble extracts were lower than the spectra signals
of authentic standards, the major fragments and their relative abundance agreed
with their corresponding standards (Fig. 3.3.S2). This result provides additional
evidence to prove the presence of citramalate synthase in X514.
(Re)-type citrate synthase. In spite of the production of citrate by X514
(Fig. 3.3.S1), the genome annotation indicates that the enzyme in the first step of
TCA cycle, i.e. the (Si)-type citrate synthase, is missing. Interestingly, the
isotopomer data from the 1st-position labeled pyruvate experiment suggests that
the α-carboxyl group of glutamate is not labeled (Table 3.3.S2). Such an
observation of the labeling pattern of glutamate is consistent with the main
.
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characteristics of (Re)-type citrate synthase, which has been discussed in detail in
our previous study on (Re)-type citrate synthase in Desulfovibrio vulgaris
Hildenborough (22). Due to the lack of a regular (Si)-type citrate synthase, X514
may employ the (Re)-type citrate synthase. Fig. 3.3.2 shows the proposed carbon
transition routes from labeled pyruvate (α-carboxyl group) to doubly labeled
oxaloacetate (both α- and β- carboxyl group). The β-carboxyl group of 2oxoglutarate and the β-carboxyl group of glutamate were ultimately derived from
the β-carboxyl group of oxaloacetate.
Pentose phosphate pathway. About 50% of alanine was not labeled ([M57]+, M0 =0.51) when the [1-13C] glucose was used as the carbon source (Table
3.3.S1). The glucose carbon backbone loses the first carbon as CO2 when it is
metabolized via the oxidative pentose phosphate pathway (PP pathway) to
synthesize 5-carbon sugars (C5P) (Fig. 3.3.2). If the oxidative pentose phosphate
pathway is not active, one glucose molecule (with either 1st or 6th carbon labeled)
converts to two pyruvate molecules, and thus ~50% of pyruvate (inferred from
alanine) is expected to be unlabeled. The fact that the fraction of unlabeled
alanine was 51±2% indicates the very low activity of the oxidative pentose
phosphate pathway, i.e., the carbon flux split ratio between G6PC5P (oxidative
pentose phosphate pathway) and G6PG3P (glycolysis) was <3% (the algorithm
for calculating the split ratio was provided in the supplementary material). Since
the oxidative pentose phosphate pathway was not active, the isotopomer labeling
.
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patterns of most amino acids in the [1-13C] glucose experiment were identical to
those in the [6-13C] experiments (Table 3.3.S1).
3.3.5 Discussion
This study has examined the pentose phosphate pathway, amino acid
biosynthesis and TCA cycle in Thermoanaerobacter sp. X514 by

13

C labeling

experiments. X514 shows very low activity in the oxidative phase of the pentose
phosphate pathway under glucose fermentation conditions. Such an observation is
consistent with the missing of 6-phosphogluconolactonase (EC 3.1.1.31) gene,
which catalyzes 6-phospho-D-glucono-1,5-lactone to 6-phospho-D-gluconate.
Considering the important role of the oxidative pentose phosphate pathway in
providing NADPH for biosynthesis, alternate NADPH pathways should be
present in X514. Some bacteria utilize transhydrogenase PntAB or UdhA for
NADPH generation (74), but a BLASTP search (75) indicates that neither of the
two transhydrogenases is encoded in the X514 genome (Fig. 3.3.S3). Although
NADPH-dependent

isocitrate

dehydrogenase

is

annotated

in

X514

(Teth514_0327), it may provide only limited NADPH since the TCA cycle is
branched and is mainly used for biosynthesis. On the other hand, ferredoxinNADP+ reductase (e.g., Teth514_0652) and pyruvate:ferredoxin oxidoreductase
(e.g., Teth514_0781, the enzyme that catalyzes the production of ferredoxin from
pyruvate) are annotated in the X514 genome and may be key sources of NADPH
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in X514. Ferredoxin-NADP+ reductase activity has been well documented in
certain thermophilic anaerobes for NADPH production (76).
The discovery of an alternative pathway for isoleucine synthesis and (Re)type citrate synthase activity demonstrates the unique metabolism of X514.
Isoleucine is synthesized from the citramalate pathway so that both leucine and
isoleucine share the same precursors (pyruvate and acetyl-CoA). Multiple lines of
evidence support an alternate isoleucine biosynthesis pathway via citramalate in
X514: 1) labeling patterns in key amino acids, 2) genomic evidence (i.e. presence
of citramalate synthase gene but absence of threonine deaminase gene), 3)
detection of citramalate synthase activity, 4) detection of citramalate via LCMS/MS. In some organisms, citramalate is used for reactions other than
isoleucine biosynthesis. For example, during Rhodospirillum rubrum phototrophic
growth on acetate and CO2, citramalate (formed via the condensation of acetate
and pyruvate) can be degraded to glyoxylate and propionate (77). This pathway
allows R. rubrum to assimilate acetate and synthesize intermediates in TCA cycle
(i.e., succinate). On the other hand, Atsumi and Liao (78) introduced citramalate
synthase (CimA) to E.coli and successfully evolved a new 2-oxobutanoate
synthetic pathway for both 1-propanol and 1-butanol production (9- and 22-fold
higher production, respectively). Therefore, the citramalate pathway in X514
could be potentially utilized in bio-butanol production.

.
107

A (Re)-type citrate synthase was recently reported in both Clostridium
kluyveri (CKL 0973) and Desulfovibrio spp. (79). (Re)-type citrate synthase and
(Si)-type citrate synthase are phylogenetically unrelated. (Re)-type citrate
synthase is O2 sensitive and thus restricted to anaerobic microorganisms. Using a
JGI genome database search by May 2009 (http://img.jgi.doe.gov, with the
BLAST search score >400 and with identity of amino acid sequences >40%), we
found that ~200 microbial species may be annotated with citramalate synthase (a
key step for an alternate isoleucine synthesis pathway), while ~40 stains may have
(Re)-type citrate synthase (with the BLAST search score >290 and with identity
>40%). A few species may contain both citramalate synthase and the (Re)-type
citrate synthase (Table 3.3.1), including Desulfovibrio desulfuricans and
Desulfovibrio

vulgaris

Hildenborough.

Thermoanaerobacter

sp.

X514,

Dehalococcoides ethenogenes and Pelotomaculum thermopropionicum species
contain neither (Si)-type citrate synthase nor the documented (Re)-type citrate
synthase, but all encode citramalate synthase. Table 3.3.1 indicates that the
citramalate pathway and (Re)-type citrate synthase may be more widespread in
microorganisms than originally thought.
(Re)-type citrate synthase-like activity was observed in X514. A
candidate (Re)-type citrate synthase gene in X514 should be identifiable through a
BLAST search of the polypeptide amino acid sequences (Fig. 3.3.S4). However,
no gene candidate is identical to the reported (Re)-type citrate synthase in
.
108

Clostridium kluyveri (CKL 0973), and thus, X514 may contain an undocumented
(Re)-type citrate synthase. However, X514 contains homocitrate synthase
(Teth514_0415: 2-oxoglutarate+acetylCoAhomocitrate) and isopropylmalate
synthase

(Teth514_0014:

3-methyl-2-oxobutanoate+acetylCoA2-

isopropylmalate), which are phylogenetically related to the reported (Re)-type
citrate

synthase

(oxalacetate+acetylCoAcitrate).

More

importantly,

Teth514_0416 is annotated as aconitate hydratase (citrateisocitrate), and this
gene is in the same operon with homocitrate synthase (Teth514_0415). Therefore,
homocitrate synthase (Teth514_0415) can be a potential (Re)-type citrate synthase
candidate, and further experimentation is required to test this hypothesis.
Interestingly,

citramalate

synthase

(Teth514_1204:

pyruvate+acetyl-

CoAcitramalate) condenses acetyl-CoA and organic acids to form metabolites
structurally similar to citrate. This enzyme also belongs to the isopropylmalate
synthase/homocitrate synthase family.
In summary,

13

C isotopic analysis is a powerful tool to examine the

metabolic networks of sequenced species and to predict novel enzymes. Our
results suggest an inactive pentose phosphate pathway and an alternate isoleucine
biosynthesis pathway via citramalate in X514. Furthermore, X514 also
demonstrates the (Re)-type citrate synthase activity. A comprehensive
understanding of metabolism in Thermoanaerobacter sp. X514 could have dual
significance for both rational genetic engineering of microorganisms in biofuel
.
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production (78) and the investigating of the evolution for phylogenetically related
pathways.
3.3.6 Supporting information
Flux calculations in oxidative pentose phosphate pathway. The flux
directed into the oxidative pentose phosphate (PP) pathway can be measured
using the labeling profile of alanine. We assume that the flux through glycolysis is
v1 and that the flux through oxidative pentose phosphate pathway is v2. The
replenished route from the oxidative pentose phosphate pathway to glycolysis is
v3. Hence, the percentage of fluxes directed into the pentose phosphate pathway
would satisfy:

v2
v1

v2

100%
.

In pure [1-13C]-glucose experiments, the flux to unlabeled alanine through
glycolysis is 0.5 v1, while the flux to unlabeled alanine through pentose phosphate
pathway is v3. Hence, the percentage of unlabeled alanine satisfies:

ala

0.5v1 v3
100%
v1 v3

When G6P enters the pentose phosphate pathway, the first carbon is lost
as CO2. Hence, only five carbons from the six-carbon glucose flow into C5P. C5P
is then re-formed to synthesize G3P. Based on the mass balance, the equilibrium
.
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should satisfy:
5
v2
6 .

v3

From the [M-57]+ data in GC-MS, the percentage of unlabeled alanine is
51%. Hence,

ala

0.5v1 v3
100%
v1 v3

51%
.

With all the equations above, the percentage of flux directed into the
pentose phosphate pathway is 2.4%.
Note: when the 6th carbon of glucose was labeled, the labeled carbon
incorporated into E4P (the precursor of phenylalanine) via the reductive PP
pathway. However, when the 1st carbon of glucose was labeled, the resulting E4P
was not labeled via PP pathway, so the labeling percentage of phenylalanine was
lower when the 1st carbon of glucose was used as carbon source (Table 3.3.S1).
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Figure 3.3.1. Thermoanaerobacter sp. X514 growth and metabolite secretion. (a)
Growth curves of Thermoanaerobacter sp. X514 in minimal glucose medium
(symbol: ○) and rich medium (with 1g/L yeast extract) (symbol: □). (b) Glucose
consumption and metabolite production by Thermoanaerobacter sp. X514 in
minimal glucose medium: glucose (symbol: ■); acetate (symbol: ◊); lactate
(symbol: □); ethanol (symbol: ○).
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60

Figure

3.3.2.

Proposed

scheme

Thermoanaerobacter sp. X514.

13

of

central

metabolic

pathways

in

C labeled positions in metabolites are marked

with an asterisk (*) for the 1st-position labeled pyruvate experiment. The inactive
pathways are marked with dashed lines. Based on the genome annotation in
KEGG database, some genes that are missed in the pathways are marked by
dashed boxes. C5P: ribulose 5-phosphate, ribose 5-phosphate and xylulose 5phosphate.
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Figure 3.3.3. Proposed scheme of isoleucine biosynthesis in Thermoanaerobacter
sp. X514 (using 1st-position labeled pyruvate as the carbon source).

13

C labeled

positions are marked with asterisks. The inactive pathway is marked by dashed
line.
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Figure 3.3.S1. Separation and detection of malate, citrate and citramalate in
Thermoanaerobacter sp. X514 sample by LC-MS/MS in MRM mode. The
multiple MRM transitions used for confident detection of the three target
compounds in the sample are: 1) malate: 133/89, 133/71, 133/73, 133/43; 2)
citrate: 191/129, 191/111, 191/87, 191/85; 3) citramalate: 147/87, 147/85, 147/57,
147/43, 147/41; 4) UN: unidentified compounds. The colors represent different
transitions used in this method. Malate eluted at 5.6 min, citrate at 7.6 min and
citramalate at 8.5 min. The peak at 9.0 min was an uncharacterized compound that
shared the same MRM transitions as malate, but with different ratios.
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Figure 3.3.S2. Comparison of CID mass spectra of authentic standards with target
compounds in sample X514. Left panel: CID mass spectra of authentic standards.
Right panel: corresponding CID mass spectra in sample X514 after background
subtraction to remove background noise.
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Figure 3.3.S3. The BLASTP (80) result of transhydrogenase PntA and UdhA in
the genome of Thermoanaerobacter sp. X514. Neither gene was annotated.
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Figure 3.3.S4. Protein sequences of (Re)-type citrate synthase (CKL0973) were
compared against the strain X514 genome (http://www.jgi.doe.gov) using BLAST
search. The resulting polypeptide amino acid sequence identity was low: 27% for
homocitrate synthase and 23% for 2-isopropylmalate synthase.
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Table 3.3.1. BLAST searches (May, 2009) for the key genes in an
isoleucine synthesis pathway (citramalate synthase, GSU 1798), for
citrate synthase (EC 2.3.3.1 from E.coli K12) and for (Re)-type citrate
(CKL 0973 from Clostridium kluyveri) in the Joint Genome
(http://img.jgi.doe.gov).
EC 2.3.3.1

alternate
(Si)-type
synthase
Institute

EC 2.3.3.3 (CKL 0973) EC 2.3.1.182

Species
(Si)-type citrate synthase (Re)-type citrate synthase

GSU1798

*Thermoanaerobacter sp. X514 (B)[F]

0%

27%

49%

Anaerocellum thermophilum DSM 6725 (B)[D]

0%

68%

51%

Caldicellulosiruptor saccharolyticus DSM 8903 (B)[F]

0%

68%

51%

Caldivirga maquilingensis IC-167 (A)[F]

39%

41%

47%

Candidatus Kuenenia stuttgartiensis (B)[F]

0%

55%

54%

Clostridium acetobutylicum ATCC 824 (B)[F]

0%

65%

50%

Clostridium botulinum A ATCC 3502 (B)[F]

0%

73%

22%

Clostridium kluyveri DSM 555 (B)[F]

28%

100%

29%

Clostridium cellulolyticum H10 (B)[F]

30%

60%

50%

Clostridium thermocellum ATCC 27405 (B)[F]

30%

60%

51%

Clostridium phytofermentans ISDg (B)[F]

30%

62%

25%

Desulfovibrio desulfuricans G20 (B)[F]

0%

48%

55%

Desulfovibrio vulgaris Hildenborough (B)[F]

0%

48%

55%

Desulfovibrio vulgaris DP4 (B)[F]

0%

48%

55%

Desulfovibrio vulgaris Miyazaki F (B)[F]

0%

49%

55%

*Dehalococcoides ethenogenes 195 (B)[F]

0%

28%

53%

Syntrophus aciditrophicus SB (B)[F]

0%

49%

55%

Syntrophobacter fumaroxidans MPOB (B)[F]

32%

50%

59%

*Pelotomaculum thermopropionicum SI (B)[F]

0%

29%

56%

Ignicoccus hospitalis KIN4/I (A)[F]

0%

50%

45%

Note:
1. Domains: (B)acteria, (A)rchaea.
2. Genome Completion: [F]inished, [D]raft.
3. Both (Si)- and (Re)-type citrate synthases in the species (with “*” in front)
may be missing due to the low identity (<30%) of polypeptide amino acid
sequences to the documented (Si)- and (Re)-type citrate synthases.
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Table 3.3.S1. Isotopic analysis of amino acids in Thermoanaerobacter X514
Amino Acids

[M-57]+
[1- C]/[6-13C]
0.51/0.49
0.47/0.50
0.01/0.01

[M-159]+
[1-13C]/[6-13C]
0.51/0.49
0.45/0.47
0.04/0.03

[f302]+
[1- C]/[6-13C]
ND

Precursors

Ions

Pyruvate

M0
M1
M2

Gly

Serine

M0
M1
M2

0.95/0.96
0.05/0.03
0/0

0.97/0.97
0.03/0.03

ND

Val

Pyruvate

M0
M1
M2

0.26/0.24
0.49/0.49
0.24/0.26

0.26/0.24
0.49/0.48
0.24/0.26

0.90/0.91
0.08/0.06
0.02/0.03

Pyruvate
Acetyl-CoA

M0
M1
M2
M3

Overlap
Peak with
f302

0.14/0.12
0.38/0.37
0.36/0.37
0.12/0.13

Pyruvate
Acetyl-CoA

M0
M1
M2
M3

Overlap
Peak with
f302

0.18/0.17
0.41/0.41
0.32/0.33
0.08/0.09

Aspartate
Methy-THF

M0
M1
M2
M3

0.35/0.32
0.48/0.51
0.16/0.16
0/0.01

0.35/0.36
0.49/0.48
0.15/0.14
0.01/0.02

G3P

M0
M1
M2

0.54/0.52
0.44/0.48
0.02/0

0.55/0.53
0.45/0.47
0.01/0

Aspartate

M0
M1
M2

0.51/0.47
0.47/0.52
0.02/0

0.52/0.46
0.48/0.51
0/0.02

M0
M1
M2
M3
M4

0.19/0.05
0.42/0.29
0.30/0.44
0.08/0.21
0.01/0.01

0.20/0.06
0.42/0.29
0.30/0.43
0.08/0.21
0/0.01

0.97/0.98
0.03/0.02
0/0

M0

0.50/0.47

0.50/0.48

0.97/0.98

Ala

Leu

Ile

Met

Ser

Thr

Phe

PEP
E4P

Asp/Asn

OAA

13
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13

ND

ND

ND

0.96/0.99
0.04/0
0/0.01

Glu/Gln

Tyr

OXO

PEP
E4P

M1
M2

0.48/0.52
0.02/0.01

0.48/0.49
0.01/0.02

0.03/0.02
0/0

M0
M1
M2
M3

0.26/0.24
0.49/0.49
0.25/0.26
0.01/0.01

0.27/0.24
0.49/0.49
0.23/0.26
0/0

ND

M0
M1
M2
M3
M4

0.19/0.05
0.42/0.32
0.30/0.41
0.08/0.21
0.01/0.01

0.20/0.08
0.41/0.31
0.310.38
0.08/0.21
0.01/0.02

0.97/0.97
0.03/0.03
0/0

Notes for Table 3.3.S1 ~ 2:
1. Ion mass values represent amino acid molecules with specific
fragmentation patterns: ([M-57]+: No loss); ([M-159]+: Loss of α carboxyl
group); ([f302]+: 1st and 2nd carbons in amino acids). ([M-159]+: Loss of α
carboxyl group) of threonine was replaced by ([M-85]+: Loss of α
carboxyl group) because the later ion had clearer signals.
2. [f302]+ peaks of some amino acids overlapped with other peaks, so [f302]+
only qualitatively reflects the labeling status in amino acids.
3. Asparagine and glutamate were converted into aspartate and glutamine
during the protein hydrolysis.
4. Abbreviations: E4P, erythrose-4-phosphate; OAA, oxaloacetate; OXO, 2ketoglutarate; PEP, phosphoenolpyruvate; G3P, 3-phosphoglycerate.
5. The standard deviations for measurement (n=2) of mass fractions are
below 2%.
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Table 3.3.S2. Isotopic analysis of amino acids in Thermoanaerobacter sp. X514
and their labeling positions ([1-13C] pyruvate)
Amino
Acids

Precursors

Ions

[M-57]+

[M-159]+

[f302]+

Ala

Pyruvate

M0
M1
M2

0.02
0.96
0.02

0.93
0.02
0.04

0.03
0.95
0.02

Serine

M0
M1
M2

0.03
0.96
0.01

0.99
0.01

ND

Pyruvate

M0
M1
M2

0.01
0.94
0.04

0.95
0.04
0

0.12
0.87
0.01

0.93
0.06

ND

Gly

Val

M0
M1

Overlap
Peak
with f302

Leu

Pyruvate
AcetylCoA

Ile

Pyruvate
AcetylCoA

M0
M1
M2
M3

Overlap
Peak
with f302

0.91
0.08
0.01
0

Met

Aspartate
MethyTHF

M0
M1
M2
M3

0
0.03
0.92
0.04

0.03
0.93
0.03
0

M0

0.02

0.97

0.03

G3P

M1
M2

0.96
0.01

0.02
0

0.95
0.02

Aspartate

M0
M1
M2

0.01
0.02
0.93

0.03
0.95
0

ND

M0

0.01

0.01

0.02

M1
M2
M3
M4

0.01
0.38
0.56
0.04

0.37
0.56
0.05
0.01

0.97
0.01

Ser

Thr

Phe

PEP
E4P

M2
M3

0.01
0.00
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Proposed 13C enriched
positions
C-C-*COOH

C-*COOH

C-C-C-C-*COOH

C-C-C-C-C-COOH
C2~C6 were not labeled.

ND
C-C-C-C-C-COOH
C2 ~C6 were not labeled

ND

C-S-*C-C-C-*COOH

C-C-*COOH

*C-C-C-*COOH

C-C-C-C-C-C-C-C-*COOH
1st carbon was labeled. The other
two carbons’ labeling positions
could not be determined.

Asp/Asn

Glu/Gln

Tyr

OAA

OXO

PEP
E4P

M0

0

0.02

0.02

M1

0.03

0.95

0.98

M2

0.96

0.02

0

M0
M1

0.02
0.93

0.02
0.94

0.82
0.18

M2
M3

0.05
0

0.03
0

0

M0
M1

0
0.02

0.02
0.37

0.02
0.98

M2
M3
M4

0.37
0.56
0.04

0.54
0.05
0.01

0

.
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*C-C-C-*COOH

*C-C-C-C-COOH

C-C-C-C-C-C-C-C-*COOH
1st carbon was labeled. The other
two carbons’ labeling positions
could not be determined

3.4 13C-pathway analysis of environmental microorganisms
13

C-pathway analysis has been applied to a number of environmental

microorganisms, including 1) Cyanothece 51142, a unicellular diazotrophic
cyanobacterium (81); 2) Heliobacterium modesticaldum, a Gram-positive
photosynthetic bacterium (82); 3) Roseobacter denitrificans OCh114, an aerobic
anoxygenic phototrophic bacterium (83); 4) Dehalococcoides ethenogenes Strain
195, an important member of bioremediation communities to detoxify
chloroethenes into the benign end product ethane (84); and 5) Mycobacterium
smegmatis, a non-virulent bacterium that is often used to study the metabolism of
a pathogenic bacterium, Mycobacterium tuberculosis (85). Novel metabolic
features

have

been

microorganisms via

uncovered

for

the

aforementioned

environmental

13

C-pathway analysis. Diverse analytical methods were

utilized to confirm the discoveries from

13

C-pathway analysis, including

biochemical assays to detect in vitro enzyme activities, quantitative RT-PCR to
profile the gene expressions, and LC-MS/MS to measure fast-turnover
metabolites.
3.4.1 Cyanothece 51142
Based on the identical labeling patterns of isoleucine and leucine in [213

C] glycerol cultures, an alternative isoleucine biosynthesis pathway via

citramalate synthase was discovered in Cyanothece 51142. Instead of using
threonine as the precursor, Cyanothece 51142 applied the citramalate pathway to
.
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induce isoleucine biosynthesis by using the same precursors (i.e., pyruvate and
acetyl-CoA) as those used in leucine biosynthesis pathway. The presence of
citramalate pathway was confirmed by measuring the in vitro enzymatic activity
of citramalate synthase via biochemical assays and by detecting the key
intermediate in citramalate pathway, citramalte, via LC-MS/MS. A report about
applications of

13

C-pathway analysis to identify citramalate pathway in

Cyanothece 51142 is attached in Appendix 2.
3.4.2 Heliobacterium modesticaldum
Heliobacteria are the only cultured Gram-positive photosynthetic bacteria.
The isotopomer data from proteinogenic amino acids was collected to probe the
central carbon metabolism of Heliobacterium modesticaldum. The CO2anaplerotic pathway was found to be active during phototrophic growth and the
citramalate pathway was employed by Heliobacterium modesticaldum for
isoleucine biosynthesis. Furthermore, the oxidative TCA cycle was operative by
using a putative (Re)-citrate synthase to produce citrate. The presence of (Re)citrate synthase was confirmed by measuring activity of citrate synthase via an
activity assay. The report of

13

C-pathway analysis for Heliobacterium

modesticaldum is attached in Appendix 3.
3.4.3 Roseobacter denitrificans OCh114

.
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Roseobacter denitrificans OCh114 is a model organism to study aerobic
anoxygenic photosynthesis in bacteria. Through measurements of 13C-isotopomer
labeling patterns of proteinogenic amino acids in a series of tracer experiments,
the metabolic routes for carbohydrate utilization, CO2 assimilation, and amino
acid biosynthesis were studied in Roseobacter denitrificans OCh114. The
anaplerotic pathways, mainly via the malic enzyme, were used to fix CO2 by R.
denitrificans. The Entner-Doudoroff (ED) pathway and the non-oxidative pentose
phosphate pathway were employed by R. denitrificans in carbohydrate
metabolism. The Embden-Meyerhof-Parnas (EMP, glycolysis) pathway was
found to be inactive, which was confirmed by the absence of in vitro enzyme
activity of 6-phosphofructokinase (PFK). In addition, isoleucine synthesis in R.
denitrificans used both threonine-dependent (20% total flux) and citramalate
pathway (80% total flux). The report of

13

C-pathway analysis for Roseobacter

denitrificans OCh114 is attached in Appendix 4.
3.4.4 Dehalococcoides ethenogenes Strain 195
Dehalococcoides ethenogenes 195 is the only known bacteria that can
fully degrade PCE to ethane (86,87). Isotopomer-based dilution analysis was
applied to differentiate the amino acids in Dehalococcoides ethenogenes from two
pathways: de novo synthesis from acetate, and amino acids import from
environment. It was found that glutamate/glutamine and aspartate/asparagine
were almost exclusively synthesized by Dehalococcoides ethenogenes, even when
.
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provided in excess in the medium. In contrast, phenylalanine, isoleucine, leucine,
and methionine were identified as the four amino acids that were most highly
imported from environment. Adding either phenylalanine or the four highly
imported amino acids to the defined mineral medium enhanced the growth rates,
dechlorination activities, and yields of strain 195 in a similar level to
supplementation with 20 amino acids. The transcriptional regulations of ABCtype amino acids transporters were also analyzed by qRT-PCR. The report of 13Cpathway analysis for Dehalococcoides ethenogenes Strain 195 is attached in
Appendix 5.
3.4.5 Mycobacterium smegmatis
Mycobacterium smegmatis is phylogenetically related to Mycobacterium
tuberculosis (MTB) and is often used as a model for studying MTB metabolism
since it is non-virulent. Isotopomer-assisted metabolite analysis was used to
investigate the metabolic transition from normal growth to a non-replicating state
under

a

hypoxic

environment.

The

glyoxylate

pathway

and

glycine

dehydrogenase were induced as the bacillus encountered hypoxic stress.
Meanwhile, the relative amount of acetyl-CoA entering the TCA cycle was
doubled, whereas little entered the glycolytic and pentose phosphate pathways.
The report of

13

C-pathway analysis for Mycobacterium smegmatis is attached in

Appendix 6.
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Chapter 4
13

C-Metabolic Flux Analysis of Central Carbon Metabolisms

4.1 13C-metabolic flux analysis (13C-MFA) protocol
13

C-MFA integrates the isotopomer measurements and the computational

optimization to quantify fluxes through a metabolic network. In general, 13C-MFA
is formulated as a nonlinear inverse problem, in which mass balance equations
and isotopomer balance equations are used to find an optimal set of metabolic
fluxes that has the smallest lack-of-fit between the simulated and measured
isotopomer labeling patterns in proteinogenic amino acids (1).

13

C-MFA is

usually applied to quantify the flux distributions in central metabolic network,
including glycolysis, Entner–Doudoroff pathway, pentose phosphate pathway, the
TCA cycle, futile pathways, and the glyoxylate shunt. At metabolic and isotopic
steady state, labeling information of proteinogenic amino acids that are
synthesized from these central metabolic pathways is collected for 13C-MFA. The
substrate uptake rates and products secretion rates are measured as the inflow and
outflow fluxes in 13C-MFA.
To quantify the intracellular metabolic fluxes, both mass and isotopomer
balance equations are applied. At metabolic steady state, there is no net
accumulation of the intracellular metabolites in the metabolic network. The mass
balance in the given metabolic network is hence represented as S ∙ v = 0, where S
.
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is the stoichiometric coefficients matrix and v is the flux distribution vector. For
an intracellular metabolite synthesized from two reactant molecules at isotopic
steady state, i.e. A+B→C, the isotopomer distribution of the product molecule can
be represented as IDVC = (IMMA→C ∙ IDVA)

(IMMB→C ∙ IDVB); where IDV is

the isotopomer distribution vector for a metabolite,

represents element-wise

multiplication, and IMMA→C represents the isotopic mapping matrix that
describes the isotopomer transitions from the precursor to the product. The
n

isotopomer balance equations can be derived as IDV

n

vj
j 1

v j IDV j ;
j 1

where IDV are the isotopomer distributions for the target metabolite, vj is the jth
reaction that produces the target metabolite, and IDVj are the isotopomer
distributions of the target metabolites synthesized from vj.
To simulate the isotopomer labeling patterns of amino acids that are
measured by GC/MS, the isotopomer distributions are converted to mass
distribution vectors (MDV) by the following MDV = M ∙ IDV equation, where M
is the conversion matrix. The difference between the simulated and measured
MDV in proteinogenic amino acids is minimized by using a series of
computational optimization algorithm, such as simulated annealing and
evolutionary algorithms. Multiple sets of metabolic fluxes are tested and the flux
distribution that best match the simulated data with the experimental data is
provided by 13C-MFA. The flowchart of 13C-MFA is illustrated in Figure 4.1.
.
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Figure 4.1. Framework for 13C-metabolic flux analysis.
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4.2.1 Abstract
The photosynthetic green sulfur bacterium, Chlorobaculum (Cba.)
tepidum, assimilates CO2 and organic carbon sources (acetate or pyruvate) during
mixotrophic growth conditions through a unique carbon and energy metabolism.
Using a

13

C-labeling approach, this study examined biosynthetic pathways and

flux distributions in the central metabolism of Cba. tepidum. The isotopomer
patterns of proteinogenic amino acids revealed an alternate pathway for isoleucine
synthesis (via citramalate synthase, CimA, CT0612).

13

C-based flux analysis

indicated that carbons in biomass were mostly derived from CO2 fixation via three
key routes: the reductive tricarboxylic acid (RTCA) cycle, the pyruvate synthesis
pathway via pyruvate:ferredoxin oxidoreductase (PFOR), and the CO2-anaplerotic
pathway via phosphoenolpyruvate carboxylase. During mixotrophic growth with
acetate or pyruvate as carbon sources, acetyl-CoA was mainly produced from
acetate (via acetyl-CoA synthetase) or citrate (via ATP citrate lyase). PFOR
converted acetyl-CoA and CO2 to pyruvate, and this growth-rate-control reaction
is driven by reduced ferredoxin generated during phototrophic growth. Most
reactions in the RTCA cycle were reversible. The relative fluxes through the
RTCA cycle were 80~100 units for mixotrophic cultures grown on acetate and
200~230 units for cultures grown on pyruvate. Under the same light conditions,
the flux results suggested a trade-off between energy-demanding CO2 fixation and
biomass growth rate: Cba. tepidum fixed more CO2 and had higher biomass yield
.
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(YX/S: mole carbon in biomass/mole substrate) in pyruvate culture (YX/S=9.2) than
in acetate culture (YX/S=6.4), but the biomass growth rate was slower in pyruvate
culture than in acetate culture.
Key words: 13C, citramalate, CO2 fixation, ferredoxin, RTCA, light-harvesting
4.2.2 Introduction
Chlorobaculum tepidum (Cba. tepidum) is a representative green sulfur
bacterium that is ecologically significant in global cycling of carbon, nitrogen and
sulfur (2,3). The Cba. tepidum genome has been sequenced, and the genetic tools
for creating Cba. tepidum mutant strains have been developed to make
transposon-based mutations or targeted gene disruptions, which offer great
potential to engineer Cba. tepidum for future applications (4). The annotated
genome reveals unique aspects in carbon and energy metabolism in Cba. tepidum.
Instead of using the Calvin-Benson Cycle for CO2-assimilation as in most
photosynthetic organisms, Cba. tepidum captures energy from light and uses it
along with electrons, primarily derived from oxidation of sulfur compounds, to
drive the reductive tricarboxylic acid cycle (RTCA) for synthesis of building
block molecules (4). Cba. tepidum can grow mixotrophically with acetate or
pyruvate as the organic carbon source (3). Although recent research has been
performed on the carbon and energy metabolism of Cba. tepidum (5,6), rigorous
quantification of the metabolic pathway activities has not yet been achieved. To
provide quantitative readout of the metabolic functions and regulatory
.
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mechanisms, this study has performed

13

C-based metabolic flux analysis of Cba.

tepidum in the following steps: 1) growing cultures of Cba. tepidum with

13

C-

labeled acetate or pyruvate, 2) using gas chromatography-mass spectrometry (GCMS) to measure the resulting labeling pattern in key metabolites, and 3)
deciphering in vivo metabolisms via a flux model (7). Isotopic labeling and
metabolic flux analysis have been developed to identify the active biosynthesis
pathways (8,9,10,11) and measure the global enzymatic reaction rates (12,13).
Such a fluxomics approach can bridge the gap between genome annotations and
final metabolic outputs, and has been applied for characterizing numerous
environmental microorganisms, including E. coli (14,15), Saccharomyces
cerevisiae (16,17), Bacillus subtilis (18), Geobacter metallireducens (19),
Shewanella oneidensis (20), Synechocystis sp. (21), etc. This paper reports on the
first studies of the fluxomics of mixotrophic metabolism in the green sulfur
bacteria, and provides complementary information to previous genomic and
proteomic studies.
4.2.3 Experimental procedure
13

C-labeled experiments. Cba. tepidum cultures were grown

anaerobically at temperatures ranging from 46–50 °C in low-intensity light (10 ± 1
W/m2). The medium composition (1L) was Na2EDTA-2H2O (0.015 g), MgSO47H2O (0.22 g), CaCl2-2H2O (0.08 g), NaCl (0.45 g), NH4Cl (0.45 g), Na2S2O35H2O (2.6 g), KH2PO4 (0.57 g), MOPS buffer (2.4 g), trace element stock (1.2
.
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mL), vitamin B12 stock (0.08 mg), NaHCO3 (0.23 g), and Na2S-9H2O (0.07 g). All
chemicals were purchased from Sigma-Aldrich. The carbon source for the trace
experiments was [1-13C] acetate (purity > 98%, 0.83g/L) or [2-13C] acetate (purity
> 98%, 0.83g/L) for cultures growing on acetate, or [3-13C] pyruvate (purity >
98%, 1.1 g/L) for cultures growing on pyruvate. The 13C-labeled acetate and
pyruvate were purchased from Cambridge Isotope Laboratories
(www.isotope.com). Cell growth was monitored at OD625. 1% cultures (100-fold
dilution) in the exponential growth phase were used to inoculate fresh media with
13

C-labeled substrates. To reduce the effect of non-labeled carbon from the initial

stock, cells were sub-cultured twice in the same labeled medium. Biomass was
sampled at two time points (4 hr interval) in the middle-exponential growth phase,
and the labeling patterns of proteinogenic amino acids in the biomass were
measured. The invariability of amino acid labeling during the two time points
confirmed the pseudo-steady-state metabolism in tracer experiments.
Metabolites and isotopomer analysis. The amount of pyruvate and
acetate during the growth period was determined by enzymatic assays (22,23,24).
For GC-MS measurement of amino acid labeling, the biomass was harvested by
centrifugation and hydrolyzed using 6M HCl (24 hrs at 100 °C) (20,25). The
amino acids were derivatized in 0.2 mL tetrahydrofuran and 0.2 mL N-(tert-butyl
dimethylsilyl)-N-methyl-trifluoroacetamide (Sigma-Aldrich, St. Louis, MO). A
gas chromatograph (Hewlett-Packard model 7890A; Agilent Technologies, CA)
.
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equipped with a DB5-MS column (J&W Scientific, Folsom, CA) and a mass
spectrometer (model 5975C; Agilent Technologies, CA) were used for analyzing
metabolite labeling profiles. Four types of charged fragments were detected by
gas chromatography-mass spectrometry (GC-MS) for all the amino acids (Table
4.2.1 and Figure 4.2.1): the [M-57]+ or [M-15]+ group (containing unfragmented
amino acids); the [M-159]+ or [M-85]+ group (containing amino acids that had
lost an α-carboxyl group). For each type of fragments, the labeling patterns were
represented by M0, M1, M2, etc, which were fractions of unlabeled, singly labeled,
and doubly labeled amino acids. The effects of natural isotopes on isotopomer
labeling patterns were corrected by previously reported algorithms (26).
To compare the relative contributions of carbon substrates and CO2 to
mixotrophic biomass synthesis, the substrate utilization ratio R was calculated
based on the labeling patterns of unfragmented amino acid X (e.g., alanine) (8):
C

0.98

n Vsub

0.01 VCO 2

(

i

Mi )

i 1

m Vsub VCO 2

C

and R

mVsub
VCO2

(Equation 1)

where R ratio reflects the carbon flux ratio of labeled carbon substrate to
unlabeled CO2 for producing the corresponding amino acid X (mol carbon from
substrate / mol carbon from CO2); Mi is the GC-MS isotopomer fraction for a
given amino acid. C is the total number of carbon atoms in the amino acid
molecule. Vsub is the uptake of

13

C-labeled organic substrates, VCO2 is the uptake
.
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of CO2; 0.98 is the purity of the labeled carbon substrate; 0.01 is the natural
abundance of 13C, m is the total number of carbons in the substrate molecule, and
n is the total number of labeled carbons in the substrate molecule.
Metabolic flux analysis. The pathway map of Cba. tepidum was
generated

based

on

genome

annotation

from

the

KEGG

database

(http://www.genome.jp/kegg/) and transcription analysis of several key pathways
(27). The simplified pathway map includes the reductive tricarboxylic acid cycle,
CO2-anaplerotic pathway, gluconeogenesis pathway, and pentose phosphate
pathway (Supplementary Figure 4.2.S1 and Table 4.2.S1). The development of a
pseudo-steady-state flux model has been discussed before (20,28,29). In brief, the
substrate (acetate or pyruvate) uptake rate was measured and normalized to 100
units. The biomass production was determined based on our previous paper (27).
The biomass composition for macromolecules such as protein and fatty acids was
assigned based on that of E. coli (14). The fluxes to biomass pools were loosely
constrained by the estimated dry cell weight (DCW) and biomass compositions.
These fluxes were used as initial inputs to the isotopomer model and optimized by
isotopomer labeling information (Table 4.2.1 and Supplementary Table 4.2.S2).
The remaining unknown intracellular fluxes were determined by reaction
stoichiometry and atom/isotopomer mapping matrices in an iterative scheme
(Supplementary Table 4.2.S3). The reaction reversibility was calculated using the
exchange coefficient (19):
.
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viexch

exch i
1 exch i

(Equation 2)

where viexch is the exchange flux defined as the smaller of the forward and
backward fluxes, and exchi is the exchange coefficient with the range of [0,1] (If
the reaction is irreversible, exchi is 0; if the reaction is “freely” reversible, exchi is
close to 1). The flux combinations were searched to minimize of the objective
function (20):

(Equation 3)

where vn are the unknown fluxes to be optimized in the program, Mi is the
measured MS data, Ni is the corresponding model-simulated MS data, and δi is the
corresponding standard deviation in the GC-MS data (1~2%). The unknown
metabolic fluxes were searched to minimize ε. The model was solved by IPOPT
(Interior Point Optimizer, https://projects.coin-or.org/Ipopt), which is a software
package for large-scale nonlinear optimization. To avoid getting trapped in a local
optimal minimum, multiple initial guesses (>100) were used for model calculation
to obtain the global solution.
To estimate the confidence interval for the calculated fluxes, a Monte
Carlo approach was employed (15). In brief, the isotopomer concentration data
sets were generated by adding 2% of normally distributed measurement noise to
.
147

actual measured isotopomer data. The same optimization routine was used to
estimate flux distribution from these data sets. Confidence limits for each flux
value were obtained from the probability distribution of calculated fluxes
resulting from the simulated data sets (n=100). To determine the cellular
metabolism’s requirements for energy and reducing power, the relative
consumption rates of ATP, NADH, NADPH and ferredoxin were quantified based
on the flux distributions in the central metabolic pathways and biomass synthesis
rates.
Calculation of biomass yield. The biomass yield (moles of carbon in
biomass/moles of substrate) was calculated based on the substrate uptake rates
(moles of substrate/L/hr) and biomass growth rates (g DCW/L/hr). The molecular
formula for Cba. tepidum was assumed to be CH1.8O0.5N0.2P0.02 (molecular weight
MW ≈ 25.5) (30). The biomass yield was calculated by:
biomass growth rate (g/L/hr)
MW of biomass (g/mol)
Yield=
substrate uptake rate (mol/L/hr)

4.2.4 Results and discussion
Carbon utilization during mixotrophic growth. During exponentialgrowth with pyruvate and acetate, Cba. tepidum had the growth rates of 0.12 h-1
and 0.17 h-1, respectively. In the trace experiments, the labeled carbons were
detected in all amino acids (Table 4.2.1), suggesting utilization of acetate or
.
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pyruvate to synthesize all building blocks. Table 4.2.2 shows the ratio of carbon
utilization (organic carbon vs. CO2) for mixotrophic synthesis of proteinogenic
amino acids. For acetate culture, the substrate utilization ratio for Ala (precursor:
pyruvate) was 0.60, which indicated that carbons in pyruvate were mainly derived
from labeled acetate. Pyruvate is the precursor for both the gluconeogenesis
pathway and the pentose phosphate pathway, so the R ratios (Equation 1) of Ser
and Phe are similar to that of alanine. The substrate utilization ratio of His was
high (0.96) for culture with [2-13C]acetate because the His precursor C1 pool (N5,
N10-methylene-tetrahydrofolate) was highly labeled. This carbon was derived
from acetate by following route:
[2-13C]acetate[3-13C]pyruvate[3-13C]Ser[13C] C1 pool.
In the mixotrophic culture with acetate, the R ratios for aspartate and
glutamate (~0.2) were significantly lower than the other amino acids. Aspartate
and glutamate were synthesized from the RTCA cycle, so the small R values
indicated that the unlabeled CO2 was the dominant carbon source for synthesizing
metabolites in the RTCA cycle. In pyruvate culture, the substrate utilization ratios
of amino acids (Ala, Phe, Ser, and Asp) were all lower than in acetate culture,
indicating a higher contribution of CO2 to synthesize building blocks.
Analysis of amino acid biosynthesis pathways. Growing in a completely
defined medium, Cba. tepidum was able to synthesize all amino acids from CO2
and organic carbon sources using the annotated pathways. Interestingly, the
.
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labeling patterns of Leu and Ile from tracer experiments were found to be
identical, which indicated that the two amino acids shared the same precursors. Ile
is commonly synthesized via threonine ammonia-lyase, with Thr and pyruvate as
the precursors, while Leu is synthesized from pyruvate and acetyl-CoA. In the [213

C] acetate trace experiment, both Thr and pyruvate are singly labeled, which

could lead only to doubly labeled Ile, instead of the triply labeled Ile detected by
GC-MS. Such an observation is consistent with the fact that a gene encoding
threonine ammonia-lyase has not been annotated in the genome of Cba. tepidum.
On the other hand, an alternative pathway for Ile biosynthesis (i.e., threonineindependent pathway) has been recently identified in several bacteria
(9,10,25,31), where Ile is synthesized from acetyl-CoA and pyruvate (i.e., using
the same precursors as Leu) through the formation of citramalate as the
intermediate (Figure 4.2.1). A search in the genome of Cba. tepidum for the gene
for citramalate synthase (CimA) as found in Geobacter (10) returned a high
identity for CT0612 (~ 52%), supporting the presence of the citramalate pathway
for Ile synthesis.
Central carbon metabolic pathways. The genome annotation from the
KEGG database indicates: 1) pyruvate:ferredoxin oxidoreductase (PFOR) (porA,
CT1628) converts pyruvate to acetyl-CoA (an end-product from RTCA cycle), 2)
phosphoenolpyruvate (PEP) is derived from pyruvate via pyruvate phosphate
dikinase (ppd, CT1682), and 3) PEP is fed into the TCA cycle via the CO2.
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anaplerotic pathway (Figure 4.2.2). The fraction of non-labeled Asp (M0=0.64,
Table 4.2.1) was much higher than that of Ala (M0=0.45, Table 4.2.1) in trace
experiments with [1-13C] acetate, which indicated that non-labeled oxaloacetate
was also generated through CO2 fixation via the RTCA cycle. Furthermore,
similar labeling patterns of Ala (precursor: pyruvate) and Ser (precursor:
glycerate-3-P) confirmed that the carbon flux through the gluconeogenesis
pathway was mainly from pyruvate.
The flux analysis results are shown in Figure 4.2.2. In general, predicted
labeling patterns of all amino acids were good matches with the measured
isotopomer data (Figure 4.2.3). Under acetate-growth conditions, acetyl-CoA
could be generated from acetate uptake or as the end-product through the RTCA
cycle. Fluxes through pyruvate:ferredoxin oxidoreductase (PFOR), the RTCA
cycle, and the CO2-anaplerotic pathway were ~152, 80-100, and ~30 units,
respectively (Figure 4.2.2). Meanwhile, the flux ratio of the gluconeogenesis
pathway to the RTCA cycle was close to 1:1. The oxidative pentose phosphate
pathway (G6P  6PG  Ru5P) was inactive under our experimental conditions.
Compared to mixotrophic growth with acetate, the flux distribution during
pyruvate growth demonstrated different patterns. In general, the fluxes into the
RTCA cycle and CO2-anaplerotic pathway were much higher (200-230 units and
~50 units, respectively) and thus more CO2 was fixed. The flux ratio of the
gluconeogenesis pathway to the RTCA cycle was reduced to 1:2, while acetyl.
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CoA was generated only from the RTCA cycle. The oxidative pentose phosphate
pathway was not active (flux<1 unit) under pyruvate mixotrophic growth (or
acetate mixotrophic growth).
In the mixotrophic cultures grown on acetate or pyruvate, most reactions
in the RTCA cycle were freely reversible (exchange coefficient close to 1). The
reversibility is consistent with the physiological free energy changes in the RTCA
cycle, where the standard Gibbs free energy for most reactions of the TCA cycle
is positive so that the magnitude of the reaction equilibrium constants is small
(32). Furthermore, PFOR catalyzes a reversible reaction between pyruvate and
acetyl-CoA (pyruvate + CoA + 2 Fdox ↔ acetyl-CoA + CO2 + 2 Fdred + 2 H+).
However, metabolic flux analysis of the mixotrophic metabolism indicates that
the net flux of this enzymatic reaction was from acetyl-CoA to pyruvate (33). The
direction of the PFOR pathway indicates that the reduced ferredoxin from
phototrophic

processes

made

the

reaction

for

pyruvate

synthesis

thermodynamically favorable.
Energy metabolism of Chlorobaculum tepidum. The mixotrophic
metabolism of Cba. tepidum consumes energy harvested from light. Since the
oxidative pentose phosphate pathway and normal TCA cycle are not fully
functional, the energy (NADPH and NADH) generation mainly depends on the
light reactions. Based on the metabolic flux distribution and previous
measurement of the absolute uptake rates of carbon substrates and biomass
.
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growth (27), the light-energy harvested for central metabolism and biomass
growth was approximately quantified (Figure 4.2.4). In general, the photons
absorbed by pigments (e.g. bacteriochlorophylls) initiate the electron flow and
oxidize sulfide. The electrons are used to reduce ferredoxin and generate
NAD(P)H (3,4). Concomitant with the oxidation of the reduced ferredoxin, the
essential cofactors for energy metabolism (i.e., NADPH and NADH) are mainly
generated by ferredoxin-NAD(P)+ reductase (3,34). Meanwhile, the oxidation of
sulfide also creates a proton motive force for ATP production. The generated
ATP, cofactors, and reduced ferredoxin then become the “driver” for the
mixotrophic metabolism and the RTCA cycle for energy-demanding CO2 fixation.
Figure 4.2.4 shows that the ATP, NADH and NADPH fluxes into biomass and the
RTCA cycle are stronger in acetate-grown cultures than in pyruvate-grown
cultures, supporting a higher growth rate during mixotrophic growth with acetate.
On the other hand, the calculated biomass yield (moles of carbon in
biomass/moles of substrate) was higher for pyruvate culture (YX/S=9.2) than for
acetate (YX/S=6.4), based on our previous experiments (27), which is consistent
with the fact that the normalized fluxes through RTCA are higher in pyruvate
culture than acetate culture. Accordingly, pyruvate metabolism has more CO2
fixation (but slower growth rate).
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Figure 4.2.1. Citramalate pathway for isoleucine biosynthesis in Cba. tepidum
(using [2-13C] acetate and NaHCO3 as the carbon sources). The asterisks indicate
the positions of labeled carbon. The dashed lines indicate inactive pathways.
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Figure 4.2.2. Metabolic flux distribution in Cba. tepidum. (A) Net flux
distribution in acetate growth conditions (based on [2-13C] acetate culture); (B)
net flux distribution in pyruvate growth conditions. The standard derivation (std)
and exchange coefficients are marked by flux +/- std and < exchange coefficient >
respectively. The inactive pathways are marked with dashed lines. The calculated
biomass yield (moles of carbon in biomass/moles of substrate): pyruvate culture
(YX/S=9.2); acetate culture (YX/S=6.4). Abbreviations: 3PG, 3-phosphoglycerate;
6PG, 6-phosphogluconate; AC.ext, extracellular acetate; AC, intracellular acetate;
ACCOA, acetyl-coenzyme A; AKG, α-ketoglutarate; CIT, citrate; DCW, dry cell
weight; E4P, erythrose-4-phosphate; F6P, fructose-6-phosphate; FBP, Fructose
1,6-bisphosphate; Fdred, reduced ferredoxin; Fdox, oxidized ferredoxin; FNR,
ferredoxin-NAD(P)+ reductase; FUM, fumarate; G6P, glucose-6-phosphate; GAP,
glyceraldehyde 3-phosphate; ICIT, isocitrate; KGOR, 2-ketoglutarate ferredoxin
oxidoreductase; MAL, malate; OAC, oxaloacetate; PEP, phosphoenolpyruvate;
PFOR, pyruvate:ferredoxin oxidoreductase; PYR, intracellular pyruvate; PYR.ext,
extracellular pyruvate; R5P, ribose-5-phosphate; Ru5P, ribulose-5-phosphate;
RTCA, the reductive tricarboxylic acid; S7P, sedoheptulose-7-phosphate; SUCC,
succinate; SUCCoA, Succinyl-CoA; Xu5P, xylulose-5-phosphate.
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B
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Figure 4.2.3. Model quality test for (A) acetate metabolism; (B) pyruvate
metabolism. ● alanine data, ○ serine data, ▼ aspartate data, Δ glutamate data, ■
leucine data, □ histidine data, ◊ phenylalanine data, and ♦ glycine data.
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Figure 4.2.4. Proposed energy metabolism in Cba. tepidum. (A) energy
requirement (mmol/gDCW/hr) in acetate growth conditions; (B) energy
requirement (mmol/gDCW/hr) in pyruvate growth conditions. The intracellular
energy metabolism was quantified in the framed figures based on the relative flux
distributions (The detailed calculations are in Supplementary Tables 4.2.S4A and
S4B). Arrows pointing to the framed figure indicated the energy demand of
intracellular metabolism. Arrows pointing to biomass indicate the energy demand
of biomass accumulation. Arrows pointing from light indicated the entire energy
harvested by Cba. tepidum. The light reaction produces reduced ferredoxin and
ATP. NADPH and NADH are mainly generated by ferredoxin-NAD(P)+
reductase. Biomass (protein) synthesis can also generate a small amount of
NADH, as indicated in the figure.
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B
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Figure 4.2.S1. Pathway map for mixotrophic metabolism of Chlorobaculum
tepidum
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Table 4.2.1. Isotopic labeling patterns in amino acids from Chlorobaculum
tepiduma
Carbon source

Amino acids
Ala
Gly
Ser

[1-13C] acetate

Leu
Ile
Asp
Glu
Phe
Ala
Gly
Ser

13

[2- C] acetate

Leu
Ile
Asp
Glu
Phe
His
Ala
Gly
Ser

[3-13C] pyruvate

Leu
Ile
Asp
Glu
Phe

Fragments
[M-57]+
[M-159]+
[M-57]+
[M-85]+
[M-57]+
[M-159]+
[M-159]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-85]+
[M-57]+
[M-159]+
[M-159]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-85]+
[M-57]+
[M-159]+
[M-159]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
[M-159]+
[M-57]+
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M0
0.45
0.44
0.54
0.54
0.46
0.47
0.21
0.21
0.64
0.65
0.63
0.63
0.11
0.12
0.43
0.42
0.94
0.95
0.44
0.45
0.13
0.14
0.61
0.62
0.62
0.63
0.13
0.14
0.16
0.28
0.67
0.65
0.96
0.97
0.71
0.71
0.47
0.47
0.82
0.83
0.75
0.76
0.38

M1
0.54
0.53
0.46
0.46
0.52
0.53
0.43
0.43
0.35
0.34
0.33
0.33
0.29
0.30
0.56
0.54
0.06
0.05
0.55
0.55
0.25
0.25
0.38
0.37
0.35
0.34
0.26
0.26
0.35
0.48
0.32
0.30
0.04
0.03
0.28
0.28
0.38
0.39
0.17
0.15
0.20
0.20
0.41

M2
0.01
0.03
0.00
0.02
0.00
0.33
0.33
0.01
0.01
0.04
0.04
0.36
0.36
0.01
0.04
0.00
0.01
0.00
0.36
0.36
0.00
0.00
0.03
0.03
0.36
0.35
0.36
0.22
0.01
0.05
0.00
0.01
0.01
0.12
0.12
0.00
0.01
0.05
0.04
0.17

His

[M-159]+
[M-57]+
[M-159]+

0.38
0.46
0.56

0.40
0.41
0.34

a. the standard deviations for GC-MS measurement were based on the
duplicate experiments (n=2), with the standard deviation below 2%.
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0.18
0.11
0.08

Table 4.2.2. Carbon substrate utilization ratiosa in amino acids from
Chlorobaculum tepidum
Amino
acids
Ala
Ser
Asp
Glu
His
Phe

[1-13C] acetate +
NaHCO3
0.60
0.58
0.20
0.18
NAb
0.62

Carbon sources
[2-13C] acetate +
NaHCO3
0.60
0.58
0.22
0.18
0.96
0.64

[3-13C] pyruvate +
NaHCO3
0.48
0.42
0.12
0.21
0.38
0.26

a. the carbon source utilization ratio (organic substrate/CO2 fixation) for amino
acid synthesis was calculated according to Equation (1); b. isotopomer labeling
pattern for histidine was not detected under [1-13C] acetate + NaHCO3 due to the
weak signal to noise ratio in GC-MS.
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Table 4.2.S1. Metabolic pathways in mixotrophic metabolism of Chlorobaculum
tepidum
Pathway
ID

Reactions

Notes

v2
v3
v4
v5
v6
v7
v8
v9
v10
v11

Extracellular acetate→Intracellular
acetate
Extracellular pyruvate→Intracellular
pyruvate
Acetate→Acetyl-CoA (-ATP)
Acetyl-CoA+CO2↔Pyruvate (-2 Fdred)
PEP/Pyruvate+CO2↔OAC (+ATP)
OAC↔MAL (-NADH)
MAL↔FUM
FUM↔SUCC (-2[H])
SUCC↔SUCCoA (-ATP)
SUCCoA+CO2↔AKG (-2 Fdred)
AKG+CO2↔ICIT (-NADPH)
ICIT↔CIT

v12

CIT↔ACCOA+OAC

v13
v14
v15
v16
v17
v18
v19
v20
v21
v22
v23
v24
v25
v26
v27
v28
v29
v30
v31
v32
v33
v34

PYR↔PEP (-ATP)
PEP↔3PG
3PG→GAP (-ATP) (-NADH)
2 GAP→FBP
FBP→F6P (+ATP)
F6P→GAP
GAP→6PG (+NADPH)
6PG→C5P+CO2 (+NADPH)
F6P+GAP↔XU5P+E4P
E4P+F6P↔S7P+GAP
S7P+GAP↔XU5P+R5P
R5P→Biomass
E4P→Biomass
F6P→Biomass
G6P→Biomass
GAP→Biomass
3PG→Biomass
PEP→Biomass
PYR→Biomass
ACCOA→Biomass
OAC→Biomass
AKG→Biomass

v1_ACT
v1_PYR

Confirmed by qRT-PCR (acsA, ackA)

Confirmed by qRT-PCR (porA)
Confirmed by qRT-PCR (ppc, pckA)

Confirmed by qRT-PCR (korA, korB)
Confirmed by qRT-PCR (icd)
Confirmed by qRT-PCR (acn)
Confirmed by qRT-PCR (gltA, aclA,
aclB)
Confirmed by qRT-PCR (ppd)

Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
Energy cost is listed in Table.S2
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Table 4.2.S2. Precursors for building blocks synthesis in Chlorobaculum tepidum
Building block

Cost of making 1 mol of each of these building blocks
(mol/mol)
Precursors

Protein amino acids
Alanine
Arginine
Asparagine
Aspartate
Cysteine
Glutamate
Glutamine
Glycine
Histidine
Isoleucine
Leucine
Lysine
Methionine
Phenylalanine
Proline
Serine
Threonine
Tryptophan
Tyrosine
Valine
RNA nucleotides
ATP
GTP
CTP
UTP
DNA nucleotides
dATP
dGTP
dCTP
dTTP
Average fatty acid
Average
carbohydrate

1 PYR
1 AKG, (-5 ATP) (-1 NADPH)
1 Asp, (-2 ATP)
1 OAC
1 Ser (-3 ATP) (-4 NADPH)
1 AKG (-1 NADPH)
1 Glu (-1 ATP)
1 Ser
1 C5P, 1 C1 unit (-5 ATP) (+2 NADH)
2 PYR, 1 ACCOA (-1 NADPH) (+1 NADH)
2 PYR, 1 ACCOA (-1 NADPH) (+1 NADH)
1 OAC, 1 PYR (-1 NADPH)
1 Asp,1 C1 unit (-1 ATP) (-2 NADPH)
1 E4P, 2 PEP (-1 ATP) (-1 NADPH)
1 Glu (-1 ATP) (-2 NADPH)
1 3PG (+1 NADH)
1 OAC (-2 ATP) (-2 NADPH)
1 C5P, 1 E4P,1 PEP (-3 ATP) (-1 NADPH)
1 E4P, 2 PEP (-1 ATP) (-1 NADPH) (+1 NADH)
2 PYR (-1 NADPH)
1 C5P, 1 3PG
1 C5P, 1 3PG
1 C5P, 1 OAC
1 C5P, 1 OAC
1 C5P, 1 3PG
1 C5P, 1 3PG
1 C5P, 1 OAC
1 C5P, 1 OAC
8.2 ACCOA
1 G6P
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Table 4.2.S3. Atom mapping matrices for metabolic reactions
PyrPEP
1 0 0
0 1 0
0 0 1

PEP3PG
1 0 0
0 1 0
0 0 1

3PGGAP
1 0 0
0 1 0
0 0 1

Acetate
ACCOA
1 0
0 1

C1GLY
0
1

ICITCO2
0 0 0 0 0 1

ACCOAPyruvate
0 0
1 0
0 1

AKGCO2
1 0 0 0 0

AKGSUCC
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1

ASPMET
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
0 0 0 0

ACCOA  LEU
1 0
0 1
0 0
0 0
0 0
0 0
E4PF6P
0 0 0 0
0 0 0 0
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1

PYR LEU
0 0 0
0 0 0
0 1 0
0 1 0
0 0 1
0 0 1
E4PPHE
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
F6PG6P
1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1
0 0 0 0 0

AKG GLU
1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1
C1MET
0
0
0
0
1

E4PTYR
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
CO2OAA
0
0
0
1

F6PC5P
1 0 0 0 0
0 1 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0

F6PE4P
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1
0 0 0 0 0

0
0
0
0
0

ICITAKG
1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1

0
0
0
1

0
0
0
0
0

F6PG6P
1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1
0 0 0 0 0
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E4PS7P
0 0 0 0
0 0 0 0
0 0 0 0
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1

0
0
0
0
0
1

0
0
0
0
0
1

F6PS7P
1 0 0 0
0
0 1 0 0
0
0 0 1 0
0
0 0 0 0
0
0 0 0 0
0
0 0 0 0
0
0 0 0 0
0
G6PC5P
0 1 0 0
0
0 0 1 0
0
0 0 0 1
0

0
0
0

C1HIS
0
0
0
0
0
1
E4PGAP
0 1 0 0
0 0 1 0
0 0 0 1

GAPF6P
0 0 1
0 1 0
1 0 0
1 0 0
0 1 0
0 0 1

0
0
0
0

0
0
0

OACMAL
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1

0 0 0 0 1
0
0 0 0 0 0
1

MALFUM
0.5 0 0 0.5
0 0.5 0.5 0
0 0.5 0.5 0
0.5 0 0 0.5
SUCCoASUCC
0.5 0 0 0.5
0 0.5 0.5 0
0 0.5 0.5 0
0.5 0 0 0.5

FUMSUCC
0.5 0 0 0.5
0 0.5 0.5 0
0 0.5 0.5 0
0.5 0 0 0.5
CO2 MAL
0
0
0
1

AKGSUCCoA
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1

SUCCoA
AKG
0 0 0 0
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
ACCOA  CIT
0.5 0
0 0.5
0 0
0 0.5
0.5 0
0 0
OACCO2
0 0 0 1

CIT  ACCOA

0.5 0 0 0 0.5 0
0 0.5 0 0.5 0 0

OACASP
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
C5PF6P
1 0 0 0 0
0 1 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0

GAPC5P
0 0 0
0 0 0
1 0 0
0 1 0
0 0 1
C5PS7P
1 0 0 0 0

C5PS7P
1 0 0 0 0
0 1 0 0 0
1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1

PYRLEU
0 0 0
0 0 0
0 1 0
0 2 0
0 0 2
0 0 1
C5PGAP
0 0 1 0 0

SUCCSUCCoA
0.5 0 0 0.5
0 0.5 0.5 0
0 0.5 0.5 0
0.5 0 0 0.5
PYROAA
1 0 0
0 1 0
0 0 1
0 0 0

PYRCO2
1 0 0

PYRACCOA
0 1 0
0 0 1

SUCCFUM
0.5 0 0 0.5
0 0.5 0.5 0
0 0.5 0.5 0
0.5 0 0 0.5

FUMMAL
0.5 0 0 0.5
0 0.5 0.5 0
0 0.5 0.5 0
0.5 0 0 0.5

MAL(OAA)CO2
0 0 0 1

MALOAC
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1

PYRMAL
1 0 0
0 1 0
0 0 1
0 0 0

CITOAC
0 0 0 0 0 1
0 0 1 0 0 0
0 0.5 0 0.5 0 0
0.5 0 0 0 0.5 0

OACCIT
0 0 0 0.5
0 0 0.5 0
0 1 0 0
0 0 0.5 0
0 0 0 0.5
1 0 0
0
OACPEP
1 0 0 0
0 1 0 0
0 0 1 0

PYRALA
1 0 0
0 1 0
0 0 1

PEPTYR
1 0 0
0 1 0
0 0 1
0 1 0
0 0 1
0 0 0
0 0 0
0 0 0
0 0 0
PYRVal
1 0 0
0 1 0
0 2 0
0 0 2
0 0 1

PEPPHE
1 0 0
0 1 0
0 0 1
0 1 0
0 0 1
0 0 0
0 0 0
0 0 0
0 0 0
C5PHis
1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1
0 0 0 0 0
S7P C5P
1 0 1 0 0 0 0

PEPOAA
1 0 0
0 1 0
0 0 1
0 0 0
G6PCO2
1 0 0 0 0 0

PYRLys
0 0 0
0 0 0
0 0 0
0 0 0
0 1 0
0 0 1
S7PE4P
0 0 0 1 0 0 0
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S7PF6P
1 0 0 0 0 0 0

PEPPYR
1 0 0
0 1 0
0 0 1

0 1 0 0
1 0 0 0
0 1 0 0
0 0 1 0
0 0 0 1
0 0 0 0
SERC1
0 0 1

0
0
0
0
0
1

CITICIT
0.5 0 0 0 0.5 0
0 0.5 0 0.5 0 0
0 0 1 0 0 0
0 0.5 0 0.5 0 0
0.5 0 0 0 0.5 0
0 0 0 0 0 1

0 0 0 1 0
0 0 0 0 1

SERGLY
1 0 0
0 1 0

0 0 0 0 1 0 0
0 0 0 0 0 1 0
0 0 0 0 0 0 1

ICITAKG
1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1

ICITCIT
0.5 0 0 0 0.5
0
0 0.5 0 0.5 0
0
0 0 1 0 0 0
0 0.5 0 0.5 0
0
0.5 0 0 0 0.5
0
0 0 0 0 0 1
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0
0
0
0
0

0
0
0
0
0

1
0
0
0
0

0
1
0
0
0

0
0
0
0
0

0
0
0
0
0

AKGICIT
1 0 0 0 0
0 1 0 0 0
0 0 1 0 0
0 0 0 1 0
0 0 0 0 1
0 0 0 0 0

0
0
0
0
0

0
0
0
0
0

0
0
0
0

1
0
0
0

0
0
0
0

1
0
0
0

0
1
0
0

GAPE4P
0 0 0
1 0 0
0 1 0
0 0 1

0
0
1
0

0
0
0
1

Table 4.2.S4A. Energy demand of Chlorobaculum tepidum in acetate growth
conditions
Acetate Metabolism
Flux ID

Flux (units)

v1_ACT
v2
v3
v4
v5
v6
v7
v8
v9
v10
v11
v12
v13
v14
v15
v16
v17
v18
v19
v20
v21
v22
v23
Sum

100.0±0.0
100.0±0.0
152.4±11.4
33.1±2.3
98.1±11.3
98.1±11.3
98.1±11.3
98.1±11.3
98.1±11.3
81.4±9.4
81.4±9.4
81.4±9.4
124.2±10.4
81.1±15.0
51.1±7.8
18.5±2.4
18.5±2.4
1.7±0.2
0.0±0.1
0.0±0.1
10.9±1.8
4.2±0.2
4.2±0.2
-

Biomass

-

Flux
(mmol/g/hr)
1.0±0.1
1.0±0.1
1.5±1.2
0.3±0.0
1.0±0.1
1.0±0.1
1.0±0.1
1.0±0.1
1.0±0.1
0.8±0.1
0.8±0.1
0.8±0.1
1.2±0.1
0.8±0.2
0.5±0.1
0.2±0.0
0.2±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.1±0.0
0.0±0.0
0.0±0.0
μ=0.17 hr-1
±0.02 hr-1

ATP

NADH

NADPH

2[H]

Fdred

0.0±0.0
1.0±0.1
0.0±0.0
-0.3±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.0±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.2±0.1
0.0±0.0
0.5±0.1
0.0±0.0
-0.2±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
3.2±0.4
40.86∙0.17
=6.9±0.7

0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.0±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.5±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.5±0.2
-3.55∙0.17
=0.6±0.1

0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.8±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.8±0.1
16.87∙0.17
=2.9±0.3

0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.0±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.0±0.1
0.00∙0.17
=0.0±0.0

0.0±0.0
0.0±0.0
3.0±0.2
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
2.0±0.2
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
5.0±0.5
0.00∙0.17
=0.0±0.0
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Table 4.2.S4B. Energy demand of Chlorobaculum tepidum in pyruvate growth
conditions
Pyruvate Metabolism
Flux ID

Flux (units)

v1_PYR
v2
v3
v4
v5
v6
v7
v8
v9
v10
v11
v12
v13
v14
v15
v16
v17
v18
v19
v20
v21
v22
v23
Sum

100.0±0.0
100.0±0.0
138.1±10.2
48.1±5.6
230.4±26.6
230.4±26.6
230.4±26.6
230.4±26.6
230.4±26.6
207.3±21.0
207.3±21.0
207.3±21.0
161.1±4.9
100.0±11.8
70.1±9.5
25.4±10.9
25.4±10.9
2.9±1.0
0.4±0.1
0.4±0.1
14.6±6.2
5.5±2.6
5.5±2.6
-

Biomass

-

Flux
(mmol/g/hr)
0.4±0.0
0.4±0.0
0.6±0.0
0.2±0.0
1.0±0.1
1.0±0.1
1.0±0.1
1.0±0.1
1.0±0.1
0.9±0.1
0.9±0.1
0.9±0.1
0.7±0.0
0.4±0.1
0.3±0.0
0.1±0.0
0.1±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.1±0.0
0.0±0.0
0.0±0.0
μ=0.12 hr-1
±0.01 hr-1

ATP

NADH

NADPH

2[H]

Fdred

0.0±0.0
0.0±0.0
0.0±0.0
-0.2±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.0±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.7±0.0
0.0±0.0
0.3±0.0
0.0±0.0
-0.1±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.7±0.2
40.86∙0.12
=4.9±0.5

0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.0±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.3±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.3±0.1
-3.55∙0.12
=-0.4±0.1

0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.9±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.9±0.1
16.87∙0.12
=2.0±0.2

0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.0±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
1.0±0.1
0.00∙0.12
=0.0±0.0

0.0±0.0
0.0±0.0
1.2±0.1
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
2.0±0.2
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
0.0±0.0
3.2±0.3
0.00∙0.12
=0.0±0.0

Biomass formation: 2.833 PYR+ 1.078 AKG+1.787 OAC+1.493 3PG+0.898
R5P+2.938 ACCOA+0.719 PEP+0.361 E4P+0.205 G6P+0.071 F6P+0.129 GAP
+16.866 NADPH+ 40.860 ATP→39.68 Biomass+3.547 NADH
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4.3 13C-metabolic flux analyses of Thermoanaerobacter species
13

C-MFA has been applied to quantify and compare metabolic flux

distributions in two Thermoanaerobacter species: Thermoanaerobacter sp. X514
and Thermoanaerobacter pseudethanolicus 39E (35). Both species were cultured
anaerobically with 2 g/L of [1-13C] glucose or 2 g/L of [1-13C] xylose. The
metabolic network of Thermoanaerobacter species included pentose phosphate
pathway, glycolysis, the branched TCA cycle, and the futile pathways.
When using glucose as the carbon substrate, the flux through the oxidative
pentose phosphate pathway, which was often used for NADPH production, was
moderately higher in 39E than that in X514. In spite of very different growth rates
between X514 and 39E in glucose and xylose cultures, the intracellular carbon
flux distributions, after normalization by carbon substrate consumption rates,
were not significantly different between these two strains. This suggested a
similar regulation of central metabolic pathways in these two phylogenetically
closely related strains. The report of 13C-MFA of Thermoanaerobacter species is
attached in Appendix 7. Beside, 13C-MFA has also been used in investigating the
metabolic robustness of Shewanella oneidensis MR-1 (36) (Appendix 8).
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4.4.1 Abstract
In a 13C-experiment for metabolic flux analysis (13C-MFA), we examined
isotope discrimination by measuring the labeling of glucose, amino acids and
hexose monophosphates via mass spectrometry. When Escherichia coli grew in a
mix of 20% fully labeled and 80% naturally labeled glucose medium, the cell
metabolism favored light isotopes, and the measured isotopic ratios (δ13C) were in
the range of -35 to -92. Glucose transporters might play an important role in such
isotopic fractionation. Flux analysis showed that both isotopic discrimination and
isotopic impurities in labeled substrates could impact the accuracy and precision
of 13C-MFA.
Key words: amino acid, glucose transporter, δ13C, mass spectrometer, isotopic
impurity
4.4.2 Methods and results
13

C-metabolic flux analysis (13C-MFA) experiments consist of feeding

microbes with enriched

13

C-labeled substrate, then measuring the isotopic

distribution in the resulting metabolites (often amino acids) to quantify absolute
fluxes through the metabolic network. In a typical

13

C-MFA experiment,

uniformly 13C-labeled substrates are often used in a mixture with the non-labeled
form to create efficient scrambling of labeled carbons in the backbone of all
metabolites (37,38). Such an experiment assumes that the microbial activity is
equal for all isotopomers, and that

13

C tracing will not change the metabolic
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kinetics. However, a kinetic isotopic effect may be present in all bio-reactions,
wherein light isotopes react faster than heavy isotopes due to the lower activation
energies for enzymatic breaking of the

12

C-12C bond than the

13

C-13C bond

(39,40,41). In the microbial process, the isotopic effect depends on isotopomer
diffusion kinetics, intrinsic enzyme characteristics, and microbial growth
conditions (such as pH, micronutrients, and growth factors) (41,42). However,
most isotopic effect studies are in the fields of biogeochemistry and ecology,
where the 13C is naturally labeled (around 1.1%).
This study investigated the isotopic effect in

13

C-MFA experiments when

highly enriched 13C-susbtrate was used. E.coli BL21 (DE3) was first grown in M9
medium with 22.2 mM of glucose (shaking flasks, 150 rpm, 37°C), which
contained non-labeled glucose (Sigma-Aldrich, USA) and fully labeled glucose
(99% purity, Cambridge Isotope, USA) in approximately a 4:1 molar ratio. To
reduce the non-labeled carbon from the initial stock, cells were then sub-cultured
(0.1% inoculation ratio) in the same
samples from the

13

13

C-labeled medium. All sub-cultured

C-MFA experiments were harvested at the mid-log phase (8

hrs) for isotopomer analysis.
We first employed an isotope ratio mass spectrometer and a gas
chromatograph-mass spectrometer (GC-MS) to analyze isotopic fractionation in
cell metabolism. The exact ratio of
carbon substrate (glucose) of

13

13

C/12C (i.e.

13

C/12C=0.2497) in the initial

C-MFA experiments was determined using an
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isotope ratio mass spectrometer after combustion of glucose to CO2 (performed
by the Stable Isotope Biogeochemistry Laboratory, Washington University).
Since the mass detector could be saturated for 13C enriched compounds (13C >5%)
(43), we made a tenfold dilution of the samples with naturally labeled glucose
before measurement (39,40). To determine the ratio of

13

C/12C in the biomass

(reflected by proteinogenic amino acids), a gas chromatograph (Hewlett-Packard
model 7890A; Agilent Technologies, CA) and a mass spectrometer (model
5975C; Agilent Technologies, CA) were employed. The sample preparation and
isotopic analysis of proteinogenic amino acids were performed as previously
described (20,25). The GC-MS was carefully tuned and the measurement errors
were determined using naturally labeled amino acids (Supplementary Table
4.4.S1)(44). In a separate 13C-MFA experiment, we used a liquid chromatographmass spectrometer (LC-MS) to investigate the isotopic effect. The first metabolite
in the glycolysis, hexose monophosphate (mainly glucose 6-phosphate, G6P), was
extracted by cold methanol. The labeling pattern was determined using ion pair
reverse phase LC-TOF(a Quadrupole Time-of-Flight, Agilent) with electrospray
ionization (ESI) in negative mode. The measurement was performed by the
Proteomics & Mass Spectrometry Facility at the Donald Danforth Plant Science
Center) (45).
The isotopic ratio (δ13C) is a standard parameter for isotopic fractionation
and was calculated as:
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13

13

12

13

12

( C / C metabolite) ( C / C glucose)
1000
C / C glucose

C

13

(Equation 1)

12

The 13C/12C ratio of glucose used in 13C-MFA experiments can be determined by
an isotope ratio mass spectrometer or LC-TOF. In this work, the 13C/12C ratios in
metabolites were calculated from the labeling patterns of metabolites. Due to their
associated pathways, each metabolite has a different value for

13

C/12C, given

below:
C

i Mi
13

12

i 1

C / C metabolite

(Equation 2)

C

C

(

i Mi)
i 1

where Mi is the isotopomer fraction for a given metabolite (i.e., M0 is the nonlabeled fraction, M1 is the singly labeled fraction, M2 is the doubly labeled
fraction, , etc). C is the total number of carbon atoms in the molecule.
Previous research has reported that when a naturally labeled carbon source
was digested, the isotopic ratio for key metabolites (including amino acids)
resulting from enzymatic conversion of glucose was around -20 (46). When E.
coli was grown with 20% [U-13C] glucose and 80% non-labeled glucose, the
growth curve was similar to that for non-labeled glucose (supplementary Figure
4.4.S1). Based on GC-MS measurement, δ13C values from key amino acids were
all negative (i.e., light isotopes were favored) and significantly above the
instrument errors (Figure 4.4.1). The δ13C values also suggest that pathways may
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have different isotope discrimination. Phenylalanine and histidine are derived
from the pentose phosphate pathway. Their δ13C values were between -47 and 45, similar to the δ13C values of serine and alanine (both of which are derived
from glycolysis). On the other hand, leucine has acetyl-CoA as one of its
precursors. The oxidation of pyruvate to acetyl-CoA has been reported to have a
strong isotopic effect (47), so the leucine synthesis route showed a higher
microbial isotopic effect (δ13C = -79) than that of alanine (converted from
pyruvate). Besides, aspartate had the highest isotopic ratio (δ13C = -92) among all
amino acids, because the anaplerotic reaction (PEP + CO2  Oxaloacetate) used
non-labeled CO2 for oxaloacetate (the precursor of aspartate) synthesis, leading to
additional dilution of the 13C pool of aspartate.
To confirm the GC-MS results, we performed independent
experiments and examined the labeling patterns of G6P and glucose in the

13

C

13

C

culture medium. Table 4.4.1 gives the LC-MS-based labeling fraction data for
G6P (M0~M6, ion m/z=259~265) and glucose (M0~M6, ion m/z=179~185). These
results indicate that cells selectively metabolize more light glucose than heavy
glucose (δ13C=-77±27) during the middle-log phase. The LC-MS-based δ13C
values were close to the δ13C values obtained by GC-MS (via analysis of amino
acid labeling). The G6P data suggests that the selectivity of glucose uptake may
also be a reason for isotopic fractionation. In general, heavy glucose (fully
labeled, molecular weight=186 Da) has a slower diffusion rate than
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12

C glucose

(non-labeled, molecular weight=180 Da). Thus the glucose transporter may favor
light glucose and cause isotopic fractionation during the glucose uptake process.
Finally, a

13

C-MFA model estimated the impact of the isotopic effect on

the accuracy of flux calculations. The pathway map of E. coli BL21 (DE3)
includes the glycolysis, citric acid cycle, pentose phosphate, and anaplerotic
pathways (supplementary Fig 4.4.S2). The development of the 13C-MFA has been
discussed previously (20). In brief, glucose, acetate, and biomass pools were
measured, and glucose uptake rates were normalized to 100 units. The unknown
fluxes were determined in an iterative scheme based on the reaction stoichiometry
and atom transition routes through the defined metabolic network. The flux
optimization was performed using the “fmincon” function in MATLAB
(MathWorks). Because local solutions may be found, the model was run 50 times
from different initial guesses to generate the solution space for each flux. By
using the amino acid labeling data (supplementary Table 4.4.S2), the flux
distributions were estimated with three sets of initial glucose-labeling patterns.
The first glucose set (case 1) was comprised of 20% fully labeled glucose mixed
with 80% non-labeled glucose, which represented the traditional approach for
13

C-MFA. The second glucose set (case 2) was adjusted to 19.2% universally

labeled glucose mixed with 80.8% non-labeled glucose, which corrected for bias
in glucose utilization (i.e., assuming that E. coli utilizes relatively more
glucose than

13

12

C-

C-glucose). Such reduced labeling was based on a microbial

isotopic fractionation ratio (δ13C = -47). The third glucose set (case 3) was based
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on Table 4.4.1, and the labeling distribution was M0=74%, M1=5%, M2=1%,
M5=1% and M6=18%. Since commercial labeled glucose is not perfectly pure
(M0≠80%, M6≠20%), the differences in fluxes from case 1 and case 3 represent a
common error in conventional GC-MS-based

13

C-MFA analysis. The estimated

global net flux distributions in the three sets of labeling data showed that the
isotopic effect slightly changed the relative fluxes in the central pathways (~1
units) (Supplementary Fig. 4.4.S3). Beside, consideration of the isotopic impurity
of glucose improved the precision of the flux calculation (i.e. smaller solution
space on case 3 than that on case 1). The flux difference in key pathways between
case 1 and 3 could be up to 5 units. Therefore, the isotopic impurity, rather than
isotopic fractionation, should be the concern for flux estimation in conventional
labeling experiments.
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Figure 4.4.1. Isotopic effect in E. coli BL21 (DE3) with 20% [U-13C] glucose and
80% non-labeled glucose. The biased isotopic ratio is defined as - δ13C, based on
GC-MS measurement. The higher the biased isotopic ratio, the more
are preferred in the amino acids synthesis.
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12

C atoms

Figure 4.4.S1. Growth curve of E. coli BL21 (DE3) with non-labeled glucose (●,
solid line) or 20% [U-13C] glucose and 80% non-labeled glucose (○, dot-dashed
line).
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Figure 4.4.S2. Flux analysis of central metabolism in E. coli BL21 (DE3). The
grey arrows indicate fluxes to biomass. Abbreviations: 6PG, 6-phosphogluconate;
ACCOA, acetyl-coenzyme A; E4P, erythrose-4-phosphate; F6P, fructose-6phosphate; G6P, glucose-6-phosphate; GAP, glyceraldehyde 3-phosphate; 3PG,
3-phosphoglycerate; CIT, citrate/isocitrate; MAL, malate; OAA, oxaloacetate;
AKG, 2-oxoglutarate; PEP, phosphoenolpyruvate; PYR, pyruvate; P5P, ribose-5phosphate

(or

xylulose-5-phosphate,

sedoheptulose-7-phosphate.
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or

ribulose-5-phosphate);

S7P,
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Figure 4.4.S3. Boxplot of metabolic flux results from MATLAB fmincon
optimization using 50 random guesses of initial fluxes. Three sets of glucoselabeling patterns were used for flux calculations. 1) not biased: 20% [U-13C]
glucose mixed with 80% non-labeled glucose; 2) biased: 19.2% [U-13C] labeled
glucose mixed with 80.8% non-labeled glucose; 3) actual: glucose labeling
patterns obtained from LC-MS measurement as listed in Table 4.4.1. All the
fluxes were normalized by taking the glucose uptake flux as 100 units, while the
optimal flux values were marked in the Figure.
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Table 4.4.1. Calculation of δ13C for G6P derived from LC-MS
Fragmentations
M0
M1
M2
M3
M4
M5
M6
(13C/12C)

G6P in E. coli
Replicate 1 Replicate 2
0.663
0.655
0.091
0.095
0.054
0.056
0.059
0.066
0.014
0.000
0.000
0.000
0.119
0.128
0.236
0.243
0.240±0.005

(δ13C)

Glucose in medium
Replicate 1 Replicate 2
0.743
0.743
0.051
0.049
0.008
0.012
0.000
0.000
0.000
0.000
0.015
0.013
0.183
0.183
0.260
0.260
0.260±0.000
-77

Note: Two independent culture experiments were performed with five technical
repeated measurements. The instrument error was 0.4%. 13C/12C was calculated
by equation 2; δ13C was calculated by equation 1.
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Table 4.4.S1. GC/MS calibration for eight amino acids fragments.
Ala 260 (C11H26O2NSi2); δ13C=-20.4
m/z
260
261
262
263
264
265
266
267
268

theory
100
23.2
9.5
1.5
0.3
0.0
0.0
0.0
0.0

data
100
22.6
9.4
1.4
0.2
0.0
0.0
0.0
0.0

difference
0.0
-0.6
-0.1
-0.1
-0.1
0.0
0.0
0.0
0.0

data
100
21.4
9.1
1.3
0.2
0.0
0.0
0.0
0.0

difference
0.0
-0.6
-0.1
0.0
0.0
0.0
0.0
0.0
0.0

data
100
29.3
11.2
2.0
0.3
0.1
0.0

difference
0.0
-0.7
-0.1
-0.1
-0.1
0.0
0.0

Gly 246 (C10H24O2NSi2); δ13C=-19.2
m/z
246
247
248
249
250
251
252
253
254

theory
100
22.0
9.2
1.3
0.2
0.0
0.0
0.0
0.0

Leu 344 (C17H38O2NSi2); δ13C=-27.6
m/z
344
345
346
347
348
349
350

theory
100
30.0
11.3
2.1
0.4
0.0
0.0
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Ser 390 (C17H40O3NSi3); δ13C=-20.4
m/z
390
391
392
393
394
395
396
397
398
399
400

theory
100
35.1
16.3
3.8
0.9
0.1
0.0
0.0
0.0
0.0
0.0

data
100
34.3
15.9
3.7
0.9
0.1
0.0
0.0
0.0
0.0
0.0

difference
0.0
-0.8
-0.4
-0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0

data
100
29.3
11.0
2.1
0.4
0.0
0.0
0.0
0.0

difference
0.0
-0.6
-0.2
0.0
0.0
0.0
0.0
0.0
0.0

data
100
35.1
16.6
3.9
0.9
0.1
0.0

difference
0.0
-1.0
-0.3
-0.1
-0.1
-0.1
0.0

Phe 336 (C17H30O2NSi2); δ13C=-14.6
m/z
336
337
338
339
340
341
342
343
344

theory
100
29.9
11.2
2.1
0.4
0.0
0.0
0.0
0.0

Asp 418 (C18H40O4NSi3); δ13C=-18.8
m/z
418
419
420
421
422
423
424

theory
100
36.1
16.9
4.0
1.0
0.2
0.0
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425
426
427
428

0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0

data
100
36.4
16.9
4.1
1.0
0.1
0.0
0.0
0.0
0.0
0.0

difference
0.0
-1.0
-0.5
-0.2
0.0
-0.1
0.0
0.0
0.0
0.0
0.0

Glu 432 (C19H42O4NSi3); δ13C=-27.1
m/z
432
433
434
435
436
437
438
439
440
441
442

theory
100
37.4
17.4
4.3
1.0
0.2
0.0
0.0
0.0
0.0
0.0

His 440 (C20H42O2N3Si3); δ13C=-24.3 (‰)
m/z
theory
data
difference
0.0
440
100
100
-0.9
441
39.2
38.3
-0.5
442
17.7
17.2
-0.2
443
4.4
4.2
-0.1
444
1.0
0.9
-0.1
445
0.2
0.1
0.0
446
0.0
0.0
0.0
447
0.0
0.0
0.0
448
0.0
0.0
0.0
449
0.0
0.0
0.0
450
0.0
0.0
Note: Table 4.4.S1 determined the instrumental errors of GC-MS using
derivatized amino acids (naturally labeled with 13C, 18O, 15N and 29,30Si). δ13C
values in the table represent the measurement bias for labeled amino acids during
13
C-MFA.
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Reference: M.R. Antoniewicz, J.K. Kelleher, and G. Stephanopoulos, Accurate
assessment of amino acid mass isotopomer distributions for metabolic flux
analysis. Anal. Chem. 79 (2007) 7554-9.

190

Table 4.4.S2. Measured and model fitted isotopomer data from TBDMSderivatized amino acids
Amino
Fragment
Acids
Ala

[M-57]+

Gly

[M-57]+

Leu

[M-159]+

Ser

[M-57]+

Asp

[M-57]+

Glu

[M-57]+

Phe

[M-57]+

His

[M-57]+

Origin
Exp
Cal_Unbiased
Cal_Biased
Cal_Actual
Exp
Cal_Unbiased
Cal_Biased
Cal_ Actual
Exp
Cal_Unbiased
Cal_Biased
Cal_ Actual
Exp
Cal_Unbiased
Cal_Biased
Cal_ Actual
Exp
Cal_Unbiased
Cal_Biased
Cal_ Actual
Exp
Cal_Unbiased
Cal_Biased
Cal_ Actual
Exp
Cal_Unbiased
Cal_Biased
Cal_ Actual
Exp
Cal_Unbiased
Cal_Biased
Cal_ Actual

M0
0.78
0.77
0.77
0.75
0.79
0.79
0.79
0.79
0.51
0.49
0.51
0.48
0.74
0.74
0.74
0.73
0.61
0.60
0.61
0.63
0.52
0.49
0.50
0.51
0.45
0.44
0.45
0.42
0.53
0.53
0.53
0.53

Isotopomer Enrichment
M1
M2
M3
0.04
0.02
0.17
0.04
0.03
0.17
0.04
0.03
0.16
0.05
0.02
0.17
0.05
0.16
0.05
0.16
0.05
0.16
0.05
0.16
0.15
0.24
0.06
0.16
0.24
0.07
0.15
0.24
0.06
0.18
0.24
0.07
0.08
0.05
0.13
0.07
0.06
0.14
0.07
0.06
0.13
0.08
0.05
0.14
0.17
0.11
0.09
0.15
0.12
0.10
0.16
0.11
0.09
0.15
0.10
0.10
0.16
0.21
0.07
0.16
0.24
0.07
0.17
0.23
0.06
0.19
0.21
0.06
0.09
0.12
0.16
0.07
0.13
0.17
0.08
0.13
0.17
0.09
0.12
0.15
0.16
0.10
0.11
0.16
0.10
0.11
0.16
0.10
0.11
0.16
0.11
0.11

M4

0.03
0.03
0.03
0.03

0.02
0.03
0.03
0.03
0.02
0.03
0.03
0.02
0.10
0.09
0.09
0.11
0.03
0.03
0.03
0.03

Note:
Cal_Unbiased isotopic data are calculated by assuming δ13C= 0.
Cal_Biased isotopic data are calculated by assuming δ13C= -47.
Cal_ Actual isotopic data are calculated based on the labeling pattern of glucose
detected by LC-MS.
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5.1 Abstract
Shewanella oneidensis MR-1 sequentially utilizes lactate and its waste
products (pyruvate and acetate) during batch culture. To decipher MR-1
metabolism, we integrated genome-scale flux balance analysis (FBA) into a
multiple-substrate Monod model to perform the dynamic flux balance analysis
(dFBA). The dFBA employed a static optimization approach (SOA) by dividing
the batch time into small intervals (i.e., ~400 mini-FBAs), then the Monod model
provided time-dependent inflow/outflow fluxes to constrain the mini-FBAs to
profile the pseudo-steady-state fluxes in each time interval. The mini-FBAs used a
dual-objective function (a weighted combination of “maximizing growth rate”
and “minimizing overall flux”) to capture trade-offs between optimal growth and
minimal enzyme usage. By fitting the experimental data, a bi-level optimization
of dFBA revealed that the optimal weight in the dual-objective function was timedependent: the objective function was constant in the early growth stage, while
the functional weight of minimal enzyme usage increased significantly when
lactate became scarce. The dFBA profiled biologically meaningful dynamic MR-1
metabolisms: 1. the oxidative TCA cycle fluxes increased initially and then
decreased in the late growth stage; 2. fluxes in the pentose phosphate pathway and
gluconeogenesis were stable in the exponential growth period; and 3. the
glyoxylate shunt was up-regulated when acetate became the main carbon source
for MR-1 growth.
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5.2 Authors’ summary
This study integrates two modeling approaches, a Monod kinetic model
and genome-scale flux balance analysis, to analyze the dynamic metabolism of an
environmentally important bacterium (S. oneidensis MR-1). The modeling results
reveal that MR-1 metabolism is suboptimal for biomass growth, while MR-1
continuously reprograms the intracellular flux distributions in adaption to nutrient
conditions. This innovative dFBA framework can be widely used to investigate
transient cell metabolisms in response to environmental variations. Furthermore,
the dFBA is able to simulate metabolite-labeling dynamics in
experiments, and thus can serve as a springboard to advanced

13

13

C-tracer

C-assisted

dynamic metabolic flux analysis by using labeled proteinogenic amino acids to
improve flux results.
Key words: 13C, enzyme usage, genome-scale, Monod, objective functions,
suboptimal, TCA cycle
5.3 Introduction
Cell metabolisms are highly dependent on environmental conditions, so
the metabolic state often shifts during the cultivation period (1,2,3).
Characterizing the transience of metabolic fluxes is important for understanding
how cells responded to environmental changes. Bioprocess models (e.g., a
Monod-based kinetic model) (4) have been widely applied to predict microbial
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dynamics, but they cannot directly obtain the intracellular flux distributions. On
the other hand, flux balance analysis (FBA) profiles the rates of enzymatic
reactions based on stoichiometric mass balance, knowledge of reaction
constraints, and measurements of inflow/outflow fluxes (5,6). As an
underdetermined model, FBA requires an objective function (e.g., “maximizing
growth rate”) for flux calculation. However, since cells may show suboptimal
metabolism and reprogram their metabolic fluxes under different environmental
conditions, the commonly used objective function is insufficient to describe cell
physiologies (7,8,9). Furthermore, FBA assumes steady-state metabolic
conditions, and thus is unable to directly analyze the transience of cell metabolism
(10,11,12).
This study developed an FBA framework that integrates Monod kinetics
and FBA to decipher the dynamic metabolism of MR-1 (Figure 5.1). MR-1 is a
facultative anaerobic bacterium, which not only plays an important ecological role
in carbon cycling and metal reduction, but also has been widely used for in situ
bioremediation and microbial fuel cell applications (13,14,15). MR-1 has a
diverse carbon utilization capability and shifts its metabolism during batch
cultivation (16). MR-1 uses lactate for initial growth and produces acetate and
pyruvate. In the late growth stage, MR-1 metabolizes less energy-favorable
pyruvate and acetate. To describe such kinetic behavior, we used unsegregated
Monod equations to simulate cell growth, lactate utilization, and metabolite
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secretion and reuse. The standard Monod model was incorporated into a genomescale FBA model, iSO783 (17), to formulate the dynamic FBA (dFBA)
framework (11), which enabled quantitative predictions of the MR-1 metabolism.
5.4 Results
5.4.1 Monod model
MR-1 growth displayed an apparent lag phase (~7.1 h) in 30 mM lactate
medium (0.1% inoculation). By incorporating a time delay function for the lag
growth phase, a standard Monod model consisting of four ordinary differential
equations was built to describe the extracellular metabolite curves and growth
kinetics (Figure 5.2). The parameters of the Monod model were estimated by
fitting the experimental data. Table 5.1 indicates that the lactate-based biomass
yield was higher than that for either pyruvate or acetate, confirming the
preferential utilization of lactate as an energy-favorable carbon substrate for MR1. Similarly, the lactate-based growth rate (μmax) was much higher than that for
either pyruvate or acetate, indicating that lactate was the major carbon substrate
for biomass growth at the early growth stage. Table 5.1 lists the rate coefficients
(kpl, kap and kal) for waste products (pyruvate and acetate) synthesis and reuse,
which indicates that MR-1 quickly consumed lactate, producing significant
metabolic overflows to the waste products. Such a strategy illustrates an
advantageous ecological niche for MR-1 in competing for favorable carbon
sources. Finally, although our standard Monod model reasonably well described
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MR-1 growth data, its results showed some lack-of-fit with statistical analysis
(Table 5.S1). Such a discrepancy was possibly due to the model’s simplification
and to measurement noises. In this study, the kinetic model represents a
compromise between complexity and practical simplicity.
5.4.2 Link kinetic model to FBA
To resolve the flux dynamics, the static optimization approach (SOA)
divided the cultivation phase into numerous pseudo-steady states so that a
conventional genome-scale MR-1 framework (iSO783, containing 774 reactions
and 634 metabolites) was able to calculate the flux distributions (17) in each fiveminute time interval. Such dFBA model consisted of ~400 mini-FBAs. To avoid
repeated and tedious measurements of biomass and metabolite concentrations for
each mini-FBA, we used the Monod model to determine the inflow/outflow fluxes
of lactate, acetate, and pyruvate in each time interval. The mini-FBAs could be
resolved by an objective function of “maximizing growth rate”, but this function
severely overestimated the actual biomass growth (Figure 5.3). To account for the
suboptimal metabolic features (7,8,9), we used a dual-objective function in dFBA:
a combination of “maximize growth rate” and “minimize overall flux”. By
appropriately weighing both objectives, we explored the trade-offs between
optimal cell growth and minimal enzyme usage. Specifically, the Monod model
determined the transient growth rate for each time interval, which tuned the
weights in the dual-objective functions for the mini-FBAs so that the biomass
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growth curve simulated by dFBA was in agreement with experimental
observations. Figure 5.3 showed that the optimal dual-objective function in miniFBAs was time-dependent. In general, these dual-objective functions were
invariable before the carbon substrate switched from lactate to acetate/pyruvate.
When lactate became scarce, the weight of “minimizing overall flux” in the
objective function increased significantly, indicating an intracellular reduction of
enzyme synthesis and minimization of intracellular fluxes.
5.4.3 Dynamic flux distributions in MR-1
The dynamic flux distributions in MR-1 were calculated using the bi-level
optimization (Figure 5.4). The carbon flows to extracellular acetate and pyruvate
were high when lactate was sufficient (~33% and ~25% of the lactate uptake flux
before the carbon substrate switch, respectively). Fluxes into the gluconeogenesis
pathway, reductive PP pathway, and ED pathway were mainly for biomass
synthesis, and remained approximately constant during the exponential growth
phase. In the middle log phase (22~25 hours), when the growth rate reached the
maximum, fluxes in the oxidative TCA cycle reached a peak (e.g., ~6 mmol/g
DCW/h for succinyl-CoA synthetase) to generate energy and building blocks.
When lactate became scarce (25~30 hrs), MR-1 had to utilize its waste
metabolites (acetate and pyruvate). During this metabolic shift, most intracellular
fluxes started to decrease. In the late log growth phase (30~34 hrs), it was also
observed that the glyoxylate shunt was up-regulated compared to TCA cycle
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fluxes after acetate became the main carbon source for MR-1 growth. The
glyoxylate shunt reduced the oxidation of carbon substrate for CO2 production by
diverting the carbon flow into a shorter metabolic route. The glyoxylate shunt
activity was further confirmed by in vitro enzyme assays at both the mid-log
phase (malate synthase activity was 0.18±0.11 μmol/g DCW/min) and the late-log
phase (malate synthase activity was 0.37±0.17 μmol/g DCW/min).
5.4.4 Simulation of dynamic 13C-labeling in proteinogenic amino acids
In

13

C-labeled tracer experiments, dFBA can be used to predict the

isotopomer dynamics in slow turnover metabolites, such as proteinogenic amino
acids. During MR-1 growth with [3-13C] lactate, the dynamic metabolism led to
variations of labeling patterns in intracellular metabolites (biomass precursors) so
that the isotopic labeling in proteinogenic amino acids was continuously changing
during cell growth (18). Here, we simulated the time-integrative labeling patterns
in proteinogenic amino acids based on fluxes from dFBA. The predicted
isotopomer labeling patterns of five proteinogenic amino acids (Ala, Ser, Glu,
Asp, and Gly, at t = 24 and 30 h) are illustrated in Figure 5.5A and Figure 5.S1.
Compared with the experimental measurements, the labeling patterns predicted by
dFBA are consistent with the measured labeling patterns, but some lack-of-fit still
exists. One of the limitations of the FBA model is that the intracellular pathway is
treated as unidirectional, so the effect of exchange fluxes on isotopomer data is
neglected. Considering that some in vivo reactions could be bi-directional, we
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implemented exchange coefficients for four pathways (e.g., the anaplerotic
pathway: pyruvate  malate) in the model to improve the simulation of

13

C-

labeling (Table 5.2). After introduction of the exchange coefficients, the measured
and the simulated isotopomer data for proteinogenic amino acids matched (R2 =
0.9619, Figure 5.5B).
5.5 Discussion
dFBA models have been developed to describe the dynamic metabolism of
E.coli (10), Saccharomyces cerevisiae (19), Lactococcus lactis (12), and even for
a more complicated coculture system of E.coli and Saccharomyces cerevisiae
(20). In this study, we developed dFBA for analyzing metabolic states of S.
oneidensis MR-1. The time-dependent inflow/outflow fluxes for dFBA can be
constrained by either a Monod model or other empirical models (such as
polynomial-fitting to the measurement data (21)). The Monod model is suitable to
uncover kinetic properties of a scale-up bioprocess and empowers the dFBA to
correlate the bioprocess parameters (such as nutrient concentrations and inhibition
coefficients) with intracellular metabolism analysis. The integration of the Monod
model and dFBA can decipher and predict cell metabolisms in response to batch
fermentation conditions.
To describe biological realities, a physiologically reasonable objective
function is important for FBA. For E.coli metabolism, 11 objective functions have
been systemically investigated under different cultivation conditions (7). It turns
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out that no single objective function can describe metabolic states accurately for
all conditions. A recent study of MR-1 indicated that futile cycles may be
operational, in which less energetically efficient enzymes are expressed at higher
levels than their counterparts and decrease biomass yield (17). Such suboptimal
metabolic features in MR-1 make the conventional objective functions difficult to
use in predicting actual cell physiology. To bridge the gap between the in silico
simulations and experimental observations, we assigned dual-objective functions
to resolve mini-FBAs. Using dual-objective functions, dFBA accurately predicted
the elevated flux ratio of the glyoxylate shunt (represented by malate synthase
activity) to the oxidative TCA cycle (represented by fumarase activity) when
acetate started to be used as the main carbon substrate (Figure 5.S2). The upregulation of the glyoxylate shunt and down-regulation of the oxidative TCA
pathways were consistent with a previous

13

C-metabolic flux analysis of MR-1

(18). In comparison, this transient metabolic shift in the glyoxylate shunt could
not be captured by a single objective function, such as maximal biomass growth.
Moreover, our dFBA results showed the weight of the two objective functions
remained relatively constant when lactate was sufficient. At the early stage of
MR-1 growth, such a pseudo-steady state has been experimentally verified by
previous isotopomer-based analysis (18). Under nutrient scarcity conditions, MR1 metabolism may reduce synthesis and usage of enzymes to achieve a
compromise between minimization of general physiological activities and
maintenance of essential cellular functions (22).
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The dFBA model can also simulate time-dependent isotopomer
enrichment in proteinogenic amino acids. In turn, the isotopomer results (Figure
5.5) can be used to validate and improve the dFBA model predictions. For
example, our dFBA model predicted low fluxes through malic enzyme during the
exponential growth because these pathways may reduce biomass production,
while the genetic analysis indicates a high functionality of malic enzyme (17). In
the dynamic isotopomer simulations, we found that the fitting of isotopomer
labeling patterns was significantly improved by introducing the bi-directional
fluxes through the pathway Malate ↔ CO2 + Pyruvate, while keeping the net flux
minimal. Such reversible reactions suggest metabolic flexibility. The activity of
malic enzyme was also confirmed by in vitro enzyme assays at both the mid-log
phase (malic enzyme activity was 0.90±0.18 μmol/g DCW/min) and late-log
phase (malic enzyme activity was 1.73±0.81 μmol/g DCW/min).
Proteinogenic amino acids are abundant in biomass and can easily be
measured by GC-MS. Complementing this instrumental data,

13

C-metabolic flux

analysis (MFA) offer analytic insight into the cell metabolisms in fermentation
processes (3,23,24). However, the turnover rate of protein is much slower than
that of intracellular metabolites, so

13

C-MFA is useful only for analyzing the

steady-state central metabolism. To perform

13

C-MFA of dynamic flux

distributions, the fast turnover metabolites have to be extracted and analyzed at
multiple time points (1,3), which requires significant sampling efforts and high-
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sensitivity analytical measurement of low-abundance/unstable metabolites.
Moreover, the calculation of dynamic fluxes with isotopomer data formulates an
inverse nonlinear optimization problem, which is computationally challenging.
Due to insufficient methods for analyzing low abundance metabolites (25), as
well as limitations in computational algorithms, dynamic 13C-MFA cannot resolve
the flux distributions in a large-scale metabolic network. To overcome these
difficulties, this study illustrates a proof-of-concept approach that exploits the
synergy between proteinogenic-amino-acid-based

13

C-MFA and genome-scale

dynamic flux balance analysis.
In our dFBA, the Monod model is solved first independently of the FBA.
As an alternative approach, we also tested to integrate the kinetic models with
FBA (integrative Flux Balance Analysis, iFBA). iFBA simultaneously optimizes
the kinetic model parameters and solves the dynamic cell metabolism in MR-1
(Supplementary Text S1). We found that iFBA also requires a dual objective
function, a weighted combination of “maximizing growth rate” and “minimizing
overall flux”, to improve the model accuracy, similar to the dFBA approach
(Figure 5.S3 and Table 5.S2). Such results indicate that it is difficult to use a
single objective to describe the flux states under all growth conditions, while the
time-dependent trade-off objective functions are effective for analyzing the
dynamic suboptimal metabolism.
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In conclusion, as in other FBA studies, the dFBA framework proposed in
this

study

links

macroscopic

bioprocess

variables

(such

as

nutrient

concentrations) to microscopic intracellular metabolism analysis. It predicts
metabolic responses under dynamic culture conditions, and reveals the impact of
the kinetic parameters (such as μmax) on intracellular flux distributions.
Furthermore, dFBA can identify the objective functions that are possibly used by
microorganisms in adaption to environmental variations. Finally, by simulating
and comparing the isotopomer labeling patterns of different metabolites, the
proposed dFBA framework can potentially improve dynamic flux resolutions by
incorporating the isotopomer data from labeled proteinogenic amino acids.
5.6 Materials and methods
Culture conditions, analytical methods, and isotopomer analysis. S.
oneidensis MR-1 (ATCC 70050) was first grown in LB medium in shake flasks
overnight. A 0.1% inoculum volume was then cultured into modified MR-1
defined medium (26) in shake flasks (100 mL culture for each of triplicate
experiments, shaken at 150 rpm) at 30°C. The initial carbon source was ~30 mM
lactate. The growth curve was monitored by dried biomass weight. The
concentrations of lactate and acetate in the medium were measured using enzyme
kits (r-Biopharm, Darmstadt, Germany). The concentration of pyruvate in the
medium was measured with the enzyme assay developed by Marbach and Weli
(27).
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To analyze the activity of malate synthase and malic enzyme, samples
were taken at early middle log phase (biomass of MR-1 ~0.08 g/L) and late log
phase (biomass of MR-1 ~0.23 g/L). The harvested cells were centrifuged and resuspended in 100 mM Tris buffer. The samples were then ultra-sonicated for 5
min to release the enzymes. Malate synthase activity was gauged based on the
reaction of CoASH with DTNB (Acetyl-CoA+glyoxylateMalate+CoASH;
CoASH+DTNBCoA-TNB+TNB), as described by Dixon and Kornberg (28). In
general, 20 μL acetyl-CoA (5 mM), 10 μL DTNB (10 mM), 50 μL cell extract,
and 500 μL of a solution containing 0.1 M potassium phosphate and 10 mM
MgCl2 were mixed with water. The mixture was then added with 20 μL 100 mM
glyoxylate. The difference in absorbance at OD412 before and after glyoxylate
addition reflected the activity of malate synthase, in which one unit ∆OD412
corresponded to 70.6 nmol of TNB produced (in a 1 mL reaction solution).
Furthermore, the activity of malic enzyme was detected based on increased
absorbance at 340 nm due to the reduction of NAD+ to NADH (29). In brief, 400
μL 250 mM Tris HCl, 20 μL 50 mM MnCl2, 25 μL 40 mM NH4Cl, 100 μL 1M
KCl, 50 μL 20 mM NAD+, 100 μL 100 mM malate, and 50 μL cell extract were
mixed with water (1 mL reaction solution). The change in absorbance at OD340
reflected the activity of malic enzyme.
In the labeling experiment, MR-1 was first grown overnight in the LB
medium in shake flasks. A 0.1% inoculum volume was then cultured into 100 mL
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of modified MR-1 defined medium at 30°C, with the initial carbon source as 30
mM

[3-13C]

lactate

(purity>98%)

purchased

from

Cambridge

Isotope

Laboratories, Inc. (Andover, MA). The biomass was harvested at ~24 h (before
lactate was depleted) and ~30 h (after the substrate had switched from lactate to
waste products). To analyze the labeling pattern of proteinogenic amino acids, we
hydrolyzed the biomass with 6M HCl at 100 oC. The isotopic analysis of
proteinogenic amino acids was performed using a GC-MS based TBDMS
method, as previously described (30,31,32). Ions of [M-57]+ (unfragmented
amino acid) were used for the 13C-simulations (33).
Monod model development. A multiple-substrate Monod model was
developed to describe the cell growth, lactate consumption and secretion, and
reuse of waste products (acetate and pyruvate).
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k e ) S(t t L )

(4)

L

where X is biomass (g DCW/L); LACT, ACT, and PYR are lactate, acetate, and
pyruvate concentrations (mmol/L), respectively; μL, μA, and μP are the specific
growth rates (h-1) on lactate, acetate, and pyruvate, respectively; ke is the
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endogenous metabolism rate constant (h-1); YX/L, YX/A, and YX/P are the biomass
yield coefficients (g DCW/mol substrate) of lactate, acetate, and pyruvate
respectively; rP,L and rA,L are the production rates (mmol/L/h) of acetate and
pyruvate from lactate, respectively. rA,P is the production rates (mmol/L/h) of
acetate from pyruvate. S(t-tL) is the dimensionless unit-step time delay function
(S=0 when t < tL; S=1 when t= tL) which described the lag phase after inoculation.
The specific cell growth rate was described by Monod equations:

max,L
L

Ks,l
max,A

A

Ks,a
max,P

P

Ks,p

LACT

(5)

LACT
ACT

(6)

ACT
PYR

(7)

PYR

where μmax,L, μmax,A, and μmax,P are the maximal growth rates (h-1) for fully aerobic
growth on lactate, acetate, and pyruvate, respectively; and Ks,l, Ks,a, and Ks,p are
Monod constants (mmol/L) for lactate, acetate, and pyruvate, respectively. The
acetate and pyruvate production rates are assumed to be proportional to the
biomass (16), as expressed below:
rA,L

k al LACT X

rP,L

k pl LACT X

rA,P

k ap PYR X

(8)
(9)
(10)
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where kal and kpl are rate constants of acetate and pyruvate production,
respectively (L∙ (h∙g DCW)-1). kap is the rate constant of acetate production from
pyruvate (L∙ (h∙g DCW)-1).
The kinetic model (Equations 1~10) contained 14 kinetic parameters. To
estimate the model parameters, an ordinary least squares (OLS) method (34) was
applied to solve the inverse problem. OLS aimed to minimize the residual sum of
the squares (R) between model simulations and experimental measurements,
expressed as

R [Y

(t; )]T [Y

(11)

(t; )]

where η represents four dependent variables simulated by the kinetic model; β
represents the vector of the parameters to be estimated; and Y is the vector of the
measured value of the dependent variables. Since the scales of the dependent
variables were different (e.g., the scale of the biomass measurement was < 1 g/L,
while the lactate measurement >10 mmol/L), the direct application of OLS would
overemphasize the fitting of dependent variables with large scales. Therefore, we
normalized dependent variables by the corresponding maximum concentrations
measured in the experiments.
The “ode23” command in MATLAB (R2009a, Mathworks) was used to
solve ODEs, and the “fmincon” command was used to find suitable settings of the
parameters. Figure 5.S4 is the histogram of normalized model residuals. The

213

standard deviations of the parameters were derived from a bootstrap analysis, in
which the experimental measurements were randomly re-sampled 1000 times and
the corresponding parameters were simulated with the same parameter estimation
approach. The 1000 re-sampling was found to be adequate since the variation of
parameters converged to within a desired tolerance of 0.1%.
Bi-level dFBA study. The growth phase was divided into 408 pseudosteady-state intervals with instantaneous transitions between the two adjacent
intervals (11). At each pseudo-steady state (~five minutes) (35), a mini-FBA was
formulated by a dual-objective function comprised of “maximizing the growth
rate” and “minimizing overall flux”; and inflow/outflow fluxes (for lactate,
acetate, and pyruvate) derived from the Monod model. The inflow/outflow fluxes
were calculated from:

dLACT
v
dt
dACT
v
dt
dPYR
v
dt

lac _ inf low

X

(12)

act _ outflow

X

(13)

pyr _ outflow

X

(14)

where vlac_inflow, vact_outflow, and vpyr_outflow are transient lactate inflow flux, acetate
outflow flux, and pyruvate outflow flux, respectively.
At each pseudo steady state, the mini-FBA followed a bi-level
optimization framework similar to ObjFind (36). The internal optimization was an
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FBA with a combined objective function in which the weighting factor of
“minimizing overall flux” ranged from zero to one. The difference between the
transient growth rate simulated from the FBA and that derived from the Monod
model was minimized in the external optimization, by tuning the weighting factor
in the combined objective function. The bi-level optimization determined a tradeoff between maximizing growth rate and maximizing enzyme efficiency under the
specified growth conditions. The bi-level optimization was formulated as:
min (

Monod

-

FBA

)2

s.t.
v i2

min [ w

( 1 w) μ FBA ]

i

(15)

s.t.
S v 0
lb v ub
vlac_ inf low , vact_outflo w , v pyr_outflo w from the Monod model
0

w 1

where μmonod and μFBA are transient growth rates derived from the Monod model
and the dFBA study, respectively; w is the weight of “minimizing overall flux” in
the combined objective function; v is the vector of the intracellular fluxes; S is the
stoichiometry matrix; lb and ub are the lower and upper boundaries for
intracellular flux.
The internal optimization was a typical quadratic programming (QP)
problem and was solved using the CPLEX solver in the TOMLAB optimization
toolbox (TOMLAB Optimization Inc, Seattle, WA) within MATLAB (R2009a).
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The external optimization problem (i.e., search for weight) was solved by a grid
search. Since the QP problem in this study was convex, the locally searched
results were also the global solutions (37).
Simulation of dynamic 13C-labeling in proteinogenic amino acids. Our
previous 13C-MFA study of MR-1 showed that the labeling patterns in its
proteinogenic amino acids changed during the late-stage of batch growth (18).
Using the dynamic flux distributions from dFBA, we could now simulate
dynamics of isotopomer labeling patterns in proteinogenic amino acids using the
algorithm below.
5

min

(MDVi ,exp

t 24 h

-MDVi ,sim

t 24 h

)2

5

(MDVi ,exp

t 30 h

-MDVi , sim

2
i 1

t 30 h

2
i 1

i

exch
1 exch
0 exch 1
f [v, vexch ]

i

s.t. vexch

(16)
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0
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IMM k 2 IDVk 2  )

)2

Since FBA neglects flux reversibility, we implemented exchange
coefficients exch to account for the reversibility of four key metabolic pathways
(ME2, GHMT, GLYCL, and SUCOAS in iSO783, Table 5.2). In Equation 16,
vexch is the vector of exchanged fluxes in the reversible reactions; v is the vector of
the transient fluxes at the t’ interval, simulated from the mini-FBA; p(t) are fluxes
to proteinogenic amino acids at each time interval; ∆t is the scale of a pseudo
steady state (5 min); ∆X(t) is the biomass produced at each time interval; IMM is
the isotopomer mapping matrices describing the carbon atoms transitions from
reactants to products in a reaction; IDV(t) are the isotopomer distribution vectors
of transient intracellular metabolites at each time interval, which is calculated
based on the different labeling patterns of precursors from n pathways; IDVint|t=t’
are the isotopomer distribution vectors in proteinogenic amino acids at the end of
the t’ time interval; MDVi,sim and MDVi,exp are the mass distribution vectors for
each of the five proteinogenic amino acids, as simulated and as measured by GCMS, respectively; M is the matrix for converting IDV to MDV; σi is the standard
deviation of the GC-MS measurement (error ~2%), which is assumed to be
constant in this study. The carbon transitions in the reactions involved were given
in Supplementary Text S2. The “fmincon” command in MATLAB was used to
find the exchange coefficients, and the “nlparci” command in MATLAB was used
to find the asymptotic confidence intervals of the exchange coefficients. These
exchange coefficients significantly improved dFBA simulation of the labeling
patterns in proteinogenic amino acids.
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5.7 Supplementary Text S1: framework of integrative Flux Balance Analysis
(iFBA)
We have tested an alternative model framework: iFBA. The dynamic
cultivation process was decomposed into numerous pseudo-steady-state time
intervals. At each time interval, the inflow/outflow fluxes in the FBA were
derived from the Monod equations; while the biomass increase during the time
interval was predicted by mini-FBAs using proper objective functions. At the end
of each time interval, the predicted biomass increase was incorporated into the
Monod equations to estimate the metabolite and substrate concentrations at the
next time interval. Then, we obtained the inflow/outflow fluxes of mini-FBA in
the next time interval (t+∆t). To improve the model accuracy, iFBA employed a
dual-objective function w(i), a weighted combination of “maximizing growth
rate” and “minimizing overall flux”. The time-dependent weight in the dualobjective function and the kinetic parameters in Monod equations were
determined by minimizing the differences between iFBA predicted MR-1 growth
kinetics and the experimentally measured data. The iFBA was formulated as
below:
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min R = [Y - η ( t; β)] [Y - η ( t; β)]
s.t.
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The new symbols introduced in iFBA are as following: num_timepoint is
the number of time intervals decomposed during the entire cultivation process,
which is 408; dt is the time of each time interval, which is 1/12 h. p1, p2 and p3 are
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three parameters used to simulate the dynamic weighting factors in the dual
objective function. The internal dFBA problem was solved using the CPLEX
solver in TOMLAB optimization toolbox (TOMLAB optimization Inc, Seattle,
WA) within MATLAB (R2009a). The external optimization problem (i.e. search
for weight) was solved by SNOPT solver in TOMLAB optimization toolbox
within MATLAB (R2009a). The histogram of normalized residuals in growth
kinetics simulated by iFBA was shown in Figure 5.S5. The Lack-of-fit test for
iFBA was shown in Table 5.S3.
5.8 Supplementary Text S2: reactions involved in 13C-labeling simulations
TCA cycle and metabolites transport
J1 (L-LACD2) LAC (abc)pyr(abc)
J2 (-ACt6) accoa(ab)↔ACT (ab)
J3 (-PYRt2) pyr(abc)↔PYR(abc)
J4 (PDH) pyr(abc)accoa(bc)+co2(a)
J5 (CS) oaa(abcd)+accoa(ef)cit(dcbfea)
J6 (ACONT) cit(abcdef)icit(abcdef)
J7 (ICDHy) icit (abcdef)akg(abcde)+co2(f)
J8 (AKGD) akg(abcde)succoa(bcde)+co2(a)
J9 (SUCD7) succ(1/2abcd+1/2dcba)fum(1/2abcd+1/2dcba)
J10 (FUM) fum(1/2abcd+1/2dcba)mal-L(abcd)
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J11 (MDH) mal-L(abcd)oaa(abcd)
J12 (PPC) pep(abc)+co2(d)oaa(abcd)
J13 (PPCK) oaa(abcd)pep(abc)+co2(d)
Glyoxylate shunt
J14 (ICL) icit(abcdef)glx(de)+succ(1/2abcf+1/2fcba)
J15 (MALS) accoa(ab)+glx(cd)mal-L(dcab)
Reversible net fluxes and C1 metabolism
J16 (GHMT) ser-L(abc)↔glx(ab)+mlthf(c)
J17 (GLYCL) glx(ab)↔co2(a)+mlthf(b)
J18 (ME2) mal-L(abcd)↔pyr(abc)+co2(d)
J19 (-SUCOAS) succoa(abcd)↔succ(1/2abcd+1/2dcba)
Gluconeogenesis
J20 (PPS) pyr(abc)pep(abc)
J21 (-ENO) pep(abc)2pg(abc)
J22 (-PGM) 2pg(abc)3pg(abc)
Amino acid biosynthesis
J23 3pg(abc)ser-L(abc)
J24 akg(abcde)glu-L(abcde)
J25 pyr(abc)ala-L(abc)
J26 oaa(abcd)asp-L(abcd)
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Notes:
1) All abbreviations are referred to iSO783, except LAC, PYR and ACT; which
represent extracellular lactate, pyruvate and acetate, respectively.
2) The reaction IDs in iSO783 are listed with brackets. The negative sign
indicates that the net flux of the pathway is in the opposite direction as set by
iSO783. The amino acids biosynthesis pathways are lumped; hence no ID in
iSO783 is available.
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Figure 5.1. Flowchart of dFBA to decipher the dynamic metabolism of S.
oneidensis MR-1.
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Figure 5.2. Monod model for growth kinetics. The green dots are the
measurements, and the blue lines are the simulated growth by the empirical
Monod model.
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Figure 5.3. Prediction of growth rates (h-1). Blue ○: growth rate determined by
the Monod model. Red ○: dFBA prediction using the objective function
(maximization of growth rate). Green □: dFBA prediction using dual-objective
functions (maximization of growth rate and minimization of overall flux). Yellow
◊: the weight of the dual-objective functions that predicted the measured growth
rates. Note: the summation of the square of fluxes (∑v2) was a very large number
(total 774 fluxes), so the magnitude of weight w was small.
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Figure 5.4. Dynamic flux distributions (unit: mmol/g DCW/h) in central
metabolic pathways. The yellow filled cycles are intracellular metabolites; the
blue filled cycles are substrates and extracellular metabolites (LAC: extracellular
lactate, PYR: extracellular pyruvate, ACT: extracellular acetate); the dashed lines
indicate inactive pathways; the green filled boxes are reactions listed in iSO783.
All the abbreviations refer to iSO783 (7,8,9).
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Figure 5.5. Experimentally observed and simulated isotopomer labeling patterns
[M-57]+ in proteinogenic amino acids. The standard error for GC-MS
measurement was below 0.02. A1: dynamic isotopomer simulation for glutamate
from dFBA without considering reaction reversibility (dFBA w/o reversibility).
A2: dynamic isotopomer simulation for glutamate from dFBA considering
reaction reversibility (dFBA w/ reversibility). Bar plot: comparison of
experimentally observed isotopomer labeling to simulated isotopomer labeling
patterns of glutamate (A1: without considering reaction reversibility; A2:
considering reaction reversibility). B: The model fitting of the isotopomer
labeling data of five key amino acids (Ala, Gly, Ser, Asp, and Glu) at t = 24 and
30 h.
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Figure 5.S1. Experimental observed and simulated isotopomer labeling patterns
[M-57]+ in key proteinogenic amino acids. The standard error for GC-MS
measurement was ~0.02. Area plot: dynamic isotopomer simulation (case 1:
simulation without considering reaction reversibility; case 2: simulation
considering reaction reversibility). Bar plot: comparison of experimental data to
simulated isotopomer labeling patterns (case 1: without considering reaction
reversibility; case 2: considering reaction reversibility).
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Figure 5.S2. Flux ratio of malate synthase (MALS) and fumarase (FUM) in
dynamic metabolism of Shewanella oneidensis MR-1. Blue ■: time profiles of flux
ratio using “maximizing growth rate” as the objective function in dFBA; red ▲:
time profiles of flux ratio using dual-objective function in dFBA: a combination
of “maximize growth rate” and “minimize overall flux”. The entire growth of
MR-1 was divided into three phases. In phase I, lactate was mainly used as the
carbon substrate. In phase II, lactate, acetate and pyruvate were used as the carbon
substrates. In phase III, acetate was used as the carbon substrate.
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Figure 5.S3. Growth kinetics simulated by iFBA using “maximizing growth rate”
as the objective function (red line) or using the dual-objective function (green
line). The blue dots are the measurements.
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Figure 5.S4. Histogram of normalized Monod model residuals.
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Figure 5.S5. Histogram of normalized residuals in growth kinetics simulated by
iFBA.
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Table 5.1. Parameters estimated in the empirical Monod model

Symbols

Notation

Unit

Value

μmax,L

Maximum specific growth rate using lactate

h-1

0.57±0.11

μmax,P

Maximum specific growth rate using pyruvate

h-1

0.14±0.02

μmax,A

Maximum specific growth rate using acetate

h-1

0.13±0.02

YX/L

Apparent biomass yield coefficient from
lactate

g DCW/mol lactate

17.0±1.3

YX/P

Apparent biomass yield coefficient from
pyruvate

g DCW/mol
pyruvate

16.7±1.3

YX/A

Apparent biomass yield coefficient from
acetate

g DCW/mol actate

11.1±4.7

Ks,l

Monod lactate saturation constant

mM

19.4±7.9

Ks,p

Monod pyruvate saturation constant

mM

19.4±8.1

Ks,a

Monod acetate saturation constant

mM

10.1±2.2

kal

Acetate production coefficient from lactate

L∙ (h∙g DCW)-1

0.71±0.06

kpl

Pyruvate production coefficient from lactate

L∙ (h∙g DCW)-1

0.45±0.04

kap

Acetate production coefficient from pyruvate

L∙ (h∙g DCW)-1

0.94±0.08

ke

Endogenous metabolism rate constant

h-1

0.013±0.016

tL

Lag time in growth

h

7.10±0.01
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Table 5.2. Exchange coefficients for key metabolic pathways of MR-1

Exchange
coefficients

Confidence
intervals

ME2

0.862

[0.803 0.921]

Serine ↔ Glycine + C1 unit

GHMT

0.270

[0.062 0.477]

Glycine ↔ C1 unit + CO2

GLYCL

0.109

[0.061 0.157]

SUCOAS

0.944

[0.906 0.983]

Pathways
Malate ↔ CO2 + Pyruvate

Succinate ↔ Succinyl-CoA

Abbreviation
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Table 5.S1. Lack-of-fit test for the Monod model.

Model
Name

Lack-offit sum
of
squares,
SSLOF

Monod
model

2.064

PureDegree
Degree
error
of
of
freedom, sum of freedom,
squares,
df1
df1
SSPE
58

0.813

144

SSLOF / df 1
SSPE / df 2

F(df1,df2)

6.303

1.390

Notes:
In order to test whether or not a model could fit the data well, we applied the lackof-fit test. It partitioned the total sum of squares of residuals in the model (SSE)
into two sources of variability: 1) the sum of squares from pure error variability
(SSPE) and 2) the sum of squares from lack of fit (SSLOF), i.e.
SSE=SSPE+SSLOF.
For testing the null hypothesis H0: the nonlinear model was adequate versus
hypothesis Ha: the nonlinear model was inadequate, the test statistic
is: F

SSLOF / df 1
. For a specified α-level of significance, we rejected the null
SSPE / df 2

hypothesis if F > Fα, where Fα is the α-level critical value (α=0.95 in this study)
corresponding to an F(df1; df2) distribution. The F-test indicates our nonlinear
model can be further improved by including new parameters. The improved
kinetic model is presented in another manuscript under review.
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Table 5.S2. Parameters estimated in iFBA
Symbols
μmax,L
μmax,P
μmax,A
YX/L
YX/P
YX/A
Ks,l
Ks,p
Ks,a
kal
kpl
kap
ke
tL
p1
p2
p3

Notation
Maximum specific growth rate using lactate
Maximum specific growth rate using pyruvate
Maximum specific growth rate using acetate
Apparent biomass yield coefficient from
lactate
Apparent biomass yield coefficient from
pyruvate
Apparent biomass yield coefficient from
acetate
Monod lactate saturation constant
Monod pyruvate saturation constant
Monod acetate saturation constant
Acetate production coefficient from lactate
Pyruvate production coefficient from lactate
Acetate production coefficient from pyruvate
Endogenous metabolism rate constant
Lag time in growth
Parameters used in tradeoff objective function
Parameters used in tradeoff objective function
Parameters used in tradeoff objective function
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Unit
h-1
h-1
h-1

iFBA
0.53
0.14
0.14

g DCW/mol lactate

17.5

g DCW/mol
pyruvate

15.5

g DCW/mol actate

10.9

mM
mM
mM
L∙ (h∙g DCW)-1
L∙ (h∙g DCW)-1
L∙ (h∙g DCW)-1
h-1
h
dimensionless
h-1
h

19.4
19.4
10.1
0.70
0.42
0.94
0.013
7.10
5.3×10-6
0.33
26.7

Table 5.S3. Lack-of-fit test for iFBA

Model Name

Lack-of-fit
sum of
squares,
SSLOF

Degree
of
freedom,
df1

iFBA

3.726

56

Pureerror
sum of
squares,
SSPE
0.813

Degree
of
freedom,
df1

SSLOF / df 1
SSPE / df 2

F(df1,df2)

144

11.78

1.396

Note: In order to test whether or not a model could fit the data well, we applied
the lack-of-fit test. The F-test indicates that the iFBA model should be further
improved to describe the experimental data.
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6.1 Abstract
Background: Parallel to the efforts currently underway in mapping microbial
genomes using high-throughput sequencing methods, systems biologists are
building metabolic models to characterize and predict cell metabolisms. The key
step in building a metabolic model is querying multiple databases to collect and
assemble essential information about genome-annotations and the architecture of
metabolic network for a specific organism. To speed up metabolic model
development for a large number of microorganisms, we need a user-friendly platform to

construct metabolic network and perform constraint-based flux balance analysis
based on genome databases and experimental results.
Results: We have developed a web-based platform (MicrobesFlux) for
generating and reconstructing metabolic models for annotated microorganisms.
The MicrobesFlux is able to load the metabolic network (including enzymatic
reactions and metabolites) of over 1,100 species from KEGG database (Kyoto
Encyclopedia of Genes and Genomes) and then automatically converting it to a
metabolic model. The platform also provides diverse customized tools, such as
gene knockouts and introduction of heterologous pathways, for users to redefine
the model network. The reconstructed metabolic network can be formulated to a
constraint-based flux model to predict and analyze the carbon fluxes in the
metabolisms. The simulation results can be output in SBML format (The Systems
Biology Markup Language). Furthermore, we also validate and demonstrate the
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platform functions by developing an FBA model (including 229 reactions) for a
recent annotated bioethanol producer, Thermoanaerobacter sp. strain X514, to
predict its biomass growth and ethanol productions.
Conclusion: The MicrobesFlux is an installation-free and open-source
platform that enables biologists with little programming knowledge to develop
metabolic models for newly sequenced microorganisms. Our system allows users
to construct metabolic networks of organisms directly from the KEGG database.
It also provides users with predictions of microbial metabolism via flux balance
analysis. This prototype platform can be a springboard to advanced and broadscope metabolic modeling of complex biological systems by integrating other
“omics” data or

13

C-assisted metabolic flux analysis results. MicrobesFlux is

available at http://tanglab.engineering.wustl.edu/static/MicrobesFlux.html.
6.2 Background
Arising interests have focused on systems analysis of cell metabolisms
(1,2,3,4,5,6). Metabolic flux analysis is a key systems biology approach that
determines the final in vivo enzyme activities in a metabolic network and links
genetics to biological functions. In the past decade, over 100 genome-scale
metabolic models have been constructed for E.coli (7,8,9), Bacillus subtilis
(10,11), and Saccharomyces cerevisiae (12,13,14), to expand our understanding
of their physiologies. While important, the pace of metabolic model
reconstructions is still much slower than the pace of high throughput genome
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sequencing of diverse microorganisms (15) due to three reasons. First,
reconstructing metabolic models is normally a tedious, slow and labor-intensive
process, including over 90 steps from assembling genome annotations of target
organisms to validating the metabolic model by various “omics” studies (16).
Second, a systemic reconstruction of metabolic model often relies on commercial
software (e.g. MATLAB) and demands proficient programming skills of the
researchers. The majority of microbiologists, who know the physiology of
environmental microorganisms well, may not gain access to commercial software
or programming skills. Third, to study less-characterized environmental
organisms, it needs to efficiently convert a vast amount of experimental data into
model constraints to reduce solution space and improve the model predictability.
Therefore, programming-free and user-friendly software need to be developed to
overcome rate-limiting steps in metabolic model reconstructions.
Currently, only a few software tools are available to assist biologists for
metabolic modeling. SimPheny is commercial software for genome-scale Flux
Balance Analysis (www.genomatica.com). Webcoli supplies diverse approaches
for users to reconstruct a genome-scale E.coli metabolic model (17). OpenFLUX
is computationally efficient software for 13C-assisted metabolic flux (18). OptFlux
is open-source and modular software for FBA and microbial strain design using
an evolutionary optimization algorithm (19). BioMet Toolbox is a web-based
resource for FBA and transcriptome analysis (20). Model SEED (21) has been
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developed to automatically generate genome-scale metabolic models for different
microbes based on RAST sequencing. Complementing these tools, we are
developing MicrobesFlux, a web platform to draft and reconstruct metabolic
models. This system has several features: 1) automatically generate metabolic
models

of

over

1,100

microbes

sequenced

in

KEGG

dataase

(www.genome.jp/kegg/), 2) fine tune the metabolic models according to userdefined requests, and 3) perform constraint-based flux analysis under both
metabolic steady states (i.e. flux balance analysis, FBA) and dynamic states (i.e.
dynamic flux balance analysis, dFBA). The marriage of high-throughput model
generation and the customized genome reconstruction is of great benefit since
biologists can easily validate or disprove various hypotheses in microbial
metabolism by drafting and comparing numerous metabolic models. Besides, this
prototype platform can potentially link to other software (e.g. OptFlux (19),
COBRA (22)) to perform broad-scope metabolic modeling of complex biological
systems.
6.3 Implementation
MicrobesFlux is an open-source platform that does not require mandatory
registration. It has three components: logic level, application level, and
achievement level. The logic level includes two fundamental databases used in
MicrobesFlux, where KGML is for organism-specific metabolic networks and
KEGG LIGAND is for general enzymatic reactions and metabolites. The basic
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principles for metabolic model reconstruction and constraint-based flux analysis
are summarized in logic level (Figure 6.1). In the application level, organismspecific metabolic network is loaded from KEGG database to generate the
metabolic model, which is pursued for customized reconstruction. The
reconstructed metabolic model is then formulated as either an FBA or a dFBA
problem to determine the flux distributions under metabolic steady or dynamic
state, respectively. The constraint-based flux analysis will be accomplished in the
achievement level, by using state-of-the-art optimization solvers, such as IPOPT
(Interior Point OPTimizer) and cloud computations. The calculated flux
distributions and the reconstructed metabolic network are recorded in SBML
format (The Systems Biology Markup Language), and the metabolic networks are
visualized using Scalable Vector Graphics (SVG). Both results are sent to users in
the output module. In summary, three key features are embedded in
MicrobesFlux: 1) high-throughput and automatic generation of metabolic model;
2) customized reconstruction of metabolic models; and 3) constraint-based flux
analysis in steady and dynamic metabolic states.
6.3.1 High-throughput and automatic generation of metabolic model
MicrobesFlux can serve as a platform to build metabolic models for 1,194
organisms sequenced in KEGG database. To generate a metabolic model for a
specific microorganism, the gene annotation information are loaded from the
corresponding KGML files, and cross-referred to KEGG LIGAND database. The

250

generated pathway network serves as a seed model and subject to further
reconstruction based on user-defined requests. The pipeline for metabolic model
generation is automatic, time-saving and high-throughput.
6.3.2 Customized reconstruction of metabolic models
The model of designated microorganisms, automatically generated from
KEGG database, should be reconstructed to fill the gaps between genome
annotation and the functional metabolism. Based on experimental knowledge,
users can manually adjust mis-annotated pathways in the original metabolic
network. Furthermore, users can knock out the native pathways or introduce
heterologous pathways in metabolic models for engineered microbial strains. The
reaction can also be set as reversible in the MicrobesFlux platform. In addition,
the uptake of carbon substrates and the extracellular secretion of metabolites can
be experimentally measured, which are constructed as “inflow” pathways and
“outflow” pathways in the metabolic model, respectively. Since numerous
metabolites are used as building blocks for biomass production, an independent
biomass formation pathway can be introduced by allowing users to input the
organism-specific biomass composition information. The metabolic pathways can
be grouped by different metabolic features to provide an intuitive manipulation of
the metabolic network by users.
6.3.3 Constraint-based flux analysis in steady and dynamic metabolic states
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For each reconstructed metabolic network, users can choose to perform
either FBA or dFBA to determine flux distribution under metabolic steady or
dynamic states. In general, the objective functions used in constraint-based flux
analysis can either be the commonly used “maximizing biomass”, or a userdefined objective function. The users can also define the upper and lower bounds
of each flux. MicrobesFlux performs the constraint-based flux analysis of the
reconstructed model using optimization solver (i.e., IPOPT). As a unique feature,
dynamic simulation of metabolic fluxes can be achieved in MicrobesFlux,
following the static optimization approach (SOA) (23). In specific, the users can
assume that the entire dynamic microbial metabolism decomposed into numerous
pseudo-steady states. At each pseudo-steady state, a conventional FBA problem is
formulated with the user-defined inflow and outflow fluxes, so a dFBA problem
will be converted to multiple mini-FBAs that are subject to constraints from the
measurement of time-dependent inflow (substrate uptake) and outflow fluxes
(metabolite production). To avoid extensive analytical efforts to measure inflow
and outflow fluxes at each time interval, the users can use an empirical or kinetic
model to estimate the time-dependent inflow fluxes and outflow fluxes for miniFBAs through entire growth period based on limited measurement data. The
dynamic flux simulation is of particular industrial interest since many biological
systems cannot maintain a meaningful metabolic steady state during fermentation
process.
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6.4 Results
We have applied MicrobesFlux to a few studies in drafting metabolic
models. We first drafted a TOY model (Figure 6.2), which has 10 metabolites and
16 fluxes, as a demonstration of MicrobesFlux workflow. We then constructed a
medium-scale stoichiometric model with 196 metabolites and 229 reactions for
Thermoanaerobacter sp. strain X514, a thermophilic bacterium that is of great
interests in cellulosic ethanol production (24). The functionality of MicrobesFlux
has been proved in both case studies.
6.4.1 Case study 1: a toy model
To demonstrate the use of MicrobesFlux platform, a simple toy model was
constructed, only including central metabolic pathways, namely glycolysis, the
pentose phosphate pathway, the TCA cycle, and the anaplerotic pathway. Glucose
represented the carbon substrate and acetate represented the extracellular
metabolite product. The TOY model was loaded from MicrobesFlux (Figure 6.3),
which included 10 reactions that described the intracellular fluxes and lumped
biomass production. The toy model was then reconstructed by introducing the
inflow flux: “Glucose  G6P” and the outflow flux: “AcCoA  Acetate”. The
drafted TOY model was then pursued for constraint-based flux analysis, by
setting the objective function as “maximizing biomass” and fixing the inflow and
outflow fluxes as 11.0 and 6.4 mmol/g/h. The simulated results from
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MicrobesFlux were confirmed by an independent linear optimization of the same
TOY model via “linprog” in MATLAB.
6.4.2 Case study 2: a medium-scale metabolic model for Thermoanaerobacter
sp. strain X514
Based on the similar flowchart, we have drafted a medium-scale metabolic
model of Thermoanaerobacter sp. strain X514. Thermoanaerobacter species are
thermophilic bacteria that can covert both pentose and hexose simultaneously to
ethanol with high yield (25,26). It can also be co-cultured with cellulosic
Clostridium thermocellum species to produce ethanol from cellulose. Strain X514
has been sequenced recently and a comprehensive study on the central carbon
metabolism has been accomplished by using

13

C-assisted pathway analysis (25).

Using the experimental data of strain X514 reported in (25) and (26), we apply
MicrobesFlux to construct a metabolic model that can describe the carbohydrate
metabolism and amino acids biosynthesis in Strain X514. The drafted model is
consisted of 196 metabolites and 229 reactions (162 intracellular reactions, 19
inflow/outflow reactions, 39 gap-filling reactions, and 9 biomass-producing
reactions). The intracellular reactions in the drafted model are derived from
genome-annotation, only considering the carbon and cofactor balance. The
inflow/outflow reactions were introduced into the metabolic model if the
transporters of the specific substrates or extracellular products have been reported
by published research. Moreover, two algorithms were employed to fill the gaps
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in the metabolic pathways. First, we have implemented un-annotated novel
pathways identified from

13

C-assisted pathway analysis (e.g. the Re-type citrate

synthase in TCA cycle) into the metabolic model of strain X514 (25). Since the
draft model is a simplified model by focusing on carbohydrate metabolism and
amino acids biosynthesis, the gaps may also be generated due to the lack of
consideration of the metabolites exchange between the pathways that were
included in the model (e.g. carbohydrate metabolism) and other pathways that
were not included in the model (e.g. purine metabolism). Accordingly, we employ
the principle of introducing the metabolite-exchange-reactions for filling the gaps.
For example, UTP is involved in both carbohydrate metabolism and RNA
synthesis. Since we did not include the RNA synthesis pathway in the
MicrobesFlux model, we instead introduced a UTP exchange pathway to fill the
gap. The gap-filling reactions were evaluated carefully to make sure that each one
of them was necessary for feasible predictions of biomass production.
The biomass composition of Thermoanaerobacter sp. strain X514 is not
yet available. In the drafted model, we used the reported biomass composition of
a close species, Clostridium acetobutylicum (27). Besides the biomass
composition, the growth-associated maintenance (GAM) and non-growth
associated maintenance (NGAM) energies have been found to play an important
role in simulating the growth rate of organisms (27,28,29). In our model
simulation, the NGAM was chosen as 7.6 mmol ATP/g DCW, as reported
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previously (29). To identify the GAM, we plotted the relations between growth
rate and GAM (Figure 6.4), and found the value of GAM that can match the
experimental measurement (i.e. growth rate of strain X514 as 0.043 h-1 reported in
(26)) was 220.0 mmol ATP/g DCW, and this fitted value is qualitatively
consistent to previous reported GAM value (150.0 mmol ATP/g DCW) in a
thermopilic ethanol producer Clostridium thermocellum (30). Based on this
drafted model, we also predicted the correlations between growth rate, ethanol
production, and waste product outflow (Figure 6.5). The prediction shows a tradeoff relation between ethanol production and growth rate. The ethanol production
can be increased by 25% (i.e. increased from 6.3 mmol/g/h to 7.8 mmol/g/h)
while halving the growth rate (i.e. decreased from 0.045 h-1 to 0.027 h-1). By
inhibiting the acetate production from 2.0 mmol/g/h to 0.6 mmol/g/h, the ethanol
production under the optimal growth conditions could be improved by 33%.
Therefore, we have shown the platform is able to make reasonable predictions for
the biomass growth in response to metabolites synthesis.
6.5 Discussion and conclusion
MicrobesFlux is designed for high-throughput drafting of metabolic
models for environmental organisms based on genome annotations in KEGG.
Unlike the model organisms that have been systemically studied via different
“omics” approaches, the environmental organisms have more complex metabolic
features but fewer measurements from laboratories. Therefore, MicrobesFlux can
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be used as a platform to construct models for predicting cell metabolism. On the
other hand, validation of a genome-scale metabolic model can be a challenge due
to requirement for manually fine tuning metabolic pathways and due to lack of
experimental

data

to

confirm

functional

pathways.

For

example,

Thermoanaerobacter sp. strain X514 used in the MicrobesFlux case study is
capable of growing under high temperature and converting sugars to ethanol,
which can be simulated by a medium-scale metabolic model. Such a convenient
FBA model has decent predictive power for in silico studies of a non-model
environmental microorganism for bioethanol production at different growth rates
(Figure 6.5). However, many other metabolic features (e.g., secondary
metabolisms) in the strain X514 are not fully understood yet. It requires extensive
experimental studies, including transcriptomics and proteomics analysis, for a
precise reconstruction of genome-scale model. Although the scale of drafted
MicrobesFlux model in this study is still small (<300 reactions) so that users can
easily fine tune the metabolic model and manually fill annotation gaps in carbon
metabolic pathways, MicrobesFlux can serve as a springboard to future advanced
genome-scale metabolic model by adding more reconstruction steps, such as the
gene-protein-reaction (GPR) correlation, charge balance, and metabolites
exchange among metabolic compartments (e.g. mitochondria in eukaryotic cells).
In summary, we have developed MicrobesFlux to draft the metabolic
models of environmental organisms from KEGG database and serves as a high-
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throughput tool for systems biology. MicrobesFlux extricates microbiologists
from programming and commercial software that are normally required to build a
metabolic model. It covers a large number of sequenced organisms in KEGG
database and provides multiple approaches to assist the model generation and
reconstruction. Both FBA and dFBA can be achieved in MicrobesFlux to simulate
the metabolic behaviors of organisms in metabolic steady state and dynamic state.
The drafted model can be further used by other software for genome-scale model
reconstruction and in silico predictions. In the future, we will implement broad
fluxomic approaches (e.g.

13

C-metabolic flux analysis) in MicrobesFlux to

improve the accuracy and predictive power of drafted metabolic models.
6.6 Availability and requirements
Project name: MicrobesFlux
Project homepage:
http://tanglab.engineering.wustl.edu/static/MicrobesFlux.html
Operating systems: Platform independent.
Programming language: Java and Python.
License: MicrobesFlux is freely available for non commercial purposes.
Any restrictions to use by non-academics: none
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Figure 6.1. Architecture of MicrobesFlux.
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Figure 6.2. (A) Pathway network of TOY model used in MicrobesFlux, and (B)
simulated flux distribution of TOY model used in MicrobesFlux. The same results
were obtained by using “linprog” in MATLAB.
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Figure 6.3. Screenshot of reconstructing TOY model by using MicrobesFlux. (A)
load TOY model from MicrobesFlux; (B) pathway information of TOY model;
(C) customized reconstruction of TOY model; and (D) constraint-based flux
balance analysis of TOY model.
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Figure 6.4. Estimation of the growth-associated maintenance (GAM) in
Thermoanaerobacter sp. strain X514. From this comparison, the GAM value (red
dotted line) consistent with experimental data (i.e. growth rate was 0.043 h-1)
could be estimated and was indicated as a 220.0 mmol ATP/ g DCW.
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Figure 6.5. Predictions of the relationship between growth rate and outflow
fluxes [Unit: mmol/g/h] in Thermoanaerobacter sp. strain X514. The glucose
inflow flux is fixed as 3.92 mmol/g/h.
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Chapter 7
Conclusions and Future Investigations
7.1 Summary
I have developed and applied multiple fluxomics tools during my Ph.D.
training.

13

C-pathway analysis has been systemically used to discover novel

pathways, investigate the mixotrophic metabolism, and optimize medium for
slow-growing bacteria. The achievements from
summarized in Table 7.1. Meanwhile,

13

13

C-pathway analysis are

C-MFA has extended the applications

from quantifying metabolic fluxes in industrial workhorses to those in
environmental microorganisms. The accurate metabolic readouts of the flux
distribution have been determined for Chlorobaculum tepidum, as the first study
in quantifying the mixotrophic metabolism of green sulfur bacteria. The isotope
discriminations have been confirmed in heterotrophic metabolism of E.coli, which
could affect the solution space in flux calculations by

13

C-MFA. Moreover, to

investigate the dynamic metabolism of environmental microorganisms, a
framework that integrates bioprocess models, dFBA, and isotopomer simulations
has been applied in Shewanella oneidensis MR-1. The dynamic flux distributions
have been profiled, which revealed a few underlying metabolic features during the
dynamic metabolism. Such dynamic flux analysis approach can bypass the
measurement of low-abundant and fast-turnover metabolites, and can address the
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suboptimal microbial metabolisms that are often adopted by environmental
microorganisms. As one of the steps in bridging the gaps between fast-paced
genome sequencing and slow-paced metabolic model constructions, a web-based
platform, MicrobesFlux, is being built based on KEGG database for highthroughput metabolic models drafting. A large database including 1,192
sequenced genomes is available in MicrobesFlux. Diverse customized tools are
provided for model reconstruction. Both FBA and dFBA can be achieved to
simulate the metabolic fluxes of environmental microorganisms in metabolic
steady state and dynamic state.
Beside fluxomics investigation on the metabolisms of environmental
microorganisms, several projects have also been accomplished by studying
bioprocess engineering, metabolic engineering, and nano-toxicity. In general, a
parsimonious kinetic model has been constructed to capture the growth kinetics of
Shewanella oneidensis MR-1 (Appendix 9). A bioprocess model was built to
describe the isobutanol fermentation of recombinant E.coli strains (Appendix 10).
The broad scope research also involved constructing a statistical model that
analyzed influential factors in production yield of metabolic engineering
(Appendix 11) (1), and characterizing the bacterial responses to nanoparticles
(Appendix 12) (2).
7.2. Current challenges in fluxomics analysis
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One of the main applications of fluxomics analysis is to identify the
bottlenecks in biochemical production by engineered microorganisms and to
assist the rational design of mutants in metabolic engineering. Unfortunately,
several barriers in current fluxomics analysis stalled the inception of fluxomicsbased biotechnology.
On one hand, the fluxomics can measure the carbon flows in central
metabolic pathways to the final product and predict the optimal operation of
metabolic network. However, the flux measurements and predictions have not yet
been coordinated systemically and left many key questions unanswered in
metabolic engineering. For example, metabolic robustness, the ability of
microorganisms to maintain the similar metabolic performances under genetic or
environmental perturbations, is a long-recognized property of microbial systems.
Comparative studies on wide-type and genetically manipulated mutants via

13

C-

MFA often fail to tell the differences in flux distributions of central metabolism,
and yield no information or predictions for the mechanisms of microbial
robustness. Constraint-based flux analysis can in silico test different hypothesis
about microbial robustness. However, most of the hypotheses cannot be proved
due to lack of accurate flux measurements in FBA.
On the other hand, metabolic engineering of industrial chassis is based on
the premise that the yield of a desired product can be increased by identifying and
over-expressing the enzymes that catalyze the rate-limiting steps in a given
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metabolic pathway. However, the rate-limiting enzymes may not always exist in
reality due to the complicated cell-wide regulations of microbial metabolisms that
involve both the well-known gene-protein-flux correlations, and the less wellknown post-transcriptional and post-translational regulations. In this case, the
increases in productivity are often achieved by coordinated expression of multiple
genes in the metabolic network, in which fluxomics analysis cannot provide
reasonable guidelines for rational design in metabolic engineering, until it is
cross-talked with other “omics” data in systems biology.
7.3 Future development of advanced fluxomics tools
Fluxomics analysis is playing an increasingly important role in systems
biology and bioengineering. One of current limits in fluxomics studies is the
tradeoff between model predictive capacity and model accuracy. FBA is wellknown for the strong predictive power by adopting genome-scale metabolic
models. However, FBA lacks the accuracy in describing the cellular metabolism.
Conversely,

13

C-MFA provides accurate metabolic readouts in a simplified

metabolic network. Unfortunately, it cannot predict metabolic behaviors well. To
further refine fluxomics analysis, my future research will focus on developing an
integrated modeling approach that not only describes the cellular metabolism
accurately in genome-scale, but also predicts the flux distributions based on
diverse assumptions. The barriers between model prediction and model accuracy
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will be removed, which can be of specific help in rational design of metabolically
engineered mutants.
Another topic in my future investigation is to cross-talk fluxomics with
transcriptomics and proteomics to unravel the cell-wide post-transcriptional and
post-translational regulations. Little is known about the post-transcriptional and
post-translational network in cellular metabolism except their complex
characteristics. The fluxomics study can provide reliable and high-throughput of
cellular metabolism. By quantitatively correlating the input (i.e., transcriptomics
and proteomics) and output (i.e. fluxomics) of metabolic system, the topology and
activities of metabolic regulatory network that controls the cellular metabolism
can be empirically deciphered. The decoding of metabolic regulatory mechanisms
will be of great value in understanding the physiology, especially the
pathophysiology of diverse biological systems.
Finally, open-source software for integrative and broad scope fluxomics
analysis is planned to be developed in future. It is expected that genome-scale
metabolic models can be automatically generated from multiple genome
sequencing databases. The drafted metabolic models can be efficiently and
successively validated based on heterogeneous databases on systems biology
experiments (e.g. transcriptional analysis, lethality tests). State-of-the-art flux
analysis approaches can be achieved in the genome-scale metabolic models,
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which provide precise readouts on metabolic flux distributions and predictive
guidelines for in silico genetic manipulations.
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Table 7.1. Novel metabolic features identified by 13C-pathway analysis
Interests

Novel metabolic
features

Collaborations

Shewanella
oneidensis MR-1

Bioremediation
and microbial
fuel cells.

Invariability of
central metabolism
under environmental
or genetic
perturbations

Dr. Adam Arkin

Mycobacteria
smegmatis

Relative of
pathogenic
Mycobacterium
tuberculosis

Induced glyoxylate
pathway and glycine
dehydrogenase
under hypoxic stress

Dr. Carolyn
Bertozzi and Dr.
Jay D. Keasling

Ethanol
Thermoanaerobacter producing at
X514
high
temperature

(Re)-type citrate
synthase and
citramalate pathway

Dr. Jizhong
Zhou

Roseobacter
denitrificans
OCh114

Aerobic
anoxygenic
phototrophs,
CO2 fixation

Inactive glycolysis
and active Entner–
Doudoroff pathway

Dr. Robert
Blankenship

Cyanothece 51142

Biofuel
producing,
nitrogen
fixation

Citramalate pathway
for isoleucine
synthesis; inhibition
of CO2 fixation by
glycerol

Dr. Himadri
Pakrasi

Heliobacterium
modesticaldum

Gram-positive,
thermophilic,
photosynthetic
bacteria

(Re)-type citrate
synthase in TCA
cycle

Dr. Robert
Blankenship

Dehalococcoides
ethenogenes 195

TCE
degradation

Exogenous amino
acids are selectively
utilized

Dr. Lisa
Alvarez-Cohen

Microbes
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Kirk D. Dolan, Tel: 517-355-8474, Fax: 517-353-8963; E-mail: dolank@msu.edu
Abstract
Understanding microbial kinetic behavior is important for bioprocessing
engineering, such as chemical synthesis and bioremediation. However,
development of proper models to capture complicated microbial kinetics is a
challenging task. In this study, we demonstrate an example for rationally
modeling the growth of Shewanella oneidensis MR-1 in a batch culture. Based on
a series of analyses, including residual analysis, scaled sensitivity coefficient
analysis, parameter correlation analysis, and the F-test, we estimated model
parameters to construct a parsimonious Monod-based model that used the fewest
parameters for best simulation of Shewanella growth using different carbon
substrates. Sequential analysis was also applied to identify the time window for
estimating each parameter in the kinetic model. This study shows that statisticsbased parameter estimation is an efficient method to successively reconstruct and
fine tune kinetic models for complex biological systems.

Key words: Monod, Shewanella, parsimonious model, sensitivity, F-test,
sequential analysis
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Introduction
The relation between microbial growth rates and substrate concentrations
(often referred to as microbial growth kinetics) has been studied and substantiated
for over a century [1]. Numerous models, including the well-known Monod
equation [2], have been established to describe the growth kinetics. In spite of the
wide applications of the Monod model, it does not always lead to a good
description of a given bioprocess. One criticism of the Monod model is that the
two parameters in the model, i.e., the maximum specific growth rate (μmax) and
substrate saturation constant (Ks), can be correlated in estimation, which results in
reported values that differ by several orders of magnitude [1]. In addition, the
complicated culture conditions (e.g., growth with mixed substrates rather than a
single substrate) make the original Monod model insufficient to reflect every
aspect of growth kinetics. To overcome this problem, the model has to be refined
by introducing additional parameters to account for the complexity of growth
kinetics. In doing so, however, there is a risk of over-parameterization [3].
In this study, we applied parameter estimation techniques [4,5] in
reconstructing the Monod model to decipher growth kinetics of Shewanella
oneidensis MR-1. MR-1 is an environmentally important bacterium that plays
important roles in bioremediation, microbial fuel cells, and ecological carbon
cycling [6,7,8,9]. As revealed by our previous kinetic study, S. oneidensis MR-1
utilizes lactate as the favorable carbon source and produces waste metabolites
.
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(acetate and pyruvate) which are consumed during the late growth stage [6].
However, the previous model has not rigorously considered the optimal selection
of model parameters to improve the quality of data fitting. To build a
parsimonious model for capturing MR-1 growth dynamics (i.e., a model with the
best simulation and fewest parameters), we applied a series of tools that were
originally used in nonlinear parameter estimation to reconstruct the Monod model
successively until it satisfied all the statistical assumptions used in parameter
estimation. During the model reconstruction, several underlying metabolic
features of MR-1 were uncovered. Finally, the impact of each experimental
measurement on estimating the updated kinetic parameters was also evaluated by
sequential parameter estimation [10,11,12,13] of the parsimonious model.

Methods
Cell culture and analytical methods
S. oneidensis MR-1 was first grown in LB medium in shake flasks
overnight. A 0.1% inoculum volume was then cultured into the modified MR-1
defined medium [14] in shaking flasks at 150 rpm and 30°C. The initial carbon
source was 30 mM lactate. The growth curve was monitored by dried biomass
weight. The concentrations of lactate and acetate in the medium were measured
using enzyme kits (r-Biopharm, Darmstadt, Germany). The concentration of
.
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pyruvate in the medium was measured with the enzyme assay developed by
Marbach and Weli, 1967. For each sampling point, we made triplicate
measurements.
Seed model for growth kinetics
To find a parsimonious model describing MR-1 growth with the fewest
parameters, a seed model was built first and then successively reconstructed
(Table 1). In the seed model, a multiple-substrate Monod model was developed to
simulate the cell growth, lactate consumption, and acetate and pyruvate secretion
and reuse.

X μL

dLACT
dt

(

dACT
dt

(r A,L

r A,P

dPYR
dt

(rP,L

X

dX
dt

X (

YX / L

rP,L r A,L )

(1)

X μA

(2)

YX / A
P

YX / P

)

r A,P )

(3)

ke )

(4)

The growth rates of MR-1 on different carbon substrates were assumed to be
additive:

μL

μL

μA

μP

(5)

μ max,L LACT
K s,l LACT

(6)
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μA

μ max,A ACT
K s,a ACT

(7)

μP

μ max,P PYR
K s,p PYR

(8)

In the above model, X is biomass (g dry cell/L); LACT, ACT, and PYR are
lactate, acetate, and pyruvate concentrations (mmol/L), respectively; μ is the
overall specific growth rate (h-1); ke is the endogenous metabolism rate constant
(h-1); YX/L, YX/A, and YX/P are the biomass yield coefficients (g dry cell /mmol
substrate) of lactate, acetate, and pyruvate, respectively; rP,L and rA,L are the
production rate (mmol/L/h) of pyruvate and acetate from lactate, respectively; rA,P
is the production rate (mmol/L/h) of acetate from pyruvate. The biomass yield
coefficients were the reported values: YX/L = 0.0212 (g dry cell /mmol lactate), YX/A
= 0.0132 (g dry cell /mmol acetate) and YX/P = 0.0195 (g dry cell /mmol pyruvate)
[15]. μL, μA, and μP are the specific growth rates (h-1) on lactate, acetate, and
pyruvate, respectively; μmax,L, μmax,A, and μmax,P are the maximal growth rates (h-1)
for fully aerobic growth on lactate, acetate, and pyruvate, respectively; and Ks,l,
Ks,a, and Ks,p are Monod constants (mmol/L) for lactate, acetate, and pyruvate,
respectively.
The acetate and pyruvate secretions were assumed to follow first order
kinetic forms in the seed model:
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r A,L

kal LACT X

rP,L

k pl LACT X

r A,P

kap PYR X

(9)
(10)
(11)

where kal and kpl are rate constants of acetate and pyruvate production from
lactate, respectively (L∙ (h∙g DCW)-1). kap is rate constant of acetate production
from pyruvate (L∙ (h∙g DCW)-1). The seed model was then reconstructed
following the flowchart in Figure 1. In general, parameter estimation was
accomplished for each reconstructed model, and then it guided the addition or
removal of parameters. Ten different models (Table 1) were built and compared
until the parsimonious model was capable of satisfying all the statistical
assumptions.
Nonlinear parameter estimation
To estimate the parameters in the seed model and the reconstructed
models, an ordinary least squares (OLS) method [4] was applied to solve the
inverse problems. In general, OLS aims to minimize the residual sum of the
squares (R) between model simulations and experimental measurements:
R = [Y – η (t ; β)]T [Y – η (t ; β) ]

(12)

where t is the time of the experimental measurements, η represents four dependent
variables (i.e., concentration of biomass, lactate, acetate and pyruvate) simulated
by the kinetic model; β represent the vector of the parameters to be estimated; and
.
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Y is the vector of the experimentally measured value of the dependent variables.
Our experiment had a total of n measurements for each of the four dependent
variables, so η and Y were vectors with a length of 4×n. The scales of the four
dependent variables had order of magnitude differences (e.g., the scale of the
biomass measurement was < 1 g/L, while the lactate measurement was > 10
mmol/L), and the direct application of OLS would overemphasize the fitting of
dependent variables with large scales. To overcome the estimation bias, each
simulated dependent variable η j (n×1 vector) and the corresponding experimental
measurements Yj (n×1 vector) were normalized by dividing by the maximum
concentrations observed in the n experimental measurements (i.e., Y j’ = Y j / max(
Y j ), η j’ = η j / max (Y j ), j = 1…4). The weighted OLS method was
R = [Y’ – η’ ( t ; β ) ]T [Y’ – η’ ( t ; β )]

(13)

To check the simulation quality, we applied a series of analyses, including
residual analysis, scaled sensitivity coefficient analysis, parameter correlation
analysis, and the F-test. The mean of the residuals in the model simulation (i.e., ε
= Y′ – η΄ (t ; β) in each model) should be close to zero (i.e., E (ε) should be close
to zero, where E is the expectation function), should be normally distributed (i.e.,
the histogram of ε should follow Gaussian distribution), and should be
uncorrelated (i.e. E { [ε

i

– E (ε i) ] [ε

j

–E (ε j)]} = 0). A simple check for

uncorrelated residuals was to count the number of runs (i.e., number of changes in
signs of the residuals) [4]. In this study, n measurements (triplicates) were taken
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at m time points (i.e., n = 3∙m). The means of the triplicates at each time point
were used to check the residual correlations. For m independent, zero-mean,
random model fitting residuals, the minimum value for non-correlated residuals
should be [4]
r = (m+1) /2

(14)

If the number of runs in the model simulation was smaller than r, the model fitting
residuals were correlated with each other, and vice versa.
The impact of parameters on the model simulation was identified by
formulating and analyzing a scaled sensitivity (SS) matrix. The scaled sensitivity
matrix is the normalization for the commonly-used Jacobian matrix, which can be
applied to compare the impact of the parameters on model simulation:
'
1
1

...

'
1
p

1

p

'
n

'
n

SS
1
1

where ηi

’

...

(15)

p
p

is the simulation in ith time point, βj is the jth parameter, n is the

number of time points in experimental measurements, and p is the number of
parameters. The units of the scaled sensitivity coefficients (SSCs) are
dimensionless since all the dependant variables are normalized in η’. Each column
of the SS matrix reflects the dynamic impact of different parameters on the model
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simulation. The SSCs of the two most influential parameters are plotted in Figure
S1, for both the seed model and the parsimonious model. From a comparison of
the scale of each column (i.e., the maximum of the absolute values in the column),
the impact generated by each parameter could be compared and used to guide the
model reconstruction. For each dependent variable, the SSCs versus time could be
plotted for each parameter. For better parameter estimation that would result in
the smallest standard error for that parameter, we desired SSCs to be large and
uncorrelated.
The correlations among parameters were characterized by a correlation
matrix Corr, which yielded the correlation coefficient of the two parameters βi
and βj, by using the covariance matrix C:

Corr(i, j)

C(i,i)
C(i, j) C(i, j)

[ 1.0 1.0]

(16)

A higher absolute value of Corr (i, j) in the correlation matrix indicated a strong
correlation between the two parameters and hence more difficult estimation for
both parameters.
The “ode23” command in MATLAB (2009a) was used to solve
differential equations, and the “fmincon” command was used to estimate the
parameters. Since many local solutions existed around the real parameter settings,
the likely global solution of parameters was derived by randomly choosing the
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initial guesses within a known range in the nonlinear optimization and running for
100 times. Next, a bootstrap method was used to find the confidence intervals of
each parameter by following the approach described before [4,16]. In general, the
residuals in the parsimonious model were randomly re-sampled to obtain a new
bootstrap set Y΄, which constructed a new parameter estimation problem that was
solved by the same procedure. The 95% confidence intervals of the parameters
were derived by running the bootstrap method 999 times [4], which added to the
original estimate gave 1,000 values for each parameter. For each parameter, the
1,000 values were sorted from lowest to highest, and the confidence interval was
found by choosing the 25th and 975th value. The standard deviation of each
parameter was calculated from the 1,000 values.
The F-test for the reconstructed models
Introducing more parameters in the reconstructed model usually led to a
better (or at least equally good) simulation of the microbial growth kinetics.
However, it was unclear whether the improvement in simulation was statistically
significant. In this study, the F-test was applied to address this question. For the
original model ηi and the reconstructed model ηj, the critical F value was
calculated as
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F =

Ri - R j
p j - pi
Rj
n - pj

(17)

where Ri and Ri are the residual sum of the squares of models ηi and ηj ,
respectively; n is the number of experimental measurements; and pi and pj are the
number of parameters in models ηi and ηj , respectively. If the F value calculated
from the reconstructed model was larger than the critical F value for some desired
false-rejection probability (e.g., 0.05 in this study), the improvement of the
reconstructed model was significant. Otherwise, the new model could not provide
a significantly better fit than the original model. The F-test can check not only
whether introducing new parameters leads to a significant improvement in model
simulation, but also can be used in a reversible way to test whether some
parameters can be removed from the original model. If the reconstructed model
with fewer parameters has a smaller F value than the critical F value, then by
removing redundant parameters, the simulation in the reconstructed model is not
degraded (i.e., the original model is over-parameterized).
Sequential analysis of the parsimonious model
To estimate the effect of experimental measurements on model
parameters, we applied a sequential analysis [10,11,12,13] by successively adding
experimental data. Each experimental data point was treated as one step in the
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parameter estimation. There were four dependent variables and 18 time-course
samples (triplicates), so the total steps were 4×18×3 = 216. At each step, the
parameters in the parsimonious model were estimated by the sequential procedure
which was developed based on a matrix inversion lemma [4]. A series of
equations was used iteratively to find the parameter at each step:
for j=1:m
e

Y'

(t, b)
'
1
1

...

'
1
p

1

p

'
n

'
n

J
1

...

p

1

p

for i=1:n-1
A (i 1)
(i 1)

P(i) J T (i 1)
(i 1)

2

(18)

J (i 1) A(i 1)

K (i 1) A (i 1) \ (i 1)
P(i 1) P(i) K (i 1) X (i 1) P(i)
B(i 1)

B(i) K (i 1){e(i 1) X (i 1)[ B(i) b]}

b_new B(n);
if (b_new b)<tol break; else b=b_new;

where e is the vector for normalized residuals; b is the vector for parameters
estimated by sequential analysis; J is the scaled sensitivity matrix, P was the
parameter covariance matrix; Ф is the vector for variance of measurement; A, ∆,
K, B, and b_new are matrices used in the sequential analysis; n is the number of
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steps in sequential analysis (i.e., 216 in this study), m is the number of runs of the
sequential analysis; tol is the convergence tolerance in the sequential analysis.
In general, the parameter vector b and the parameter covariance matrix P
were initialized. The residual vector e and the scaled sensitivity matrix J were
calculated based on b, and they initiated one round of sequential analysis, as
shown in the inner for-loop. The sequential analysis then updated b, which was
used as the new initial parameter vector in the next round of sequential analysis.
This procedure was repeated until the difference between b and B converged
below the tolerance, 0.3% in this study.

Results and discussion
Simulation of growth kinetics by the seed model
As a starting point to investigate the growth kinetics of S. oneidensis MR1, a seed model (Model 0, eq.1-11) assumed that the growth rate on different
carbon substrates was additive and that first-order kinetics in the carbon substrate
switch from lactate to acetate and pyruvate. The seed model showed gaps between
the model simulation and experimental measurements. For example, the
concentrations of lactate were always overestimated, while the biomass
productions were underestimated by the model prediction at the early growth
stage (Figure 2A). The differences between the simulation and experimental
.
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measurements made the residuals of the seed model highly correlated (Figure 2B)
and of large variance as indicated in the width of histogram (Figure 2C).
In the seed model, the largest SSCs for the seed model are those related to
the growth rates of lactate (μmax,L) and of acetate (μmax,A). These two SSCs v.s.
time are plotted for each dependent variable (i.e., biomass, lactate, acetate and
pyruvate) in Figure S1A, C, E & G, respectively. For best estimation results, we
desire SSCs to be large and uncorrelated. The maximum absolute value of each
SSC is shown by its corresponding length in the bar charts in Figure S2 A-F,
where each chart is for a different model. For example, the maximum absolute
value of SSC for μmax,L in acetate simulation was 5.57 (Figure S1E). The
corresponding bar runs from 5.78 to 11.35 (Figure S2A, green bar). In this way,
Figure S2 A-F could readily show which parameter is the most or least influential
for each model. Figure S2 usefully summarizes the large number of SSCs and
avoid clutter in Figure S1.
In addition, the scaled sensitivity analysis (Figure S2A) of the seed model
indicated that the impacts of μmax,P and Ksp (the two parameters related to MR-1
growth with pyruvate) on simulation of growth kinetics were 7~8 magnitudes
lower than the other parameters. The correlation analysis among parameters (Text
S1) showed that the two parameters μmax,L and Ksl (the two parameters related to
Shewanella growth with lactate) were correlated with each other (correlation
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coefficient was 0.885). Based on the fitting analysis of the seed model, a series of
model reconstructions were made following the procedure in Figure 1.
Monod model reconstructions
The imperfection of the growth kinetics simulation in the seed model
initiated the successive model reconstructions to find the parsimonious model
(Figure 1). In general, based on the statistical analysis of the seed model, the
model was reconstructed by either adding or removing parameters in the growth
kinetics. The reconstructed model with the hypothesized kinetics was analyzed by
a series of statistical methods, including scaled sensitivity analysis (Figure S2),
residual analysis (Figure S3), parameter correlation analysis (Text S1), and
residual correlation analysis (Text S2). The reconstructed model was accepted as
the new seed model if it passed the F-test. The procedure was repeated until a
parsimonious model was found to satisfy all the statistical assumptions.
In this study, ten reconstructed models were built and improved (labeled
as Model 0-Model 3.1 in Table 2). The entire reconstruction procedure was
composed of two steps. The first step in model reconstruction (Model 0-Model
1.3) was to remove the parameters in Model 0 that were not necessary in
describing the growth rates with multiple carbon substrates. Since the scaled
sensitivity coefficients of the parameters μmax,P and Ks,p related to Shewanella
growth with pyruvate were 7~8 magnitudes lower than for the other parameters
(Figure S2A), the pyruvate term had a trivial contribution to MR-1growth.
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Therefore, we built Model 1.1 (Table 1) by removing μmax,P and Ks,p from the seed
model. By using the F-test in reverse, it was found that the reconstructed model
did not lead to a significantly worse simulation (i.e. F < F_critical in Table 2), and
thus Model 1.1 was accepted for further reconstruction. To build Model 1.2, the
Monod constant Ksa was then removed because it had the lowest maximum value
of scaled sensitivity (Figure S2B). This assumption was again proved to be
reasonable by the F-test. Next, it was found that μmax,L and Ksl could be mildly
correlated (the correlation coefficient is 0.776) in Model 1.2, which indicated that
the value of the Monod constant Ksl was much more influential than lactate
concentrations in the experimental measurements, and hence first-order kinetics
would be sufficient to describe the growth kinetics with lactate. Model 1.3 was
accordingly built by assuming that the biomass production from lactate followed
first order kinetics. Although such an assumption affected the kinetic model
simulation (Figure S3), the smaller F (F = 2.308) than the critical F (F = 4.043)
value in Table 2 suggested that the reconstructed model avoided overparameterization.
Reconstruction from Model 0 to Model 1.3 aimed at a more concise
description of the growth kinetics. However, owing to the improper assumption of
first-order kinetics in the substrate switch, the simulated growth kinetics needed to
be improved. Therefore, the second step in model reconstruction (Model 2.1Model 2.3.3) was to increase the complexity of products secretion kinetics in the
.
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reconstructed model. From Model 2.1 to 2.3.3 (Table 1), five different kinetics
were constructed to describe the acetate and pyruvate production. We used the
rational function to empirically simulate the product secretion kinetics. The
denominator function was set as a first-order polynomial, while the numerator
function was gradually made more complicated from Model 2.1 to Model 2.3.3
(Table 1) by increasing the degrees of the polynomial function. The F-test was
applied to each reconstructed model to test whether the rational function was
sufficient to describe the growth kinetics. As identified in the F-test (Table 2),
first-order kinetics was sufficient for acetate production from lactate or pyruvate.
However, the kinetics of pyruvate production from lactate was more complicated
than first-order or Monod kinetics. Therefore, we described pyruvate production
from lactate by adding a second order polynomial term in the numerator of the
Monod equation (i.e., Model 2.2, Table 1). The reconstructed model, Model 2.2,
dramatically improved the fitting of biomass, acetate, and pyruvate concentrations
by decreasing both the scale and variances of residuals (Figure S3 D1 and D2, vs.
E1 and E2). However, correlated residuals were still found in the model
simulation. So we added a hypothetical kinetic term to describe additional lactate
loss during the cultivation or measurement processes (Model 3.1). Based on the
F-test, the introduction of the hypothetical lactate loss coefficient did not
significantly reduce the residual sum of squares for the entire model. However, it
did improve the overall fitting by eliminating the correlated residuals (Text S2) in
the biomass, lactate, and acetate simulations. Accordingly, the lactate loss term
.
424

was retained in the parsimonious model to account for the consumption of lactate
not considered by the original Monod kinetics (Model 3.1, Table 3).
Compared to Model 0, the residuals in the parsimonious model were
smaller (a root mean square error of 0.15, compared to 0.26 in Model 0, Figure
2D). The residuals were also non-correlated in biomass, lactate, and acetate
simulations (Figure 2E), and normally distributed with a smaller variance (0.004,
compared to 0.012 in Model 0, Figure 2F). All parameters were confirmed to be
uncorrelated and to influence the growth kinetics simulation. Therefore, the
statistical assumptions were satisfied in the parsimonious model. The largest
SSCs for the parsimonious model were those related to the growth rate of lactate
(β2) and of acetate (β1), as shown in Figure S1 B, D, F, H and Figure 3. The
parameter values in the parsimonious model and 95% confidence intervals
derived from the bootstrap method are listed in Table 4.
Sequential analysis of the parsimonious model
In designing experiments to reveal microbial growth kinetics, it is
necessary to know the best time window for estimating each parameter. By
gradually including more experimental measurements in parameter estimation, we
applied a sequential analysis to investigate the impact of experimental
measurements on parameter estimation in the parsimonious model. The
sequentially estimated parameters initially fluctuated as expected with the
addition of more experimental measurements (Figure 4), but eventually converged
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to results similar to those from nonlinear parameter estimation (Text S3).
However, the measurement steps in sequential analysis at which the parameters
no longer varied were not the same. For example, parameter ke could be
accurately estimated within 100 measurement steps (i.e., ~18 h), while kap could
not be reasonably estimated until the 150th measurement step (i.e., ~25 h). Some
parameters (i.e., β11) could not smoothly converge, indicating that current
experimental measurements may not be effective in estimating such parameters,
or that a longer experiment may be necessary for estimating the parameter. All
other parameters converged to a constant well before the experiment ended,
strengthening the conclusion that the model is appropriately reconstructed to
simulate the growth kinetics of MR-1.
Concluding remarks
The Monod model was successively reconstructed in this study until a
parsimonious model emerged that described the growth kinetics of Shewanella
oneidensis MR-1. From the model reconstructions, we found that pyruvate made a
trivial contribution to biomass production; rather, it served as a transient
metabolite in producing acetate. The growth rate with lactate and acetate could be
sufficiently described by first-order and zero-order kinetics, respectively. The
kinetics of carbon substrate utilization, especially for pyruvate production by
lactate, was more complicated than first-order reactions, and it suggest that
unidentified lactate loss may be involved in the growth of MR-1. Finally, by using
.
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sequential analysis in the parsimonious model, the time windows necessary for
parameter estimation were provided, which can be further used for guiding the
experimental designs in microbial growth kinetics studies. The general modeling
approach in this research can also be potentially used to study other complex
biological systems.
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Figure Legends
Figure 1. Flowchart of Monod model reconstruction.
Figure 2. Growth kinetics of Shewanella oneidensis MR-1. Left (A, B, and C),
simulation by seed model; right (D, E, and F), simulation by the reconstructed
parsimonious model. In the fitting plots (A, D), the experimental measurements
are plotted with markers (○: lactate concentration, mmol/L; ◊: measured acetate
concentration, mmol/L; ×: pyruvate concentration, mmol/L; □: biomass, g/L) and
the model predictions were plotted in solid lines. In the residual plots (B, E), the
normalized residuals were plotted with different markers (○: normalized lactate
residuals; ◊: normalized acetate residuals; ×: normalized pyruvate residuals; □:
normalized biomass residuals). The residual histograms (C, F) are plotted for all
the normalized residuals.
Figure 3. The maxima of scaled sensitivity for parameters in the parsimonious
model. Black bars: the maximum scaled sensitivity for biomass simulation; red
bars: maximum scaled sensitivity for lactate simulation; green bars: the maximum
scaled sensitivity for acetate simulation yellow bars: the maximum scaled
sensitivity for pyruvate simulation.
Figure 4. Sequential analysis for the reconstructed Monod model.
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Table 1. Models used in the F-test
Model
0

Assumptions
Seed model as developed in eq. (1) - (11)

1.1

Extracellular pyruvate was neglected for biomass production: μ = μL+ μA
in eq. (5)

1.2

Biomass production from acetate was assumed to follow zero order
kinetics: μA = β1 in eq. (7)

1.3

2.1

2.2

2.3.1

2.3.2

2.3.3

3.1

Biomass production from lactate was assumed to follow first order
kinetics: μL = β2∙LACT in eq. (6)
Pyruvate production from lactate was assumed to follow Monod kinetics:
3 LACT
rP,L
in eq. (10)
LACT
4
Pyruvate production from lactate was assumed to follow the kinetics:
2
5 LACT
3 LACT
rP,L
in eq. (10)
LACT
4
Pyruvate production from lactate was assumed to follow the kinetics:
3
2
6 LACT
5 LACT
3 LACT
rP,L
in eq. (10)
LACT
4
Acetate production from lactate was assumed to follow Monod kinetics:
7 LACT
rA,L
in eq. (9)
LACT
8
Acetate production from pyruvate was assumed to follow Monod
9 PYR
kinetics: rA,P
in eq. (11)
PYR
10
Lactate was assumed to have non-growth related degradation:
X L
dLACT
(
rP,L rA,L 11 LACT) in eq. (1)
dt
YX/ L

.
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Table 2. F-test for different models
Model
No.

No. of
Parameters
,
p

Degree of
freedom,
n-p

Sum
of
squar
es, R

Mean square,
s2=R/(n-p)

0

10

44

2.9174

0.0663

1.1

8

46

2.9174

0.0634

1.2

7

47

2.9717

0.0632

1.3

6

48

3.6794

0.0767

2.1

7

47

2.4463

0.0520

2.2

8

46

1.1603

0.0252

2.3.1

9

45

1.1603

0.0258

2.3.2

9

45

1.1603

0.0258

2.3.3

9

45

1.1603

0.0258

3.1

9

45

0.9650

0.0214

Mode
ls
comp
ared

Model
0 v.s.
1.1
Model
1.1
v.s.
1.2
Model
1.2
v.s.
1.3
Model
1.3
v.s.
2.1
Model
2.1
v.s.
2.2
Model
2.2
v.s.
2.3.1
Model
2.2
v.s.
2.3.2
Model
2.2
v.s.
2.3.3
Model
2.2
v.s.
3.1

∆R

F_ critical

Bes
t
Mo
del
No.

0.0
000

0.000

F(0.95,2,46
)=3.200

1.1

0.0
543

0.215

F(0.95,1,47
)=4.047

1.2

0.7
077

2.308

F(0.95,1,48
)=4.043

1.3

1.2
331

5.923

F(0.95,1,47
)=4.047

2.1

1.2
860

12.746

F(0.95,1,46
)=4.052

2.2

0.0
000

0.000

F(0.95,1,45
)=4.057

2.2

0.0
000

0.000

F(0.95,1,45
)=4.057

2.2

0.0
000

0.000

F(0.95,1,45
)=4.057

2.2

0.1
953

2.277

F(0.95,1,45
)=4.057

3.1
*

* Based on the F-test, Model 3.1 cannot significantly improve the sum of squares,
R. However, Model 3.1 can eliminate the correlation among residuals and hence
improve the overall fitting.
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Table 3. A parsimonious model for S. oneidensis MR-1 growth
No.

Reaction

Equations

dX
( L
ke ) X
A
dt
X L
dLACT
(
rP,L rA,L
dt
YX/ L

1

Bacteria growth

2

Lactate consumption

3

Acetate production and
reuse

dACT
dt

(rA,L

Pyruvate production and
reuse
Specific growth rate with
lactate
Specific growth rate with
acetate
Acetate production from
lactate
Acetate production from
pyruvate

dPYR
dt

(rP,L rA,P )

4
6
7
8
9
10

Pyruvate production from
lactate

rA,P

LACT

L

2

A

1

rA,L

k al LACT X

rA,P

k ap PYR X
5

rP,L

.
436

X A
)
YX/ A

LACT 2
3 LACT
LACT
4

11

LACT)

Table 4. Parameters of Monod model for S. oneidensis MR-1 growth

Symbols

Notation

Unit

Value

SD
(%)

95%
Confidence
Intervals

Zero order
growth
β1

coefficient

0.0773[6][16][16](Tang

-1

h

et al., 2007)

0.33

0.0070

0.37

18.8010

0.35

1.6223

7.36

-0.6916

2.64

0.0057

0.36

from

[0.0768
0.0778]

acetate
First order
β2

growth
coefficient

L∙(h∙mmol
lactate)-1

[0.0070
0.0071]

from lactate
Coefficient
β3

for pyruvate
production

mmol lactate∙
-1

(h∙g DCW)

[18.6442
18.9666]

from lactate
Coefficient
β4

for pyruvate

mmol

production

lactate∙L-1

[1.4174
1.9163]

from lactate
Coefficient
β5

for pyruvate
production

L∙ (h∙g DCW)1

[-0.7315 0.6630]

from lactate
Non-growth
β11

g

related

DCW∙(h∙mmol

lactate

lactate)-1
.
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[0.0057
0.0058]

degradation
coefficient
Acetate
kal

production

L∙ (h∙g DCW)-

coefficient

1

0.4672

4.86

2.5487

3.36

0.0063

5.46

[0.4378
0.5334]

from lactate
Acetate
production
kap

coefficient

L∙ (h∙g DCW)1

from

[2.3986
2.7851]

pyruvate
Endogenous
ke

metabolism

h-1

rate

.
438

[0.0061
0.0074]

A
A
C

B

C

D

E

F

G

H

.
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Figure S1. Scaled sensitivity coefficients (SSCs) in the seed model and the
parsimonious model. Left column (A, C, E and G): the scaled sensitivity
coefficients of μmax,L (blue line) and μmax,A (green line) in the seed model. These
two parameters were chosen as examples to plot because they had the largest
values. Right column (B, D, F and H): the SSCs of β1 (blue line) and β2 (green
line) in the parsimonious model. These two parameters were chosen because they
had the largest value. The maximums of the scaled sensitivity coefficients plotted
in Figure 3 were the maximums of the absolute values in the corresponding scaled
sensitivity plots above. We desire SSCs to be large and uncorrelated for best
parameter estimation.
Note: SSCs for triplicate measurements were the same.
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A

B

C

D

E

F

A

A

Figure S2 The maximal scaled sensitivity coefficients (SSCs) of parameters in
reconstructed models. A: Model 0; B: Model 1.1; C: Model 1.2; D: Model 1.3; E:
Model 2.1; F: Model 2.2. Black bars: scaled sensitivity on biomass simulation;
red bars: scaled sensitivity on lactate simulation; green bars: scaled sensitivity on
acetate simulation; yellow bars: scaled sensitivity on pyruvate simulation. The
length of each colored bar came from the absolute maximum value of the
corresponding scaled sensitivity coefficient plots such as those in Figure S1.
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Note: the maximal SSCs of certain parameters (e.g. μmax,P and Ks,p in Figure S2A)
were too small to see.
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A1

A2

B1

B2

C1

C2

D1

D2

.
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E1

E2

Figure S3 Residual analysis for reconstructed models. A1 and A2: Model 1.1; B1
and B2: Model 1.2; C1 and C2: Model 1.3; D1 and D2: Model 2.1; E1 and E2:
Model 2.2. Green dots: normalized lactate residuals; orange diamonds:
normalized acetate residuals; red crosses: normalized pyruvate residuals; blue
squares: normalized biomass residuals.
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Text S1 Correlation matrix in reconstructed models.

Correlation matrix in Model 0
umax_L

umax_A

umax_P

Ksl

Ksa

Ksp

kpl

kal

kap

ke

umax_L

1.000

0.700

0.027

0.885

0.931

0.056

0.653

-0.187

0.373

-0.300

umax_A

0.700

1.000

-0.058

0.433

0.854

0.040

0.359

-0.456

0.888

-0.500

umax_P

0.027

-0.058

1.000

0.046

0.046

0.993

0.357

0.331

-0.169

0.019

Ksl

0.885

0.433

0.046

1.000

0.683

0.036

0.603

0.010

0.064

-0.303

Ksa

0.931

0.854

0.046

0.683

1.000

0.105

0.627

-0.278

0.593

-0.387

Ksp

0.056

0.040

0.993

0.036

0.105

1.000

0.341

0.246

-0.052

-0.043

kpl

0.653

0.359

0.357

0.603

0.627

0.341

1.000

0.341

0.001

0.070

kal

-0.187

-0.456

0.331

0.010

-0.278

0.246

0.341

1.000

-0.713

0.497

kap

0.373

0.888

-0.169

0.064

0.593

-0.052

0.001

-0.713

1.000

-0.519

ke

-0.300

-0.500

0.019

-0.303

-0.387

-0.043

0.070

0.497

-0.519

1.000

Correlation matrix in Model 1.1
umax_L umax_A
1.000
0.887
umax_L
0.887
1.000
umax_A
0.937
0.858
Ksl
0.962
0.899
Ksa
0.746
0.859
kpl
-0.046
0.313
kal
0.680
0.797
kap
-0.211
-0.166
ke

Ksl
0.937
0.858
1.000
0.834
0.625
-0.097
0.696
-0.405

Ksa
0.962
0.899
0.834
1.000
0.825
0.084
0.666
-0.179

kpl
0.746
0.859
0.625
0.825
1.000
0.246
0.829
0.009

kal
-0.046
0.313
-0.097
0.084
0.246
1.000
0.031
0.247

kap
0.680
0.797
0.696
0.666
0.829
0.031
1.000
-0.118

ke
-0.211
-0.166
-0.405
-0.179
0.009
0.247
-0.118
1.000

Correlation matrix in Model 1.2
umax_L
1.000
umax_L
-0.149
beta_1
0.776
Ksl
-0.406
kpl
-0.593
kal

beta_1
-0.149
1.000
0.294
0.477
0.551

Ksl
0.776
0.294
1.000
-0.259
-0.412

kpl
-0.406
0.477
-0.259
1.000
0.279
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kal
-0.593
0.551
-0.412
0.279
1.000

kap
0.031
0.582
0.300
0.655
-0.082

ke
-0.048
0.014
-0.500
0.287
0.292

0.031
-0.048

kap
ke

0.582
0.014

0.300
-0.500

0.655
0.287

-0.082
0.292

1.000
-0.005

-0.005
1.000

Correlation matrix in Model 1.3

beta_2
beta_1
kpl
kal
kap
ke

beta_2
1.000
-0.762
-0.558
-0.620
-0.514
0.535

beta_1
-0.762
1.000
0.687
0.863
0.601
0.120

kpl
-0.558
0.687
1.000
0.365
0.865
0.050

kal
-0.620
0.863
0.365
1.000
0.216
0.104

kap
-0.514
0.601
0.865
0.216
1.000
0.049

ke
0.535
0.120
0.050
0.104
0.049
1.000

Correlation matrix in Model 2.1

beta_2
beta_1
kal
kap
ke
beta_3
beta_4

beta_2
1.000
-0.704
-0.478
-0.431
0.411
-0.517
0.187

beta_1
-0.704
1.000
0.643
0.624
0.342
0.689
-0.141

kal
-0.478
0.643
1.000
-0.058
0.110
0.003
-0.214

kap
-0.431
0.624
-0.058
1.000
0.292
0.849
0.112

ke
0.411
0.342
0.110
0.292
1.000
0.231
0.026

beta_3
-0.517
0.689
0.003
0.849
0.231
1.000
0.217

beta_4
0.187
-0.141
-0.214
0.112
0.026
0.217
1.000

Correlation matrix in Model 2.2

beta_2
beta_1
kal
kap
ke
beta_3
beta_4
beta_5

beta_2
1.000
-0.690
-0.549
-0.243
0.466
-0.600
-0.271
0.461

beta_1
-0.690
1.000
0.695
0.514
0.301
0.392
-0.098
-0.273

kal
-0.549
0.695
1.000
-0.029
0.069
0.311
0.104
-0.361

kap
-0.243
0.514
-0.029
1.000
0.351
0.011
-0.361
0.130
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ke
0.466
0.301
0.069
0.351
1.000
-0.246
-0.430
0.213

beta_3
-0.600
0.392
0.311
0.011
-0.246
1.000
0.672
-0.936

beta_4
-0.271
-0.098
0.104
-0.361
-0.430
0.672
1.000
-0.588

beta_5
0.461
-0.273
-0.361
0.130
0.213
-0.936
-0.588
1.000

Correlation matrix in Model 3.1
beta_2

beta_1

kal

kap

ke

beta_3

beta_4

beta_5

beta_11

beta_2

1.000

-0.486

-0.586

-0.234

0.621

-0.417

0.245

0.275

-0.432

beta_1

-0.486

1.000

0.552

0.398

0.360

0.293

-0.515

0.003

-0.271

kal

-0.586

0.552

1.000

-0.042

-0.209

0.096

-0.338

-0.210

0.295

kap

-0.234

0.398

-0.042

1.000

0.075

0.308

-0.763

-0.152

0.129

ke

0.621

0.360

-0.209

0.075

1.000

-0.174

-0.101

0.331

-0.806

beta_3

-0.417

0.293

0.096

0.308

-0.174

1.000

-0.457

-0.852

0.187

beta_4

0.245

-0.515

-0.338

-0.763

-0.101

-0.457

1.000

0.437

-0.204

beta_5

0.275

0.003

-0.210

-0.152

0.331

-0.852

0.437

1.000

-0.432

beta_11

-0.432

-0.271

0.295

0.129

-0.806

0.187

-0.204

-0.432

1.000

.
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Text S2 Residual correlations in reconstructed models
Model
No.
0
1.1
1.2
1.3
2.1
2.2
3.1

Residuals of
biomass
simulation
Correlated
Correlated
Correlated
Non-correlated
Correlated
Correlated
Non-correlated

Residuals of
lactate
simulation
Correlated
Correlated
Correlated
Correlated
Correlated
Correlated
Non-correlated

Residuals of
acetate
simulation
Correlated
Correlated
Correlated
Correlated
Correlated
Correlated
Non-correlated

Residuals of
pyruvate
simulation
Correlated
Correlated
Correlated
Correlated
Correlated
Correlated
Correlated

Note: the criteria for checking residuals correlations were following the countingnumber-of-runs method as described in the main content. The residuals were
treated as correlated if the number of runs was smaller than value given by Eq 14
in the main content.
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Text S3 Parameters estimated by sequential analysis in the Parsimonious
model
Symbols

Unit

Value from OLS
0.0773[6][16][16](Tang

-1

β1

h

β2

L∙(h∙mmol lactate)-1

β3
β4
β5
β11

mmol lactate∙ (h∙g
DCW)-1
mmol lactate∙L-1
L∙ (h∙g DCW)

-1

g DCW∙(h∙mmol
lactate)-1

Value from Sequential
analysis

et al., 2007)

0.0768[6][16][16](Tang et al., 2007)

0.0070

0.0071

18.8010

19.1150

1.6223

1.7057

-0.6916

-0.7078

0.0057

0.0058

kal

L∙ (h∙g DCW)-1

0.4672

0.4631

kap

L∙ (h∙g DCW)-1

2.5487

2.5951

ke

h-1

0.0063

0.0064

.
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Abstract
This study constructed an E. coli strain for isobutanol fermentation via the
Ehrlich pathway, which included two genes from Lactococcus lactis: a kivd gene
encoding 2-ketoisovalerate decarboxylase and an adhA gene encoding aldehyde
reductase. We performed fermentation under aerobic and oxygen-limited
conditions, and then built an empirical Monod model with 19 parameters to
simulate glucose consumption, biomass growth, and product secretion and loss.
Based on fermentation kinetics and

13

C-isotopic experiments to analyze nutrient

utilization for isobutanol and biomass synthesis, we had following findings. 1)
Oxygen-limited conditions showed the highest isobutanol titer (0.95 g/L). 2)
Isobutanol production took place during both growth and stationary phases
(described by mixed-growth-associated product formation kinetics). 3) Aerobic
condition had better isobutanol yield from glucose than oxygen-limited
conditions. 4) Nutrient supplement (yeast extract) provided building blocks for
both biomass and isobutanol synthesis, but it also enhanced the waste product
secretion (such as acetate and lactate) and thus reduced glucose-based isobutanol
yield. This study offered both metabolic insights and bioprocess guidelines for
designing scaled-up isobutanol fermentation using engineered E. coli strains.

Key words: 13C-isotopic experiment, Ehrlich pathway, Mixed-growth-associated,
scaled-up bioprocess, yeast extract
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Introduction
Bioethanol produced by yeast fermentation is a common biofuel used as a
gasoline additive. Other biofuels, such as butanol and biodiesels, have higher
energy density and lower water solubility than ethanol, and thus receive extensive
study. Among these biofuels, butanol is compatible with automotive internal
combustion engines. Acetone-butanol-ethanol (ABE) fermentation is a bioprocess
that uses Clostridium acetobutylicum to produce n-butanol [17], but such a
process is restrained by a relatively low alcohol production rate during the
anaerobic fermentation. To overcome this disadvantage, the n-butanol pathway
derived from Clostridium has been reconstructed in fast-growing E. coli or yeast
strains [18,19,20,21]. Butanol biosynthesis via Clostridium pathway has
limitations including low product titer, accumulation of toxic metabolites, and the
requirement of large nutrient supplements (such as yeast extract). Another novel
approach is via the non-fermentative pathway to produce low-toxicity isobutanol
[22], where the amino acid biosynthesis pathways and the Ehrlich pathway
[23,24] are utilized for alcohols synthesis. The non-fermentative pathway was
previously found in yeast and lactic acid bacteria, which form fuel alcohols from
intermediates in amino acids pathways [23]. A non-fermentative pathway, with
ketoisovalerate as the central intermediate, has shown promising industrial
potential for effective isobutanol production.
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Diverse butanol production strategies have been reported (Table 1),
including overexpression of targeted pathway, elimination of competing
pathways, systems redesign of host metabolism, and in situ removal of inhibitory
products using gas stripping. However, very few studies have developed process
models to study the kinetics of engineered microbial platform for butanol
fermentation. To apply a newly developed host in the biofuel industry, a kineticbased model is of practical importance not only for designing optimal scaled-up
fermentation, but also for understanding the internal metabolic features of
microbial hosts in responses to various nutrient sources and cultivation
conditions. To fulfill the gap between microbial strain reconstruction and
industrial bioprocess engineering, we have first created an E. coli mutant that is
able to produce isobutanol via the standard non-fermentative pathway. The model
strain provided isobutanol fermentation data from a well-controlled bioreactor
under different cultivation conditions. Based on the experimental data, we
developed an empirical model to simulate the key bioprocess variables and
investigate the influential factors affecting isobutanol fermentation. To provide
metabolic insights into the kinetic model, 13C-experiments were also performed to
investigate the nutrient utilization for biomass and isobutanol synthesis.

Materials and Methods
Pathway construction
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The non-fermentative isobutanol pathway was introduced into E. coli
BL21 (DE3) (Fig. 1), in which glucose was converted to 2-ketoisovalerate via
glycolysis and valine biosynthesis pathway, and then transformed to isobutanol by
the Ehrlich pathway. Via heterologous expression of Kivd (2-ketoisovalerate
decarboxylase) and AdhA (aldehyde reductase), the E. coli strain can produce
isobutanol as well as other higher alcohols. In this study, kivd and adhA were
amplified from Lactococcus lactis by PCR with high fidelity DNA polymerase
Pfx (Invitrogen).
Primers for kivd:
5’-GACACTCGAGTAATGTATACAGTAGGAGATTAC-3’;
5’- TGCGGGTACCTTATGATTTATTTTGTTC-3’.
Primers for adhA:
5’TCAACTAGTGGTACCAGGAGATATAATATGAAAGCAGCAGTAGTAAG
AC-3’;
5’- ATTTGCGGCCGCGCATGCTTATTTAGTAAAATCAATGAC-3’.
The genes kivd (treated with XhoI / KpnI) and adhA (treated with KpnI /
SphI) were cloned into pTAC-MAT-Tag-2 Expression Vector (Sigma-Aldrich)
using XhoI / SphI to create the plasmid pTAC-KA, and then transformed into E.
.
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coli BL21 (DE3). To confirm the expression of Kivd and AdhA, we performed
SDS-PAGE analysis of the recombinant strain and observed the protein bands of
Kivd (60.9 kDa) and AdhA (30.8 kDa). Moreover, the measurement also showed
that the strain synthesized isobutanol, acetate, lactate, ethanol, and a small amount
of n-propanol and methyl-butanol. Therefore, the host had similar product profiles
to other isobutanol producing E.coli strains [22], and thus could be used as a
model to study the general kinetic behaviors of engineered E.coli for isobutanol
fermentation.
Fermentation conditions
Fermentations were performed in a 1 L New Bruswick Bioflo 110
fermentor with dissolved oxygen (DO) electrode, temperature electrode, and pH
meter. The 100% DO value was defined as the point where the cell-free medium
was saturated and achieved by purging air (~2 L/min) for 15 minutes. The culture
reached 0% DO in the oxygen limited condition (air rate 0 L/min) after the cell
had consumed the residual oxygen in the culture. Two culture media were used in
this study: A minimal medium contained 2% glucose, M9 salts (Difco), 10 mg/L
vitamin B1, and 50 mg/L ampicillin; a rich medium contained minimal medium
with 5 g/L yeast extract. The culture (400 mL) was inoculated with 5 ml overnight
LB culture (OD600~2) of the recombinant E. coli strain. The pH value, measured
by the pH meter, was maintained around 7.0 by addition of 2 mol/L NaOH via an
auto-pump. The temperature was held at 30 °C and the stirring speed was kept at
.
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200 rpm. Cultures in the bioreactor were first grown for 5~7 hours under aerobic
conditions (OD600 0.3~0.5; DO>50%), before adding 0.2 mM IPTG (Isopropyl βD-1-thiogalactopyranoside) to induce the isobutanol pathway.
After the E. coli entered the isobutanol production phase, we imposed
three different fermentation conditions. The first fermentation (F1: aerobic
condition and minimal medium) was carried out in aerobic condition. Air (airflow
rate: ~1 L/min) was bubbled in the bioreactor to provide oxygen and to remove
isobutanol (i.e., gas stripping) from bioreactor. In the second fermentation (F2:
oxygen-limited condition and minimal medium), air was turned off and the DO
was maintained around zero throughout the fermentation in a closed bioreactor. In
the third fermentation (F3: oxygen-limited condition and rich medium containing
5 g/L yeast extract), air was turned off and the DO was maintained around zero
for the duration of the fermentation in a closed bioreactor.
Analytical methods for biomass and metabolites
The biomass growth was monitored based on optical density (OD600).
There was a linear relationship between the dry weight of E. coli cells and OD600.
To measure the dry biomass weight, biomass samples were harvested by
centrifugation and washed with DI water and dried at 100°C until their weight
remained constant. The concentrations of glucose, ethanol, acetate, and lactate
were measured using enzyme kits (R-Biopharm). The alcohols could be detected
using GC (Hewlett Packard model 7890A, Agilent Technologies, equipped with a
.
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DB5-MS column, J&W Scientific) and a mass spectrometer (5975C, Agilent
Technologies). The GC-MS spectrum revealed that alcohols in the culture
samples were mainly ethanol and isobutanol. We also detected small amounts of
propanol and methyl-butanols. Isobutanol concentration was determined by a
modified GC-MS method [19]. Briefly, 400 µl of supernatant was extracted with
400 µl of toluene (Sigma-Aldrich) by 2-min vortex, followed by high-speed
centrifugation (16000×g). The organic layer was taken for GC-MS analysis under
the following program: hold at 70 °C for 2 min, ramp to 230 °C at 20 °C min-1,
and then hold at 300 °C for 6 min. The carrier gas was helium. The MS scan
mode was from m/z 20 to 200. Samples were quantified relative to a standard
curve of 16, 32, 64, 125, 250, 500, and 1000 mg/L isobutanol for MS detection,
and methanol was taken as an internal standard.
13

C-experiments for analyzing carbon substrates
In the

13

C-experiments, the minimal medium with 2% fully labeled

glucose (U-13C, Cambridge Isotope Laboratories) was supplemented with either
0.1% or 0.5% yeast extract (Bacto). By measuring

13

C-abundance in key

metabolites, we could estimate the contribution of yeast extract (non-labeled) to
biomass and isobutanol synthesis in the
cultures (with

13

13

C-glucose medium. Specifically, 5 mL

C-glcuose and yeast extract) were inoculated with 5 µl of

overnight LB culture of engineered strain in a 50 mL falcon tube with a closed
cap to prevent product vaporization (shaking at 200 rpm, 30°C). The cultures
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were induced by 0.2 mM IPTG (at t=7 hours), and the samples were taken (at
t=24 hours, middle-log growth phase) for isotopomer analysis. The isobutanol
content was determined using the previously described GC-MS procedure [19].
The ratio of two mass-to-charge peaks (m/z=74 for unlabeled isobutanol and
m/z=78 for labeled isobutanol) corresponded to the ratio of isobutanol synthesized
from unlabeled yeast extract vs. labeled glucose. Concurrently, we also performed
isotopic analysis of proteinogenic amino acids to identify the incorporation of
unlabeled carbon from yeast extract into biomass (i.e., protein). The
measurements were based on a previously published GC-MS based protocol [25],
using TBDMS (N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide, SigmaAldrich) to derivatize hydrolyzed amino acids from the biomass. The m/z ions
[M-57]+ from unfragmented amino acids were used for analysis [26] except
leucine and isoleucine. Because the [M-57]+ in leucine and isoleucine overlap
with other ions, the [M-159]+ group was used to obtain the isotopomer labeling
information of leucine and isoleucine.
Model formulation
We developed a Monod-based kinetic model, with six ordinary differential
equations, to describe three different batch fermentation processes. Here, we
should emphasize that the model only describe the fermentation data after IPTG
induction (i.e., the E. coli strain entered into the butanol production phase).
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dX
R X k d X R X ,YE
dt
dACT
R A YAL k act LACT X
dt
dLACT
RL k act LACT X
dt
dEtOH
RE
dt
dIB
RIB
X k IB IB
dt
RX
R A RE
RL RIB
dGlu
dt
YXG YAG YEG YLG YIBG

(1)
(2)
(3)
(4)
(5)
(6)

The model contained six time-dependent process variables:

X, ACT,

LACT, EtOH, IB, and Glu, which represented the concentrations (g/L) of biomass,
acetate, lactate, ethanol, isobutanol, and glucose, respectively. In the above
equations, kd was the cell death rate; YAL was the acetate yield from lactate (equal
to 0.67 g ACT/g LACT, based on a 1:1 mol ratio); YXG, YAG, YEG, YLG, and YIG were
the glucose-associated yields of biomass, acetate, ethanol, lactate, and isobutanol,
respectively. kIB was the first-order removal rate of isobutanol due to gas stripping
under aerobic fermentation F1. The isobutanol loss was minimal in a closed
bioreactor during oxygen-limited fermentations (kIB was equal to zero). Under
oxygen-limited conditions (i.e. F2 and F3), we used a first-order kinetic parameter
(kact) to describe acetate production from lactate.

RX

max,app

KS

Glu

Glu

1

1
X
ACT
K iA

(7)
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(8)
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EX

RX

(9)

RL

LX

RX

(10)

RIB

IBX

R X , YE

RX
max,YE

(11)

e

kYE t

(12)

X

Equations 7 represented a Monod-based growth kinetics. Since acetate
inhibited E. coli growth by decreasing the intracellular pH and interfering with
enzyme reactions, a non-competitive inhibition KiA (assumed to be constant in F1,
F2 and F3) was included in the model [27]. The dependence of the growth rate on
oxygen necessitates (i.e., aerobic growth vs. anaerobic growth) was implicitly
included in the calculation of the apparent maximal growth rate, μmax,app, (i.e., the
oxygen conditions affected μmax,app in different fermentation process). The Monod
constant KS was set to be constant for all three cultures (F1, F2 and F3). Equations
8~11 simulated the extracellular metabolite production associated with biomass
growth. RX, RA, RE, RL, and RIB were the production rates of biomass, acetate,
ethanol, lactate, and isobutanol from glucose, respectively; αAX, αEX, αLX, and αIBX
were the growth-associated coefficients of acetate, ethanol, lactate, and isobutanol
productions, respectively. β was the non-growth associated isobutanol production
coefficient. For experiments using rich medium (F3), the isotopic experiments
indicated that the yeast extract was quickly consumed to support biomass growth
at the early stage of the fermentation. Since precise measurement of yeast extract
concentrations was difficult, we included a yeast-extract-associated biomass
.
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growth rate (RX,YE) using a two-parameter exponential decay function (Equation
12). Table 2 summarized model parameters and their units.
For each batch culture, 18 unknown model parameters were determined by
minimizing the sum of the squares of the differences between the model’s
predictions and the experimentally observed growth and metabolite profiles (data
after IPTG induction) [28]. The “ode23” command in MATLAB (R2009a,
Mathworks) solved differential equations, while the “fmincon” command
searched suitable values of parameters. To avoid having local solutions during the
nonlinear parameter estimation, we perturbed the initial guesses for 30 times
within the range of possible values (as observed experimentally) to identify the
global solution. Meanwhile, to narrow the search-range for reasonable parameters,
we assumed that the values of each parameter acquired from different
fermentations differed by less than one order of magnitude.
To evaluate the quality of the parameter estimates, a statistical analysis
checked the reliability and the sensitivity of the estimated parameters to the
measurement inaccuracies. Fifty simulated fermentation data sets (including both
biomass and metabolite data) were generated by addition of normally distributed
noise to the measured fermentation data set (i.e., randomly perturbed the
measured data by 30%). The same data-fitting algorithm found new sets of
parameters. From the probability distribution of these parameter distributions,
confidence limits of model-fitted parameters were estimated.
.
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Results and discussion
Isobutanol fermentation results
We engineered an E. coli strain which was used as a model to study
isobutanol fermentation kinetics. The isobutanol pathway of the strain was in
Fig.1. The key precursor, 2-ketoisovalerate (KIV), is also an intermediate of
valine biosynthesis and degradation pathways. When E. coli converts one mole of
glucose to two moles of pyruvate through glycolysis, it generates two moles of
NADH, whereas the isobutanol synthesis consumes one mole of NADPH by ketoacid reductoisomerase and one mole of NADH by aldehyde reductase. To keep
balance, the cell metabolism has to remove the redundant NADH by O2
oxidization (aerobic condition) or by synthesis of reduced metabolites (leading to
lactate and ethanol secretion). In the F1 (Fig. 2), ethanol and lactate were barely
detected. Isobutanol concentration only reached (0.2 g/L), and the in situ removal
of isobutanol was considerable since the airflow carried isobutanol out of the
fermentor. Such gas stripping has been reported as an effective strategy to avoid
the isobutanol accumulation in the bioreactor to cause inhibitory effect on alcohol
production [29].
In the oxygen-limited conditions (Fig. 3 & 4), the F2 generated 0.95 g/L
isobutanol, 1.5 g/L ethanol, 2 g/L acetate, and 5 g/L lactate, while the lactate was
reused in the late fermentation stage (stationary growth phase). With the addition
.
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of yeast extract, the F3 had fast biomass growth (Fig. 4). The cell density reached
the peak (2 g DCW/L biomass) after seven hours of IPTG induction, and glucose
was consumed within ~12 hours (compared to ~40 hours in the F1 and F2). The
high rates for biomass growth and glucose uptake promoted isobutanol production
rate. It took the F3 15 hours to generate 0.6 g/L isobutanol (it took F2 40 hours to
generate same amount of isobutanol). The F3 produced 0.7 g/L isobutanol and 2.0
g/L ethanol. The addition of yeast extract also resulted in a large amount of
growth-associated organic acids (6.0 g/L lactate and 3.6 g/L acetate).
Kinetic modeling of isobutanol fermentation
The kinetic model simulated biomass growth, isobutanol production, and
metabolic byproduct (lactate, ethanol, and acetate) secretion and reuse in all three
culture conditions. Here, we should emphasize that all data points in Fig. 2~4
were after IPTG induction (i.e., cell entered isobutanol production metabolic
status). Table 2 listed the kinetic parameters, where the maximal glucose-based
cell growth rate μmax,app (0.007~0.026 h-1) in the anaerobic culture conditions was
lower than that in the aerobic culture condition (0.051 h-1). To simulate the
influence of yeast extract on alcohol fermentation, the Monod growth equation
included a yeast-extract associated biomass growth rate (μmax,YE=0.44 hr-1) that
was more than one order of magnitude higher than glucose-associated growth
rates.
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As for the intrinsic biomass yield YXG, YXG (0.18) under aerobic condition
was higher than that in the anaerobic condition F2 (0.11). Aerobic fermentation
produced less extracellular waste metabolites, while the citric acid cycle in cell
metabolism was highly active to provide energy and building blocks for biomass
and butanol synthesis. Isobutanol was produced in both aerobic and oxygenlimited conditions. The growth (αIBX) and non-growth (β) associated isobutanol
production coefficients were both positive, indicating the isobutanol production
took place during both growth and stationary phases. Although cell metabolism
shared the same pathway for synthesizing both biomass building block (valine)
and isobutanol, this pathway was still functional after biomass growth stopped.
The theoretical isobutanol yield from glucose is 0.41 g isobutanol/g glucose. In
this study, coefficient YIG under aerobic condition was 0.25 g isobutanol/g
glucose, which was higher than anaerobic conditions. For anaerobic condition F2,
non-growth associated isobutanol production β was ~0.11 (g isobutanol/g biomass
∙ h), while aerobic condition F1 showed much smaller non-growth associated
productivity (β ~0.002 g isobutanol/g biomass ∙ h). For anaerobic condition F3,
the addition of yeast extract significantly improved the growth associated
isobutanol production (αIBX = 0.91 g isobutanol/g biomass), but it also generated
significantly more acetate, lactate and ethanol. The yield coefficients associated
with waste products (YAG, YEG, YLG) were all the highest in the F3. Although the
addition of nutrients improved the biomass growth and cell energy (such as
NADH) generation, the NADPH-dependent valine synthesis pathway could not
.
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utilize NADH to produce isobutanol precursors (Figure 1). The excessive NADH
from fast cell metabolism had to be redirected to waste extracellular metabolites.
To alleviate such co-factor imbalance, an NADH-dependent keto-acid
reductoisomerase or transhydrogenase PntAB could be used to consume NADH
for isobutanol synthesis [30].
Analysis of the role of yeast extract for isobutanol synthesis
Nutrient supplements often plays important role in improving fermentation
performance. Rich media have been commonly used for butanol fermentations
[19,21,22,31]. In addition to providing the building blocks for biomass growth, it
has been reported that E. coli can also utilize the Ehrlich pathway to convert
protein hydrolysates to higher alcohols by engineering nitrogen flux [32]. To
reveal the contribution of nutrient to biomass and isobutanol production during
the cell growth stage, we used

13

C-experiemnts to determine the ratio of carbon

utilization from two different sources (nonlabeled yeast extract vs. fully labeled
13

C-glucose) under oxygen limited condition via GC-MS analysis (Fig. 5). When

yeast extract was minimal (1 g/L), isobutanol mostly came from labeled glucose
in the medium (isobutanol was all labeled with four carbons, m/z=78), and yeast
extract mainly supported biomass growth. In the more nutrient-rich medium, yeast
extract (5 g/L, commonly used for biobutanol production) provided major
building blocks for cell growth. Based on the labeling data, proteinogenic amino
acids (histidine, leucine, isoleucine, valine, lysine, and proline) in the biomass
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protein were highly imported from exogenous amino acids (>95%, corresponding
to the

12

C-dilutions), while other proteinogenic amino acids (alanine and serine)

were largely synthesized from

13

C-glucose (50~60%). Furthermore, high

concentration of yeast extract (5g/L) provided the precursors (i.e., keto-acids from
exogenous amino acid degradation pathway) for production of alcohols (nonlabeled isobutanol ~ 50%). A similar observation was also found in the glucoselabeled medium supplemented with Lysogeny broth (LB) powder (data not
shown). These results implied that the nutrient supplements provided building
blocks for both biomass and isobutanol synthesis in the glucose-based culture
medium. However, nutrient addition may not enhance butanol yields from its
main carbon source (glucose) due to higher waste metabolite production.

Concluding remarks
This study developed an empirical Monod model for capturing the
influential process factors during isobutanol fermentation using an engineered E.
coli strain. The model strain shared common kinetic features with other reported
isobutanol producers. These features included similar biomass growth behavior
and generation of multiple-metabolites, such as acetate, ethanol, and isobutanol.
The model results implied that byproducts were deleterious to isobutanol
synthesis (which could be the genetic targets for future improvement). Nutrients
(such as yeast extract) increased the production rates for both alcohols and
organic acids, but reduced isobutanol yields. The kinetic model may not only
.
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provide guidelines for controlling isobutanol fermentation conditions, but also
serve as a springboard to develop useful bioprocess models for higher alcohols
fermentations in the biotechnology industry.
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Table 1. Recent studies on butanol production by genetically engineered
microorganisms
Products

Substrate

Host cell

Titer

Research Highlights

Ref

Isobutanol

Glucose

E. coli

22
g/L

[22]

Isobutanol

Glucose

E. coli

Isobutanal

CO2

Synechococcus
elongatus

50
g/L
1.1
g/L

Isobutanol

Cellulose

Clostridium
cellulolyticum

0.66
g/L

Isobutanol

Glucose

E. coli

1.7
g/L

Isobutanol

Glucose

E. coli

13.4
g/L

Isobutanol

Amino
acids

E. coli

~1g/L

n-Butanol

Glucose

E. coli

1 g/L

n-Butanol

Galactose

n-Butanol

Glucose

Saccharomyces
cerevisiae
E. coli

2.5
mg/L
4.6
g/L

n-Butanol

Gluocse

E. coli

30
g/L

n-Butanol

CO2

Synechococcus
elongatus 7942

14.5
mg/L

Introduction of a non-fermentative
pathway to produce isobutanol;
elimination of competing pathways to
reduce waste metabolite secretion
In situ isobutanol removal from the
bioreactor using gas stripping
Overexpression of both nonfermentative pathway and Rubisco for
autotrophic isobutanol production
Direct conversion of cellulose to
isobutanol using engineered
cellulolytic bacterial species
A strain optimized for isobutanol
production via elementary mode
analysis
Utilization of the NADH-dependent
enzyme to enable anaerobic
isobutanol production
Utilization of protein hydrolysates for
C4 and C5 alcohols synthesis by
introducing enzymes for exogenous
transamination and deamination
cycles to biobutanol producing strains
A strain engineered for 1-butanol and
1-propanol production via isoleucine
biosynthesis pathway
Overexpression of n-butanol pathway
derived from Clostridium
Increase of the barrier for the reverse
reaction of butyryl-CoA to crotonylCoA via trans-enoyl-CoA reductase
Construction of butanol pathway by
employing trans-enoyl-CoA reductase
and creating NADH & acetyl-CoA
driving forces
Anaerobic production of 1-butanol
from CO2 using CoA-dependent
butanol pathway
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[29]
[33]

[34]

[35]

[30]

[32]

[36]

[21]
[19]

[20]

[37]

Table 2. Parameters of Monod kinetic model for E. coli isobutanol
fermentation
Symbo
l

Notations

Units

Aerobic,
condition F1

Anaerobic,
condition F2

KS

Monod parameter for Glu

g/L

0.30±0.08 a

KiA

Inhibition of acetate for growth

g/L

Maximal growth rate with glucose

/h

26±5 a
0.0070±0.002
0

μmax,app
YXG

Intrinsic biomass yield from Glu

YAG

Acetate yield from Glu

YEG

Ethanol yield from Glu

YLG

Lactate yield from Glu

YIG

Isobutanol yield from Glu

αAX

Growth associated acetate synthesis

αEX

Growth associated ethanol synthesis

αLX

Growth associated lactate synthesis

αIBX

Growth associated isobutanol synthesis

YAL

Acetate yield from lactate

kd

Cell death rate

kIB
kact

g
biomass/g
glucose
g acetate/g
glucose
g ethanol/g
glucose
g lactate/g
glucose
g
isobutanol/
g glucose
g acetate/g
biomass
g ethanol/g
biomass
g lactate/g
biomass
g
isobutanol/
g biomass
g acetate/g
lactate

0.051±0.005

μmax,YE
β

0.026±0.004

0.18±0.03

0.11±0.01

0.23±0.03

0.08±0.01

0.08±0.01

0.39±0.03

NA

0.27±0.01

0.46±0.03

NA

0.60±0.02

0.85±0.06

0.25±0.05

0.03±0.00

0.18±0.02

0.62±0.02

0.29±0.03

2.8±0.3

NA

6.7±1.0

3.2±0.3

NA

26±4

11±2

0.57±0.04

0.10±0.01

0.91±0.12

NA

0.67

0.67
0.0087±0.000
7
NA

/h

0.010±0.002

gas stripping rate coefficient for isobutanol

/h

0.11±0.02

0.0010±0.000
5
NA

First-order acetate production from lactate

(h∙g
biomass/L)

NA

0.012±0.001

0.0022±0.000
3

NA

NA

0.55±0.04

NA

NA

0.44±0.05

0.011±0.001

0.0038±0.000
6

-1

kYE

Anaerobic,
condition F3

Yeast extract first-order decay rate

/h

Apparent maximal growth rate with yeast
/h
extract
Non-growth associated isobutanol production
(g isobutanol)/( g
rate
biomass∙h)

0.0021±0.001
7

a): assuming same value for all three fermentations.
Glu: glucose; NA: not applicable.
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Figure legend
Figure 1. Pathways and kinetics for isobutanol and metabolites production in
the recombinant E. coli BL21 (DE3)/pTAC-KA. RX, RX,YE, RA, RE, RL, and RIB
were shown in the Equation 1~12. Abbreviations: G6P, glucose 6-phosphate;
F6P, fructose 6-phosphate; G3P, glyceraldehydes 3-phosphate; PYR, pyruvate;
ACA, acetyl-CoA; ALA, 2-acetolactate; DHI, 2,3-dihydroxy-isovalerate; KIV, 2keto-isovalerate; Val, valine; IBA, isobutanal; NADH, reduced nicotinamide
adenine dinucleotide; NADPH, reduced nicotinamide adenine dinucleotide
phosphate; PP pathway, pentose phosphate pathway; TCA cycle, tricarboxylic
acid cycle; Kivd, 2-keto-isovalerate decarboxylase; AdhA, aldehyde reductase.
Figure 2: Growth kinetics of aerobic culture after IPTG induction (condition F1).
The dots were experimental measurements, and the solid lines are simulations
from the Monod kinetic model.
Figure 3: Growth kinetics of anaerobic culture after IPTG induction (condition
F2). The dots are experimental measurements, and the solid lines are simulations
from the Monod kinetic model.
Figure 4: Growth kinetics of anaerobic culture with 0.5% yeast extract after IPTG
induction (the F3 includes two replicated cultivation experiments). The dots were
experimental measurements, and the solid lines were simulations from the Monod
kinetic model.
.
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Figure 5. The fraction of
metabolite. The fraction of

13

13

C carbon (13C carbons/total carbons) in each

C carbon represents the contribution of labeled

glucose to metabolite synthesis. The cells were grown on M9 medium (Difco),
containing 20 g/L fully labeled 13C-glucose, with 1 g/L (black bar) or 5 g/L (gray
bar) nonlabeled yeast extract. All samples were taken at 24 hrs (n=2, GC-MS
standard errors < 2%).
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Appendix 11
Evaluating Factors That Influence Microbial Synthesis Yields by
Linear Regression with Numerical and Ordinal Variables
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Appendix 12
Bacterial Responses to Cu-doped TiO2 Nanoparticles

.
491

.
492

.
493

.
494

.
495

